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Zusammenfassung 
Kalzium ist von zentraler Bedeutung im Prozess der axonalen Degeneration. In Vor-
arbeiten zu der hier vorliegenden Arbeit gelang es mittels intravitaler 2-Photonen-
Mikroskopie nachzuweisen, dass der Anstieg des intraaxonalen zytoplasmatischen 
Kalziums maßgeblich das Schicksal von Axonen in neuroinflammatorischen Läsio-
nen beeinflusst. Axone mit erhöhtem zytoplasmatischem Kalziumgehalt zeigten 
eine höhere Tendenz den Degenerationsprozess der so genannten fokalen axona-
len Degeneration (FAD) bis hin zur irreversiblen Fragmentierung zu durchlaufen. 
Als mögliche Quelle des beobachteten Kalziumanstiegs in läsionalen Axonen der 
experimentellen Autoimmunenzaphalomyelitis (EAE), einem Mausmodell der Mul-
tiplen Sklerose, war das endoplasmatische Retikulum (ER) mit einer Kalziumkon-
zentration, die das Zehntausendfache der zytoplasmatischen Kalziumkonzentration 
betragen kann, von besonderem Interesse.  
Um Messungen der Kalziumkonzentration des endoplasmatischen Retikulums 
durchführen zu können, exprimierten wir zunächst den Kalziumindikator Twitch2B 
54 S+ im endoplasmatischen Retikulum und charakterisierten den Sensor in 
HEK293-Zellen. Die Vorteile dieses Kalziumindikators liegen darin, dass er gene-
tisch kodiert ist und ratiometrische Messungen erlaubt, welche eine Voraussetzung 
für die in-vivo Mikroskopie darstellen. Mit Twitch2B 54 S+ ER unter der Kontrolle 
des neuronalen Thy1 Promoters generierten wir transgene Mauslinien, welche wir 
nach für die intravitale spinale 2-Photonen-Mikroskopie geeigneten spinalen axona-
ler Expressionsmustern auswählten und pharmakologisch charakterisierten. Unter 
in-vivo Bedingungen konnte nach ER-Kalzium Depletierung durch Zugabe des 
SERCA-Inhibitors Thapsigargin ein Sensor-Dynamikbereich von 300 Prozent 
(Rmax/Rmin) ermittelt werden. Im weiteren Verlauf untersuchten wir mit den Thy1-
TwitchER Mäusen auch die FAD. Eine Reduktion des ER-Kalziumgehalts konnte 
hier nur in irreversibel geschädigten, fragmentierten Axonen gemessen werden. So-
mit war es möglich, eine ER-Kalziumfreisetzung als Ursache für den in der FAD 
beobachteten frühen zytoplasmatischen Kalziumanstieg auszuschließen. Nachfol-
gende Experimente unserer Arbeitsgruppe konnten stattdessen plasmalemmale 
Nanoporen als Eintrittspforte des vermehrten zytoplasmatischen Kalziums in EAE-
Läsionen identifizieren. 
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Im Unterschied zur FAD konnte in einem spinalen Kontusionsmodell sowie in spi-
nalen Laserläsionen eine deutliche ER-Kalziumfreisetzung gemessen werden. 
Diese Depletierung ging mit strukturellen Alterationen in Form einer ER Fragmen-
tierung einher. Der Prozess der ER Fragmentierung war bisher nur in Dendriten in 
einem Herzstillstand-Modell beschrieben. Die beobachtete traumatische ER Frag-
mentierung und ER Kalziumdepletierung waren über einen Zeitraum von mehreren 
Stunden partiell reversibel.  
In der Zukunft könnte die Thy1-TwitchER Mauslinie es ermöglichen weitere neuro-
logische Erkrankungen auf strukturelle und funktionelle ER Alterationen zu untersu-
chen, wie wir sie in Kontusionen und Laserläsionen nachweisen konnten, sowie de-
ren biologische Relevanz zu evaluieren. Auch für physiologische Fragestellungen, 
wie zum Beispiel der Einfluss von ER-Kalzium bei der synaptischen Plastizität, stellt 
die Thy1-TwitchER Mauslinie ein wertvolles Modell dar. 
 
 
 xii 
Summary 
Despite the fact that little is known about the endoplasmic reticulum (ER) in axons, 
it is repeatedly implicated as a potential effector in neurodegeneration. Our labora-
tory has demonstrated the impairment of mitochondrial structure and axonal 
transport in experimental autoimmune encephalomyelitis (EAE), which has raised 
the question of whether the ER could also be involved. Since we have established 
that increased cytoplasmic calcium levels determine the axonal fate in EAE, the ER 
(which can maintain ten-thousand-fold the cytoplasmic calcium concentration) was 
considered a possible source of elevated detrimental cytoplasmic calcium. 
In order to measure ER calcium, the genetically encoded ratiometric and low-affinity 
calcium indicator Twitch2B 54S+ was targeted to the ER and characterised in cell 
culture. Subsequently, the novel transgenic mouse line Thy1-TwitchER was gener-
ated, screened for suitable subset axonal labelling and pharmacologically charac-
terised via a 2-photon spinal-cord in-vivo imaging approach. A dynamic range of 
300% (Rmax/Rmin) was determined by ER depletion with the sarco/endoplasmic 
reticulum Ca2+-ATPase inhibitor thapsigargin. Inducing EAE in Thy1-TwitchER 
mice revealed that axons undergoing focal-axonal degeneration (FAD) did not dis-
play a marked decrease of ER calcium unless the axonal continuity had already 
been disrupted. Consequently, cytoplasmic calcium elevations in FAD are not 
caused by ER calcium release, but rather by calcium entering the axons through 
plasma-membrane nanopores, as corresponding work in our laboratory concluded. 
However, in the paradigms of spinal-cord contusion and laser-transection injury, a 
marked depletion of ER calcium could be measured. This depletion coincided with 
the structural alteration of ER fragmentation, which had hitherto only been described 
in dendrites following cardiac arrest. Traumatic axonal ER fragmentation and ER 
calcium depletion were demonstrated to be partially reversible over a period of sev-
eral hours. In the future, the Thy1-TwitchER mouse line could be employed to 
screen further neuronal-disease paradigms for structural and functional ER altera-
tions. In addition, this mouse line could serve as a valuable tool for physiological  
research, for example regarding the role of ER calcium in synaptic plasticity.
 
  1 
1 Introduction 
1.1 Motivation 
Many neurological diseases ultimately lead to the degeneration of neurons and their 
processes, namely Alzheimer’s disease (AD), Parkinson’s disease (PD), traumatic 
brain - and spinal cord injury (TBI, SCI) as well as neuro-inflammatory diseases, 
such as multiple sclerosis (MS) (Dziedzic et al., 2010; Trapp et al., 1998; Williams 
et al., 2014). Of these, MS and SCI will be in the spotlight of this thesis. Due to the 
central nervous system’s limited capacity for regeneration, counteracting neuronal 
degeneration can be seen as the last line of defence to prevent irreparable damage. 
However, the process of neuronal degeneration is still poorly understood and thus 
strategies for therapeutic intervention remain scarce. 
Our laboratory has been previously able to demonstrate that axonal degeneration is 
not a one-way street. Even morphologically severe axonal damage with localized 
axonal beading in neuro-inflammatory lesions, a process termed focal axonal de-
generation (FAD), can potentially reverse to a configuration that appears normal, 
rather than undergoing complete fragmentation (Nikić et al., 2011). Consequently, 
a better understanding of axonal degeneration including its terminal converging 
pathways might help us identify promising therapeutic targets. 
One common effector of degeneration is the rise of cytoplasmic calcium, which we 
recently showed to be an important predictor for the fate of swollen axons in FAD. 
High calcium favours progression to complete fragmentation, whereas reconstitu-
tion to low calcium levels favours morphological recovery of beaded axons (Witte et 
al., 2019). This observation combined with the abundance of calcium homeostasis 
related pharmacological targets puts calcium into focus for intervention strategies 
(Zündorf & Reiser, 2011). Therefore, it is important to identify the source of calcium 
elevations in degenerating axons. Feasible sources appear to be the extracellular 
space and/or intraorganellar stores, such as the endoplasmic reticulum (ER) and 
mitochondria. With regard to the high calcium level of ER in neurons, in the range 
of 1000 – 5000 times of the cytoplasmic calcium concentration (Berridge, 2002), we 
suspected ER calcium to be a likely contributor to the deleterious calcium rise seen 
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in FAD. Recent work has emphasised the importance of ER-derived calcium in ax-
onal degeneration (Ouardouz et al., 2003; Stirling, Cummins, Chen & Stys, 2014; 
Villegas et al., 2014). 
The neuronal endoplasmic reticulum spans all the way from dendrites to axons and 
reaches even the most distant processes as one continuous structure (M. Terasaki, 
Slater, Fein, Schmidek & Reese, 1994). Apart from calcium sequestration and cal-
cium signalling it serves a plethora of functions which include the biosynthesis of 
membrane and secretory proteins in the rough ER, while smooth ER contributes 
predominantly to the secretory pathway of vesicle budding and fusion as well as 
lipid and sterol synthesis (Shibata, Voeltz & Rapoport, 2006). In addition, the ER 
interacts intricately with other organelles like the plasma membrane and mitochon-
dria. Disturbances in the mitochondria-associated ER membranes (MAMs) have 
been implicated in a variety of neurodegenerative diseases including AD, PD and 
Amyotrophic lateral sclerosis with associated frontotemporal dementia (ALS/FTD). 
Diseases with MAM disruption have in common, that they all exhibit similar down-
stream pathological hallmarks including damage to mitochondria, defects in axonal 
transport and pathological ER activation patterns, such as the unfolded protein re-
sponse (UPR), as well as disrupted calcium homeostasis (Paillusson et al., 2016).  
Lesions in the  mouse model of MS, experimental autoimmune encephalomyelitis 
(EAE), have been demonstrated to exhibit similar characteristics including wide-
spread axonal transport deficits (Sorbara et al., 2014) as well as the appearance of 
swollen, dysmorphic mitochondria (Nikić et al., 2011). The close interrelation be-
tween ER and mitochondrial pathologies as well as the search for the source of 
detrimental cytoplasmic calcium elevation in axons prone to degenerate in EAE led 
us to investigate the role of the ER in neuro-inflammatory lesions. 
Since neither ER morphology nor functional alteration had been studied before, we 
aimed at shedding light on both. To this end we generated a transgenic mouse line, 
which expresses a high Kd variant of the recently published FRET calcium indicator 
Twitch2B under the control of the neuronal Thy1.2 promoter (Thestrup et al., 2014). 
This tool allowed us to visualize the behaviour of the ER and its calcium content as 
surrogate for its functional state in EAE lesions. Furthermore, we evaluated the ER 
response in a spinal cord contusion model in comparison to EAE. 
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In this chapter I will outline in detail the topics of axonal degeneration, the ER, its 
pathological responses and interactions as well as the use of biosensors and suita-
ble imaging methods to study the ER. 
1.2 Endoplasmic reticulum 
Before the advent of high-resolution imaging techniques, the outer part of the cyto-
plasm was described as empty ground substance or hyaloplasm, due to the lack of 
optically definable structures (resulting from similar optical densities between orga-
nelles and the cytoplasm). Animal-cell ER was first discovered only by the means 
of electron microscopy in the thin periphery of chicken-embryo fibroblasts as ‘lace-
like reticulum’ (Porter, Claude & Fullam, 1945). The organelle was baptised endo-
plasmic reticulum due to its enrichment in the endoplasm, the non-spreading region 
of fibroblasts and relative scarcity in the ectoplasm, which defines the cytoplasm 
contained in fibroblasts’ pseudopodia (Porter, 1953). 
While Porter described the three-dimensionality of the ER and the variations in its 
thickness, the ER’s structure has been defined much more thoroughly today. All 
eukaryotic cells contain ER. It consists of a network of branching tubules and flat-
tened sacs; these enclose one continuous lumen that can constitute more than 10% 
of the cell volume (Alberts, Johnson, 2002). The ER consists of structurally distinct 
domains, including the nuclear envelope (NE), which forms the two lipid-bilayer 
sheets that wrap around the nucleus, the rough endoplasmic reticulum (RER), the 
intermediate ER and the smooth endoplasmic reticulum (SER), as well as domains 
that interact with other organelles, such as the subsurface cisternae, closely ap-
posed to the axolemma. While ribosome-studded RER is characterised by flattened 
sheets, the SER without attached ribosomes extends to the cell periphery and is 
often shaped as rather dilated and convoluted small tubules (Voeltz, Rolls & 
Rapoport, 2002). 
The RER with its membrane-bound ribosomes serves as a synthesis hub for virtually 
all secreted, luminal and membrane-bound proteins, except for those found in mito-
chondria and peroxisomes. Since all nucleated cells synthesise proteins, they all 
contain RER. Large amounts of RER correlate with high protein synthesis, either for 
secretion or for local requirements, as in neurons and pancreatic acinar cells and B 
cells. 
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An intermediate type of ER is transitional ER, which can be partly smooth and partly 
rough. It features Golgi exit sites, where newly synthesised proteins and lipids bud 
off to form vesicles directed to the Golgi apparatus. 
The SER has distinct functions. Cells specialising in lipid metabolism have abundant 
SER, such as steroid hormone-producing cells of the adrenal cortex, since the ster-
oid-synthesis enzymes are found in the SER membrane. Likewise, hepatocytes pos-
sess plentiful SER, which synthesises the lipid components of lipoproteins and har-
bors enzymes of the cytochrome P450 family for detoxification reactions. Depending 
on the presence of hydrophobic detoxification substrates, the amount of SER in 
hepatocytes is tightly regulated by lysosome-dependent autophagocytosis (Alberts, 
Johnson, 2002). Another example of a specialised SER function is the sarcoplasmic 
reticulum (SR) in muscle cells. The purpose of the SR is the sequestration of calcium 
ions, which can be released in a near-synchronous fashion following the process of 
excitation-contraction coupling. This process is dependent on two types of recep-
tors: dihydropyridine receptors (DHPR), types of voltage-gated L-type calcium chan-
nels in the plasma membrane, and ryanodine receptors (RyR), which act as ER 
calcium release channels, located on the SR membrane. Depolarisation of the sar-
colemma leads to a conformational change of the DHPR, which activates the RyR. 
The subsequent release of calcium leads to muscle contraction. The sequestration 
of the large amounts of SR calcium necessary for excitation-contraction coupling is 
enabled by the abundance of the calcium-binding protein calsequestrin (Khurana, 
2006). The function of SER in neurons is less established. One hypothesis is that 
its endomembrane system serves as an internal-signalling organelle via a precisely 
orchestrated release of calcium similar to the SR (Berridge, 2002). This concept of 
the ER as a ‘neuron inside a neuron’ will be further evaluated in the following chap-
ter. 
1.2.1 Neuronal ER 
Before addressing the intricacies of ER calcium handling, I will focus on the organi-
sation of the ER in neurons. Neuronal ER is an internally continuous organelle. This 
idea was originally proposed by microscopic studies, such as from serial section 
electron-microscopic reconstructions of Purkinje-cell dendrites in chickens. Here, 
around 90% of SER profiles in the reconstructions were contained within a single 
network (Martone, Zhang, Simpliciano, Carragher & Ellisman, 1993). Additionally, 
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Terasaki et al. (Terasaki et al., 1994) demonstrated that the dye 1,1’-dihexadecyl-
3,3,3’,3’-tetramethylindocarbocyanine perchlorate (DiIC16), which diffuses in strictly 
continuous lipid bilayers, was able to spread throughout the cell body and dendrites 
and into the axons of cerebellar Purkinje neurons in rats in acutely prepared brain 
slices. The dye clearly delineated ER in the somata as resolvable by confocal mi-
croscopy, and its distribution was independent of membrane trafficking since it also 
labelled fixed neurons. The neuronal ER is structurally diverse, albeit continuous. 
Somata and proximal dendrites possess abundant, ribosome-rich RER organised 
into large stacks, which is why they show Nissl bodies in the well-known aniline 
stain. The Nissl stain and RER alike exclude the axon hillock (Kühnel, 2003). 
The ER in more distal dendrites forms an irregular network of thin tubules and vari-
able flat, widened regions. Approximately 20% of dendritic spines are reached by at 
least one tubule, termed the ‘dendritic spine apparatus’ and characterised by the 
presence of the protein synaptopodin (Spacek & Harris, 1997). Dendritic ER is 
highly dynamic, and local ER configuration is influenced by synaptic signalling. For 
example NMDA-type glutamate receptors’ activations can lead to the segregation 
of the dendritic ER into vesicular bodies (Kucharz, Krogh, Ng & Toresson, 2009), 
possibly leading to sequestration of functional micro-compartments or local limita-
tion of harmful events. 
Axonal ER morphology appears more organised. In the internodal parts, SER tu-
bules run longitudinally in axons, branch occasionally and concentrate in the sub-
axolemmal space. Free vesicles and cisternae are rarely observed, at least in the 
phrenic nerve internode. At the nodes of Ranvier, cisternae-like structures are more 
commonly registered, and the SER is more beaded, runs straight, barely branches 
and forms small bundles (Tsukita & Ishikawa, 1976). Axonal ER is very narrow. In 
fact, tubules with a diameter between around 15 and 30 nm are the most abundant 
type of ER found in axons, while in non-neuronal cells, tubules are (on average) 60 
nm in diameter (Terasaki, 2018). Exemplary electron microscopic depictions of ER 
in an axon, soma, dendrite and dendritic spine, respectively, are shown in Figure 1. 
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The axonal SER bears resemblance to its somatic and dendritic counterparts re-
garding its protein repertoire. The luminal ER chaperones calreticulin, BiP, ERp29 
and protein disulfide isomerase – important for protein synthesis and quality control 
– as well as calnexin and glucose-6-phosphatase, have all been found in the three 
compartments, respectively (Ramirez & Couve, 2011).  
In spite of the continuity of the ER and similarities in luminal-protein content, the 
neuronal ER is astoundingly spatially heterogeneous. The ER’s capability of sorting 
mRNA is remarkable; for example, mRNA can be targeted to dendrites to enable 
 
Figure 1: Structure of ER in soma and neurites 
(A) A schematic neuron with multiple dendrites and one axon. Coloured boxes 
represent dendritic (green), somatic (red) and axonal (purple) regions. (B) Three-
dimensional reconstructions of a dendrite depicting ER (yellow), mitochondria 
(green) and endosomes (blue) (C) and of an ER spine apparatus, ER (yellow) (D) 
and reconstruction of a neuronal cell body depicting ER (yellow) and mitochondria 
(green) in mouse nucleus accumbens, from focused ion-beam electron-micro-
scopic image stacks. Pictures from Wu et al. (2017). (E) Three-dimensional recon-
structions of ER (yellow) in a mouse optic-nerve axon from serial blockface scan-
ning electron-microscopic image stacks. Picture from Yin et al. (2016). Scale bars 
in (B) 800 nm, in (C) 80 nm, in (D) 400 nm and in (E) 1 µm. Figure is modified from 
Ramirez & Couve (2011).  
 
 
  7 
the synthesis of locally demanded proteins (Steward, 1997). The synthesis of cho-
lesterol and phospholipids is also spatially distributed to distinct ER compartments 
(Verkhratsky, 2005). In contrast to the mentioned pan-neuronal ER proteins, other 
ER proteins have been found to be localised to SER sub-compartments, such as 
Inositol trisphosphate receptors (IP3R) and RyR, as well as calcium-binding proteins 
like calreticulin and calsequestrin (Ramirez & Couve, 2011). The neuronal ER fas-
cinates with the dualism of localised functional sub-compartments integrated into a 
coherent network spanning the entire neuron. This phenomenon is especially inter-
esting when discussing the ER’s role in calcium signalling and homeostasis. One 
possible implication of functional sub-compartments in neurons is that the ER can 
act as a modular signalling system. ER in neuronal spines can release its calcium 
content independent of the neighbouring spines, thus being immediately interesting 
for spatial integration of synaptic signals (Berridge, 2002). In fact, an IP3R-mediated 
coincidence detection of parallel and climbing fibre input has been demonstrated in 
Purkinje-cell dendrites of cerebellar brain slices in rats and is discussed as the func-
tional basis of long-term depression (Wang, Denk & Häusser, 2000). 
1.2.2 ER calcium homeostasis 
In order to better understand ER calcium and its role in neurodegeneration, I will 
outline the molecular components and their interactions in calcium homeostasis 
here. The ER is an essential store of calcium, which has various sinks and sources. 
Overall, the ER maintains a high calcium concentration reaching the millimolar 
range, which sets it apart from the nano- to micro-molar range of cytoplasmic cal-
cium, thereby creating an electrochemical gradient in favour of ER calcium release 
(Suzuki et al., 2014). The ER is an intrinsically leaky organelle and constantly loses 
calcium ions through aqueous pores in the translocon complex. This basal leak is 
regulated by the amount of protein synthesis and, consequently, the number of ri-
bosomes blocking the translocon pores (Lomax, Camello, Van Coppenolle, 
Petersen & Tepikin, 2002). The activity of the sarco/endoplasmic reticulum Ca2+-
ATPase (SERCA), which pumps in calcium against the electrochemical gradient by 
hydrolysis of adenosine triphosphate (ATP), counteracts the constant leak. The 
SERCA itself is subject to different control and feedback mechanisms, which involve 
the ER-membrane proteins phospholamban, sarcolipin and myoregulin (Okubo, 
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Mikami, Kanemaru & Iino, 2018). Furthermore, calcium-buffering luminal ER pro-
teins, including calreticulin and calnexin, regulate SERCA activity (John, Lechleiter 
& Camacho, 1998; Roderick, Lechleiter & Camacho, 2000). ER calcium-binding pro-
teins and chaperones are essential for maintaining the ER’s high calcium concen-
tration and regulation of the intra-ER free calcium level. Importantly, their calcium 
Kd-value is in the millimolar range (e.g. calreticulin, the most abundant buffering 
protein, Kd~1 mM), so that intra-ER free calcium at disposal remains high and is 
able to diffuse unimpededly. In contrast, cytoplasmic calcium-binding proteins dis-
play high calcium affinity in the ten to several hundred nanomolar range and cause 
more rapid buffering. The high amount of free ER calcium allows for the generation 
of a large number of constant calcium signals (Berridge, 2002). 
Supporting SERCA-mediated refilling, a coupling of ER calcium depletion and 
plasma-membrane calcium entry has recently been defined in molecular detail: 
store-operated calcium entry (SOCE), or capacitative calcium entry. ER calcium-
sensing ER transmembrane proteins – called stromal interaction molecules (STIMs) 
– oligomerise upon the reception of ER calcium depletion (Brandman, Liou, Park & 
Meyer, 2007). The oligomers activate Orai1 calcium channels in the plasma mem-
brane and lead to cytosolic calcium influx (Schindl et al., 2009). 
Apart from the passive calcium efflux from the ER, two extensively regulated calcium 
channels control the active calcium release: RyR and IP3R. Both of them are found 
abundantly in neurons. While all three subtypes of RyR (RyR1, 2 and 3) are ex-
pressed in neurons (Mori, Fukaya, Abe, Wakabayashi & Watanabe, 2000), IP3R is 
predominantly expressed as subtype 1 in the central nervous system (CNS) 
(Furuichi et al., 1993). IP3R are activated by inositol triphosphate (IP3), in unison 
with cooperative calcium binding. IP3 is generated after a Gq-coupled or receptor 
tyrosine kinase activation of phospholipase C, caused by neurotransmitters or neu-
rotrophins binding to their respective receptors (Berridge, 2016). RyR activation is 
caused by calcium ions with modulation by phosphorylation status and cytosolic 
factors, including reactive oxygen species (ROS). Thus, calcium entry through the 
plasma membrane can lead to an opening of RyR with subsequent calcium release 
from the ER and potentiation of the cytoplasmic calcium rise. The same principle 
holds true for IP3R, the opening probability of which is increased by cooperatively 
bound calcium in the presence of IP3. This phenomenon is called ‘calcium-induced 
calcium release’ (CICR; Verkhratsky, 2005).  
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A graphical summary of the proteins mentioned that are involved in ER calcium 
handling and an illustration of the process of CICR can be found in Figure 2. 
The ER’s remarkable endowment with calcium regulatory proteins and its capability 
of positive auto-feedback via CICR have given rise to the concept of the ER as a 
signalling organelle. CICR allows the ER to create regenerative calcium waves, 
which backpropagate signals to the nucleus. IP3R-mediated calcium waves have 
been demonstrated in pyramidal neurons of acute cortical slices. Glutamatergic or 
electric dendritic stimulation first led to localised calcium waves and, with higher 
intensities, to a regenerative calcium increase, which reached the soma and nucleus 
with possible implications for gene expression (Ross, 2012).  
ER calcium regulation is closely coupled to mitochondria. After calcium is released 
from the ER, mitochondria rapidly take up the excess of cytoplasmic calcium, buffer 
it and then redistribute it to the ER. Mitochondria are capable of signalling back to 
the ER by the means of hydrogen peroxide, which can transgress the lipid bilayer 
membranes and influence, for example, RyR conformation, thereby establishing a 
mutual communication between the two organelles. A calcium shift from the ER to 
 
Figure 2: ER calcium signalling and CICR 
(A) A schematic depiction of ER Ca2+ signalling and the involved channels and 
pumps located in ER and plasma membrane. Additional information to text: NO 
can facilitate calcium release through RYR, which is implicated in excitotoxicity. PS 
(presenilin) and CALHM1 (calcium homeostasis modulator 1) can form putative 
calcium leak channels. Mutated PS leads to ER calcium overload and impaired 
SOCE in AD. Figure adapted from and caption modified from Okubo et al. (2018) 
(B) Illustration of the formation and propagation of a regenerative calcium wave. 
Allosteric calcium binding combined with IP3 can trigger IP3 receptor opening. The 
released calcium ions again allosterically activate the same receptor and adjacent 
receptors and result in CICR, a process that is limited by the range of IP3 diffusion. 
Figure adapted from and caption modified from Ross (2012).  
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mitochondria can result in apoptosis via the induction of mitochondrial permeability 
transition pores (MPTP; Berridge, 2002). 
ER calcium also interacts with protein homeostasis. ER resident chaperones im-
portant for protein folding rely on high luminal-calcium concentrations, so that a re-
duction of ER-calcium content inhibits protein synthesis (Kimball & Jefferson, 1992). 
The accumulation of misfolded proteins triggers the unfolded protein response 
(UPR), which represents an important cellular stress response and constitutes an-
other method of ER-to-nucleus signalling. The UPR’s importance is widely implied 
in neurodegeneration (Li, Yang, Selzer & Hu, 2013). 
1.2.3 ER stress and the UPR 
The ER is responsible for the synthesis, posttranslational modification and folding 
of about 30% of the cell’s proteome. Despite the large number of chaperones and 
foldases involved in this process, the misfolded proteins can pile up in the ER lumen, 
a state called ‘ER stress’. The ensuing activation of the UPR must achieve several 
factors in order to reconstitute proteostasis. The pro-adaptive phase of the UPR 
aims at a reduction of the protein translation, degradation of misfolded proteins and 
increases of chaperone and foldase expression. Unless these measures suffice to 
re-establish proteostasis, the UPR can also progress into its pro-apoptotic phase 
(Carreras-Sureda, Pihán & Hetz, 2017; Hetz, Chevet & Oakes, 2015). 
There are three major ER type I transmembrane proteins, which transduce the UPR: 
activating factor 6 (ATF6), PKR-like endoplasmic reticulum kinase (PERK), and in-
ositol-requiring enzyme 1 (IRE1). All three proteins institute different signalling cas-
cades leading to the activation of transcription factors, which increase the expres-
sion of UPR-related genes. These include multifarious proteins like foldases and 
chaperones, as well as proteins involved in autophagy, quality control, lipid synthe-
sis, secretion, amino-acid metabolism, redox metabolism and, ultimately, cell death 
(Peter & David, 2011). 
Here, I will only outline these cascades in short. Paramount in sensing the UPR is 
the ER chaperone 78 kDa glucose-regulated protein, also known as binding immu-
noglobulin protein (GRP78/BiP), which binds to the luminal side of the three UPR-
transducer proteins under normal conditions. Under ER stress however, GRP78/BiP 
resorts to preferential binding of misfolded proteins, due to their increased display 
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of hydrophobic domains and insufficient glycosylation. Thereby, GRP78/BiP loses 
its inhibitory effect on the three UPR transducers (Kimata & Kohno, 2011).  
IRE1, one of these three UPR transducers, acts as a transmembrane endoribonu-
clease and leads to post-transcriptional alternative splicing of X-box binding protein 
1 (XBP1) mRNA, which is located at the ER membrane. The spliced gene product 
is imported to the nucleus as a transcription factor. In addition, IRE1 also degrades 
other RNAs in a process called IRE-1 dependent decay, thereby further reducing 
the protein burden. PERK1 phosphorylates eukaryotic initiation factor 2α (eIF2α), 
leading to a shut-down of global gene expression and simultaneously increasing the 
expression of the activating transcription factor 4 (ATF4). ATF6 is exported to the 
Golgi apparatus, where its cytoplasmic fragment, a potent transcription factor, is 
cleaved by the proteases S1P and S2P (Hetz et al., 2015).  
Calcium plays several important roles in the UPR. It sets the threshold for UPR ac-
tivation by adjusting the ER chaperones’ activity; it modulates ATP production via 
coupling to mitochondria, and it can induce apoptosis via MPTP induction (Carreras-
Sureda et al., 2017). Furthermore, the activity of IP3R type 1 downregulates when 
GRP78/BiP and an ER resident oxidoreductase are expressed at higher levels un-
der ER stress, possibly forming a negative-feedback loop. Reducing ER calcium 
efflux could help maintain a high intra-ER free calcium level, which is, in return, fa-
vourable for protein expression and maturation (Higo et al., 2010).  
Convergent with the idea that excitotoxicity, oxidative stress and calcium dysregu-
lation contribute to axonal degeneration, it has been proposed that the UPR could 
also be involved (Shaohua Li et al., 2013). In fact, spinal motor neurons have been 
shown to exhibit ER stress after ischemic injury (Yamauchi, Sakurai, Abe, 
Matsumiya & Sawa, 2007) and in an SCI contusion model (Penas et al., 2007). Re-
garding axonal injury, it has been hypothesised that ER stress might be retrogradely 
transmitted to the perikaryon and lead to secondary damage and degeneration of 
the neuron itself. In support of this idea, XBP-1 mRNA splicing following brain-de-
rived neurotrophic-factor application has been demonstrated to occur in neurites, 
and activated XBP-1 was retrogradely transported to the neuronal soma (Hayashi 
et al., 2007). Moreover, chronic ER stress has been linked to many neurodegener-
ative diseases, including PD, ALS, Huntington’s disease and prion-related disorders 
(Cabral-Miranda & Hetz, 2017). 
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In recent years, the UPR has become a credible pharmacological target, and poten-
tial attenuators of the ER stress response have been identified (Hetz, Chevet & 
Harding, 2013). An example of such substances are chemical chaperones. In an 
animal model of ischemia and reperfusion injury, the chemical chaperone sodium 4-
phenylbutyrate conferred a neuroprotective effect by reducing ER stress signalling 
(Qi, Hosoi, Okuma, Kaneko & Nomura, 2004). In a model of brain ischemia, dantro-
lene, which can increase the load of ER calcium by acting as an RyR antagonist, 
was also observed to alleviate ER stress (Li et al., 2005). 
Another site of UPR signalling on which current research focuses is the interface 
between the ER and mitochondria – the MAMs. The association between ER and 
mitochondria fine-tunes energy demands in UPR signalling and can ultimately in-
duce apoptosis. AD, PD, ALS and Charcot-Marie-Tooth disease are all known to 
combine signs of ER stress and morphological changes of MAMs (Hetz & Mollereau, 
2014). Interestingly, calcium-signalling molecules, chaperones and UPR transduc-
ers often colocalise at the MAMs, raising interest in these organelle contact sites 
(Carreras-Sureda et al., 2017). 
1.2.4 ER contact sites 
In order to exert its plentiful functions, the ER apposes tightly to other organelles’ 
membranes and forms contacts. The contacting organelles include endosomes, pe-
roxisomes and the Golgi apparatus (which exceed the scope of this thesis), as well 
as the mitochondria (MAMs) and the plasma membrane. These contact sites repre-
sent a rather localised and rapid means of interorganellar communication, in addi-
tion to classical secretory and endocytotic pathways and vesicular traffic to the 
plasma membrane (Wu et al., 2017). 
One function of these contacts is lipid switching between the membranes. This is 
achieved by lipids transporting proteins without requiring vesicle fusion. This alter-
native way of lipid exchange is crucial for membrane homeostasis in neuronal pro-
cesses far away from the Golgi apparatus, as well as for the lipid transfer to mito-
chondria, which are excluded from vesicular transport (Lahiri, Toulmay & Prinz, 
2015). In addition to the delivery and recycling of lipids, the ER-plasma membrane 
contact sites are also involved in calcium signalling via SOCE (see chapter 1.2.2) 
and concentrate STIM1 and Orai proteins, as well as RyR (Wu et al., 2017).  
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Five percent to twenty percent of the mitochondrial surface is situated in a range of 
10–30 nm from the ER and can thereby be classified as MAMs (Paillusson et al., 
2016). At this distance, electron microscopy has shown electron-dense proteina-
ceous tethering structures spanning the membranes (English & Voeltz, 2013a). The 
MAMs facilitate phospholipid exchange between the ER and mitochondria, enabling 
the synthesis of phospholipids that require the enzyme repertoire of both ER and 
mitochondrial membranes – namely, the conversion of phosphatidylserine to phos-
phatidylcholine (Rowland & Voeltz, 2012). Moreover, the protein mitofusin 2 is 
known to localise at MAMs and act as a tether, implying the ER’s involvement in 
mitochondrial fusion (de Brito & Scorrano, 2008). 
ER-mitochondria contact sites are tightly involved in cellular calcium homeostasis. 
In their restricted inter-membrane space, local calcium microenvironments can form, 
which help to prevent the spill-over of calcium to the cytosol and lead to relatively 
high local calcium concentrations. Calcium is needed in the mitochondrial matrix to 
stimulate calcium-regulated enzymes of the tricarboxylic-acid cycle and to promote 
ATP synthesis (Carreras-Sureda et al., 2017). In order to channel calcium into the 
mitochondrial matrix, calcium first passes the IP3R in the ER membrane, traverses 
the small stretch of cytosol between the organelles, enters the mitochondrial inter-
membrane space through the voltage-dependent anion channel (VDAC) and finally 
reaches the matrix via the mitochondrial calcium uniporter (MCU). Due to the MCU’s 
low calcium affinity, calcium concentrations in the micromolar range are prerequi-
sites for efficient calcium shuttling to the mitochondrial matrix. This highlights the 
pivotal role of MAMs in cellular metabolism (Patron et al., 2013). The disruption of 
the MAMs can lead to various neurodegenerative diseases (see chapter 1.2.4). 
Identification of potential tethers, functional characterisation of the calcium microdo-
mains and the search for therapeutic targets are topics of broad current interest. 
1.2.5 Structural ER dynamics 
There are several proteins at work to build the complex geometry of RER and SER. 
The membrane curvature of ER tubules is generated by a wedge-shaped protein 
family called reticulons. These act in concert with members of the 
DP1/Yop1/REEP5/6 and REEP1-4 protein families (Shibata et al., 2010). Overex-
pression or depletion of reticulons result in expansion or shrinkage of ER tubules in 
relation to sheets, respectively (Schwarz & Blower, 2016). 
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The typical three-partite junctions of ER tubules are formed by the process of ho-
motypic fusion. The protein atlastin, a dynamin-like GTPase, is essential for this 
process. The knockdown of atlastin results in a reduction of branch points and elon-
gated SER tubules (Hu et al., 2009). The protein Rab10 is also involved in ER as-
sembly and marks the position of new ER tubule growth (English & Voeltz, 2013b). 
Structural ER protein defects, including atlastin mutations, have been discovered in 
hereditary spastic paraplegia, a disease in which motor neuron axons degenerate, 
leading to progressive lower-limb spasticity. This is another indication of the im-
portance of functional ER in distal neurites (Westrate, Lee, Prinz & Voeltz, 2015).  
The ER is an incredibly dynamic organelle. It undergoes continuous remodelling of 
its network through a number of different processes. Among these are the dynein-
and kinesin-dependent mechanisms of microtubule sliding, extension of tubules by 
the tip-attachment complex at the plus end of growing microtubules, and actin/myo-
sin-mediated interactions (Ramirez & Couve, 2011; Westrate et al., 2015). Apart 
from minor remodelling, more severe kinds of ER morphology alterations have been 
reported. Despite the earlier notion of the ER as being a continuous organelle, there 
are instances, in which this continuity is disrupted. ER fragmentation, or ER fission, 
into small vesicles has been observed in neurons in different models. Murine pri-
mary neuronal-cell cultures instantaneously displayed a vesicular disintegration of 
their ER following the administration of either glutamate or NMDA in live-cell fluo-
rescent imaging in the entire field of view. This fragmentation was not accompanied 
by morphological changes of the dendrite, which remained structurally intact 
(Kucharz et al., 2009). ER in hippocampal-slice cultures also fragmented following 
depolarisation with 50 mM potassium, which can likewise lead to endogenous glu-
tamate release (Kucharz, Wieloch & Toresson, 2011a), and finally two-photon im-
aging of ER-targeted green-fluorescent protein (GFP) in the intact mouse brain re-
vealed the same disintegration process of the ER, with ensuing cardiac arrest and 
ischemia (Kucharz, Wieloch & Toresson, 2011b).  
Remarkably, this fragmentation was entirely reversible following the application of 
the NMDA-receptor antagonist MK-801 or removal of the depolarising medium in 
case of the slice and primary cultures within a time frame of 15–30 minutes. This 
implies a cellular coping mechanism and even the appearance of ER fragmentation 
as a physiological regulatory process. After fragmentation, the fragments showed a 
curious tendency to cluster in regularly spaced intervals, potentially by microtubular 
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rearrangement following extracellular-calcium influx. Interestingly, the fragmentation 
process was seemingly unaffected by depletion of ER calcium with the SERCA in-
hibitor thapsigargin and appeared to rely primarily on calcium entry through the 
plasma membrane (Kucharz, Wieloch & Toresson, 2013). Speculations on the func-
tion of ER fragmentation include the local sequestration of excitotoxicity by impeding 
the formation of CICR-mediated calcium waves and the generation of confined ER 
vesicles, which can exert their functions locally (for example in synaptic plasticity). 
However, the molecular mechanisms underlying this curious process remain un-
known to date. 
1.3 Axonal degeneration 
Pathological loss of axons is an early hallmark of almost all neurodegenerative dis-
eases, as well as neural injuries. It represents the primary cause of functional disa-
bility in patients (Neukomm & Freeman, 2014). This thesis explores axonal degen-
eration in different disease paradigms: axonal degeneration in EAE, a mouse model 
of MS, and axonal degeneration in spinal-cord injury induced by either blunt-force 
contusion or focal-laser lesioning. Accordingly, the following chapter will focus on 
these pathologies and provide a detailed review of the molecular processes in-
volved.  
1.3.1 Modes of axonal degeneration 
A loss of axons is not only observed under pathological conditions, but is also es-
sential for developmental remodelling of neuronal circuits through a tightly regulated 
process called ‘axonal pruning’. Pruning enables the nervous system to cherry-pick 
the best neuronal connections from an initial excess of immature processes (Luo & 
O’Leary, 2005). Several morphologically defined and molecularly distinct pruning 
processes exist. These include simple axon retraction, shedding of axosomes and 
local axon degeneration. Local axon degeneration is the favoured way of pruning 
for long-projecting axons. Morphologically, the whole axon fragment supposed for 
removal undergoes simultaneous granular disintegration over a course of a few 
hours; afterwards, the fragments are removed by the surrounding glial cells (Saxena 
& Caroni, 2007). Pruning has been studied extensively in vivo as well as in vitro 
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models induced e.g. by nerve growth-factor deprivation in microfluidic chambers 
(Taylor et al., 2005).  
Remarkably, axonal degeneration under pathological conditions can look strikingly 
similar to this pruning process. Hence, there have been endeavours to identify func-
tional similarities between these modes of axonal degeneration. The most exten-
sively studied type of pathological axonal degeneration is called Wallerian degener-
ation (WD). It ensues axotomy, the most severe axonal damage, and results in syn-
chronous pan-fragmentation of the part of the axon distal to the site of injury (Ching‐
Yuen, 1963). WD-matching patterns have been described in a number of diseases 
including AD, PD and MS (Neukomm & Freeman, 2014). The time frame of WD is 
very peculiar and defining. After the initial severing of the axon, the distal fragment 
remains structurally intact for 12 hours to 2 days, the so-called lag phase. Only after 
this period does the pearl-like swelling (‘beads on a string’) occur, followed by the 
explosive disintegration of the axonal portion distal to the injury site. The swelling 
and fragmentation likely reflect a destabilisation of the cytoskeleton by calcium-in-
flux-dependent proteases like calpain (Misgeld, 2011).  
Initially, it was hypothesised that a mere lack of trophic support from the soma could 
lead to the distal axonal dismantling. However, the staggering discovery of a mu-
tated strain of mice with massively delayed WD, in which severed distal axonal por-
tions remained intact for weeks after axotomy, completely changed the understand-
ing of WD (Lunn, Perry, Brown, Rosen & Gordon, 1989). Since the distal axonal 
fragment appeared sufficiently autonomous to survive over an extended period of 
time without its soma, there had to be an actively regulated mechanism at work 
driving the axon disassembly; moreover, this mechanism can be impeded. The 
mouse strain is referred to as C57BL/WldS for slow Wallerian degeneration pheno-
type. Later, the mutation that corresponded to the WldS phenotype was identified. It 
results in a fusion protein consisting of the N-terminal part of E4 ubiquitin ligase 
Ube4b and the NAD+ scavenging enzyme nicotinamide mononucleotide adenyl-
transferase 1 (NMNAT1). This chimeric enzyme protects axons from WD in a dom-
inant manner (Mack et al., 2001a). NMNAT-conferred axon protection is described 
in more detail in chapter 1.3.2. 
Notably, WldS does not impede developmental pruning and consequently distin-
guishes it from WD, although they share morphological similarities (Hoopfer et al., 
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2006). The relevance of the WldS mutation has been examined in many neurologi-
cal-disease models. Models of traumatic nerve injury, glaucoma, toxic neuropathy 
or PD were alleviated by the WldS mutation, while hereditary spastic paraplegia and 
ALS were unresponsive to it (Conforti, Gilley & Coleman, 2014), and some degree 
of protection is assumed for EAE (Kaneko et al., 2006). The underlying theory is 
that spontaneous axonal transections occur in WldS sensitive diseases, which are 
instigated by local activations of axonal programs similar to WD (T. Misgeld, 2011). 
Another mode of axonal degeneration precedes WD and is initiated within minutes 
after nerve transection: acute axonal degeneration (AAD). Here, both the proximal 
and distal parts of the transected axon equally undergo a rapid process of dying 
back over a distance of several hundred micrometres in a WldS-sensitive manner. 
This mode of degeneration might potentially deteriorate localised axonal damage, 
due to its ability to spread across branch points and thereby denervate initially 
spared side branches proximal to the lesion. Within 6 to 24 hours after the axotomy 
event, erratic regeneration attempts of the proximal axon tip have been observed, 
either by fast and straight outgrowth or by the formation of numerous lateral sprouts. 
However, neither method can effectively approximate the two severed ends 
(Kerschensteiner, Schwab, Lichtman & Misgeld, 2005). A hypothesis for the spa-
tially restricted manner of AAD is that incipient calcium influx through the severed 
axolemma activates calpains locally. The cytoplasm’s calcium-buffering capacity 
and spontaneous membrane resealing of the tip can subsequently stall the progres-
sion (Misgeld, 2011). Despite being locally destructive, AAD could also have bene-
ficial effects on subsequent regeneration. It has been posited that destabilisation of 
the cytoskeleton of the proximal axon can facilitate growth-cone formation (Spira, 
Ruthi, Ada & Daniel, 2003). Moreover, the void created by the proximal axon’s re-
traction could be filled by glial cells, providing a more favourable milieu for regener-
ation (Wang, Medress & Barres, 2012). 
Another compelling mode of axonal degeneration has recently been discovered: fo-
cal axonal degeneration (FAD). It can be identified as a stereotypical process in 
inflammatory lesions in EAE, the mouse model of multiple sclerosis. Three morpho-
logical distinct stages have been defined: stage 0, which is morphologically unal-
tered; stage 1, in which the axons display one or several focal swellings but still 
maintain a continuous structure; and stage 2, which is characterised by the disrup-
tion of the axon’s continuity. The eventual disruption of the axon membrane is often 
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initiated at the nodes of Ranvier and can synchronously occur at several different 
positions of the same axon. Importantly, congruent morphological patterns can be 
determined in actively demyelinating MS lesions in patients. Figure 3 shows the 
characteristic morphological patterns in EAE and MS. 
Remarkably, the swellings in the prodromal stage 1 are yet undetermined in their 
fate. Repeated imaging over the time course of several days showed that these 
swellings either persisted, progressed to complete fragmentation (i.e. stage 2) or 
reverted to stage 0 and recovered. The susceptibility to FAD depends on the axon 
diameter and favours small-calibre axons. Unexpectedly, the myelin sheath in axons 
undergoing FAD is generally intact, which necessitates the presence of membrane-
permeable mediators of axon injury. By employing a fluorescent reporter mouse line 
labelling mitochondria, it can be demonstrated that stage 1 axons and even mor-
phologically intact stage 0 axons displayed swollen dysmorphic mitochondria. 
These were also functionally impaired, as their membrane potential was reduced. 
Thus, mitochondrial damage precedes morphological alterations. Strikingly, the 
morphological characteristics of FAD can be reproduced in a model of ROS/RNS 
application on healthy spinal axons; accordingly, ROS/RNS scavenging can rescue 
a large proportion of stage 1 axons in EAE (Nikić et al., 2011). 
 
 
Figure 3: Stages of FAD in EAE and MS 
(A) Schematic FAD stages used throughout this thesis. (B) Normal appearing 
(green, top), swollen (yellow, middle), and fragmented (red, bottom) axons in an 
EAE lesion (confocal projection images), (C) Exemplary axons of stages 0, 1 and 
2 of FAD in a human multiple sclerosis lesion (Bielschowsky staining). Scale bars 
10 μm, Figure 3B, C adapted from and caption modified from Nikić et al. (2011). 
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1.3.2 Molecular mechanisms of axonal degeneration 
In this chapter, I will focus on the molecular mechanisms of WD in particular, as the 
WLDS mutation also has positive impacts on AAD. This allows us to surmise at least 
a similar molecular program to WD. Subsequently FAD will be treated in-depth, to-
gether with its related disease entity (see chapter 1.3.3).  
Regarding the molecular mechanisms underlying WD, researchers tend to focus on 
disparate mechanisms, which comprise either calcium or the interplay between sur-
vival and degeneration proteins as primary effectors of degeneration. Here, I will try 
to interweave the two concepts and describe a common basis. 
It has been established that the nicotinamide adenine dinucleotide (NAD+) biosyn-
thetic enzyme component NMNAT1 of the chimeric WLDS protein confers its axo-
protective function. This occurs through a gain-of-function mutation, which leads to 
a mistargeting of NMNAT1 to axons, instead of to its physiological nuclear localisa-
tion (Sasaki & Milbrandt, 2010). NMNAT2, which also confers axoprotection, is a 
more labile isoform of NMNAT1 and appears in axons physiologically (Gilley & 
Coleman, 2010). Consequently, it is presumed that NMNAT1 can substitute and 
prolong the enzymatic activity of NMNAT2, even after the proteasomal depletion of 
NMNAT2 in the severed axonal portion. This concept is in accordance with the the-
ory of the loss of trophic support after denervation, since NMNAT2 or its products, 
which supposedly represent survival factors, cannot reach the severed distal axon 
and slowly deplete. Such a mechanism could serve as molecular clock and assist 
in explaining the lag phase in WD. However, NMNAT2 overexpression does not lead 
to an increased level of its product NAD+, since the rate-limiting step in NAD+ syn-
thesis is the upstream conversion of nicotinamide to nicotine amide mononucleotide 
(MNM) (Mack et al., 2001b). Thus, the protective effect is not caused by NAD+ levels 
alone.  
An alternative to an axonal survival factor is a pro-degenerative program. In contrast 
to a gain-of-function mutation, a degenerative signal can be identified by loss-of-
function mutations, which promote axonal degeneration. The first protein that could 
be identified as promoter of axonal degeneration was dual leucine zipper kinase 
(DLK) (Miller et al., 2009), which is one out of three proteins of the MAPKKK family. 
These all serve as degeneration triggers, and their combined knockdown leads to a 
robust axoprotective phenotype (Yang et al., 2015). Notably, DLK has contrary func-
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tions in the axon parts proximal and distal to axotomy. While promoting degenera-
tion in the severed part, it supports regeneration in the proximal stump. The activa-
tors of DLK discussed include disruption of the cytoskeleton and calcium influx. 
Downstream effectors of MAPKKK proteins are proteins of the MAPK family. Excit-
ingly, MAPK proteins have been shown to be differentially regulated: in an inhibitory 
manner (by the axoprotective NMNAT2), and in a stimulatory manner (by another 
prodegenerative protein, SARM1, which is discussed below). This could serve as a 
mechanistic link between these pathways (Gerdts, Summers, Milbrandt & 
DiAntonio, 2016). 
Sterile alpha and TIR motif-containing protein 1 (SARM1) was discovered in a large 
genetic screen in Drosophila (Osterloh et al., 2012). SARM1 knockout protects ax-
ons from WD for up to 14 days in mice, which is similar to NMNAT-conferred pro-
tection (Gerdts, Summers, Sasaki, DiAntonio & Milbrandt, 2013). SARM1 has been 
demonstrated to be functionally connected to the rapid decline of NAD+ levels after 
axotomy. SARM1 negative axons display a markedly reduced loss of NAD+. Conse-
quently, SARM1 acts upstream of NAD+ loss (Gerdts, Brace, Sasaki, DiAntonio & 
Milbrandt, 2015). 
An important point to explore is the way, in which calcium fits into this complex in-
terplay of pro-degenerative and pro-survival cues. Extracellular calcium entry was 
found to be both necessary and sufficient for WD induction. For this purpose, the 
calcium level had to reach a concentration > 200 µM. (George, Glass & Griffin, 
1995). In response to the calcium elevation, the proteases of the calpain family de-
grade the cytoskeletal components and destroy the axonal integrity. The calpain 
inhibitor calpastatin, which is constitutively active, must be diminished in preparation 
for the axonal-dismantling process (Ma et al., 2013).  
The lingering question is at which point of process the cascade calcium comes into 
play. It was found that the exogenous addition of calcium was sufficient to abolish 
protection of WLDS, which likely positions calcium downstream of WLDS (Glass, 
Schryer & Griffin, 1994). 
The initial gash in the membrane is an unlikely contributor to the eventual degener-
ation following axotomy. In fact, the highest calcium concentrations can be found at 
a distance of more than 100 µm from the injury site, and the membrane cut is re-
sealed within two minutes post-axotomy by calcium-dependent vesicular fusion 
(Eddleman, Ballinger, Smyers, Fishman & Bittner, 1998; Ziv & Spira, 1993).  
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Organellar and extracellular calcium are estimated to be more potent contributors 
to calcium elevation. Mitochondria can sequester calcium through selective calcium 
uniporters, such as the MCU. Likewise, they are capable of rapid calcium release 
by MPTP formation, when mitochondrial calcium reaches a certain threshold. The 
pharmacological and genetic targeting of cyclophilin D, which is a component of the 
MPTP, causes a protection of severed axons for up to four hours (Barrientos et al., 
2011). In addition, ER calcium depletion is implicated as potential source for the 
deleterious cytoplasmic-calcium rise (see chapter 1.3.5). 
Extracellular calcium has been assumed to enter primarily through L-type calcium 
channels, since channel blockers are capable of a potent four-day protection after 
axotomy (George et al., 1995). Williams et al. (2014) managed to bring another 
compelling mode of calcium into play, though in a model of spinal cord contusion. 
Axolemmal mechanopores which fail to reseal and allow the diffusion of macromo-
lecular dyes are major contributors to elevated calcium levels. However, the exact 
nature of these pores and their contribution in other injury paradigms have yet to be 
established. 
An exciting link between the NMNATs and calcium has been proposed. NAD+ levels 
can influence the axonal calcium homeostasis by modulating ion-channel activity 
(Tamsett, Picchione & Bhattacharjee, 2009). Interestingly, a terminal decrease in 
NAD+ levels has been reported prior to the deleterious calcium cascade. Although 
it seems appealing, this potential link between NAD+ decrease and calcium dysreg-
ulation still requires experimental validation (Wang et al., 2012). 
In summation, the puzzle of how NMNAT, SARM, MAPKKK proteins and calcium, 
ROS and the MPTP interact remains unsolved. It seems as though the interplay of 
NMNAT, SARM, MAPKKK leads to the generation of an as-yet-unknown execution 
signal (potentially the NAD+ decrease), which is then answered by a downstream 
cascade with calcium as primary effector. 
1.3.3 Axonal degeneration in MS and EAE 
MS is a major cause of neurologic disability. Patients who suffer from MS experience 
acute episodes of neurological dysfunction, followed by often incomplete remis-
sions, the so-called relapsing-remitting MS (RRMS). In later stages, the disease can 
convert to a mode of secondary progression characterised by the perfidious accu-
mulation of disability, termed secondary progressive MS (SPMS). Approximately 
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10% of patients suffer from primary progressive MS (PPMS), which is ‘amputated’ 
from the relapsing-remitting phase that usually precedes it. Here, the disease adopts 
a steady functional decline with a complete lack of periods of recovery. PPMS ap-
pears to be a consequence of more diffuse immune mechanisms and neurodegen-
eration. Clinical symptoms of MS include, among others, paraesthesia, dysaesthe-
sia, paresis and visual disturbances with scotoma as a consequence of optic neuritis 
(Lee, Taghian & Petratos, 2014; Wilkins & Scolding, 2008). 
MS is characterised by inflammatory lesions, which can preferentially be found in 
certain CNS locations, including the paraventricular region, the callosal commis-
sure, brain stem and optic nerve as well as subcortically (Compston & Coles, 2008). 
These lesions contain a large number of inflammatory cells, which comprise primar-
ily macrophages and T-lymphocytes but also B-lymphocytes and plasma cells 
(Lassmann, 2013). A pathognomonic feature of these lesions is demyelination. Au-
toreactive lymphocytes enter the CNS via the blood-brain barrier and elicit the local 
production of harmful cytokines and ROS/RNS, which can impair oligodendrocyte 
function (Hemmer, Kerschensteiner & Korn, 2015). 
Although demyelination is the classical hallmark of MS, its assumed dominance in 
the pathogenesis of MS has come under scrutiny in recent years. The insights 
gleaned from magnetic resonance imaging and histological studies demonstrate 
that, concomitant to inflammation, the loss of axons is an important determinant of 
clinical symptoms and the switch to progressive disease (Ontaneda, Cohen & 
Amato, 2017). Here, I will focus on the pathogenetic aspects of this axonal loss in 
multiple sclerosis. 
Histologically, it has been shown that axonal density is significantly reduced in 
periplaque white matter (PPWM) as well as MS plaques (Bitsch, Schuchardt, 
Bunkowski, Kuhlmann & Bruck, 2000). Trapp et al. (1998) established the presence 
of axonal transections in MS lesions. The susceptibility to degeneration varies with 
the anatomical location (e.g. upper posterior column > lower posterior column) and 
axon diameter, where small-calibre axons (<3 µm2) are more prone to degenerate 
(DeLuca, Ebers & Esiri, 2004). 
Amyloid precursor protein (APP), which is transported along the axon, accumulates 
in disease and can be used as marker for acute disruption of axonal function. Stain-
ing against APP detected axonal damage in active and, to a lesser extent, in chronic 
MS lesions (Kuhlmann, Lingfeld, Bitsch, Schuchardt & Bruck, 2002). The intensity 
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of APP staining correlates with the number of inflammatory cells, specifically CD8-
positive T-lymphocytes, macrophages and microglia (Bitsch et al., 2000). 
Interestingly, many studies pointed out the reduction of axonal density in early lesion 
stages and even in normal-appearing white matter (Lassmann, 2013). Two alterna-
tive explanations are either that axons are locally damaged outside of the lesions or 
degenerate because of the result of a multi-segmental, long-standing degeneration 
which affects distant tracts by WD. The latter has been deemed more likely, since 
WD was found to be a major contributor to periplaque white-matter axonal demise 
(Dziedzic et al., 2010). In contrast to demyelination, which can be in part remedied 
by the recruitment of oligodendrocyte precursor cells (albeit with considerable inter-
individual disparity) (Patrikios et al., 2006), axonal degeneration is irreversible. 
Hence, it is important to study the precise mechanisms of axonal degeneration in 
the context of neuroinflammation in order to find potential neuroprotective treatment 
strategies.  
A broad spectrum of pathomechanisms has been suggested to contribute to axonal 
damage in MS. Perhaps the most obvious candidate is demyelination. Loss of 
trophic support from oligodendrocytes and increased energy demand due to unfa-
vourable nerve-conduction properties are plausible. In fact, sodium channels for-
merly concentrated at the nodes of Ranvier become dispersed as a consequence 
of demyelination (Smith, 2007). This can lead to a state of virtual hypoxia, leading 
to increased cellular Na+ levels as a result of reduced Na+/K+-ATPase activity. As a 
consequence, the Na+/Ca2+-exchanger can revert its function and pump Ca2+-ions 
into the cell. Increased axonal-calcium levels can impair axonal transport, compro-
mise mitochondria (thereby creating a vicious cycle) and ultimately prompt a degen-
eration cascade, which involves calpains and other calcium-dependent proteases 
(Haines, Inglese & Casaccia, 2011). 
However, it has been demonstrated in EAE that the axonal-degeneration mode of 
FAD (see chapter 1.3.1) occurs in generally myelinated axons (Nikić et al., 2011). 
Haines et. al (2011) posited the following hypothesis: ‘Axonal damage in multiple 
sclerosis might be concurrent to demyelination, but not necessarily consequent to 
myelin destruction’. Several possible pathomechanisms independent of demye-
lination have been suggested. Promising candidates in an inflammatory milieu are 
mononuclear phagocyte-produced ROS and RNS, which are membrane diffusible 
and can thus permeate intact myelin. ROS/RNS have been demonstrated to induce 
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an FAD-like pattern of axonal degeneration, and scavenging them alleviated FAD 
(Nikić et al., 2011). A mechanism for RNS-mediated axonal damage is inhibition of 
the mitochondrial respiration (Kapoor, Davies, Blaker, Hall & Smith, 2003) and pro-
motion of activity-dependent axonal destruction (Smith, Kapoor, Hall & Davies, 
2001). ROS can derange the complex signalling at ER-mitochondria nanodomains 
and elicit ER calcium release (Booth, Enyedi, Geiszt, Várnai & Hajnóczky, 2016).  
Equally compelling is the finding that axonal transport is markedly reduced in EAE 
lesions, despite intact myelination and normal morphological appearance – yet de-
myelination caused an increased disturbance of transport. Transport deficits again 
interplayed with ROS/RNS levels and could act detrimentally via reduced mitochon-
drial supply (Sorbara et al., 2014). 
Glutamate excitotoxicity has also been posited as an axonal noxa. Glutamate is 
produced extensively by immune cells and can mediate both myelin and axonal 
damage. AMPA/kainate-types of glutamate receptors inhibition ameliorated clinical 
symptoms in EAE (Pitt, Werner & Raine, 2000). The downstream mechanism is 
again thought to involve calcium rise and Na+/Ca2+-exchanger reversal. A parallel 
study in my host laboratory could not, however, determine a significant amelioration 
of axonal calcium overload following treatment with the Na+/Ca2+-exchanger block-
ing agent bepridil (Witte et al., 2019). 
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Figure 4: Cytoplasmic calcium levels predict axonal fate in 
 neuroinflammatory lesions 
(A) Representative in vivo 2-photon microscopy intensity projections (top, YFP 
channel) and the corresponding colour-coded cytoplasmic calcium ratios (bottom, 
YFP/CFP ratio) under control conditions (left) and subsequent to EAE induction, 
two days after developing symptoms (right). The images show the superficial dor-
sal funiculi of the spinal cord in Thy1-CerTN-L15 mice. (B) Exemplary images col-
our-coded for cytoplasmic calcium (YFP/CFP ratio) of axons under control condi-
tions (upper left) and axons representative of the morphological FAD stages 0 (up-
per right), 1 (lower left) and 2 (lower right) 2 to 3 days after onset of disease follow-
ing EAE induction. (C) Cytoplasmic calcium levels (YFP/ CFP channel) of control 
axons and axons representative of FAD stages 2 to 3 days after onset of EAE. The 
percentages on top correspond to the fraction of axons with cytoplasmic calcium > 
3 times the standard deviation above the control mean value (colour-coded yellow 
in graph). The data is displayed as mean ± SEM (statistical testing performed per 
animal with n=6 control and n=11 EAE mice; Mann-Whitney U test). (D) Axons with 
colour-coding and experimental conditions analogous to (A) traced over time. Tran-
sition of a low calcium stage 0 to a high calcium stage 0 axon (top), of a high 
calcium stage 1 to a high calcium stage 2, fragmented axon (middle) and revorvery 
of a low calcium stage 1 to a low calcium stage 0 axon (bottom). (E) Graphical 
depiction of transition probabilities. Yellow = high calcium axons, purple = low cal-
cium axons in n=307, 8 mice and 1201 axon hours. Scale bars: (A) 25 mm, (B) and 
(D) 10 mm. *p < 0.05; ***p < 0.001 
Figure adapted from and caption modified from Witte et al. (2019). Experimenter: 
Adrian-Minh Schumacher 
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Despite not entering through a reversed Na+/Ca2+-exchanger, previous work in my 
laboratory established calcium as an important determinant of axonal fate in FAD 
by in-vivo imaging of transgenic mice which express the calcium indicator CerTN-
L15 in neurons. Swollen and calcium high axons (stage 1) had a higher probability 
of undergoing fragmentation (stage 2) and a lower probability of recovery compared 
to swollen axons with normal calcium levels. See Figure 4 for a graphical summary. 
Consequently, elevation of cytoplasmic calcium is a potent trigger of FAD progres-
sion in neuroinflammatory lesions. Additionally, the removal of extracellular calcium 
by bath application of the calcium chelator ethylene glycol-bis(β-aminoethyl ether)-
N,N,N',N'-tetraacetic acid (EGTA) completely blocked fragmentation in EAE lesions. 
The likely portal of entry was determined to be nanoruptures in the membrane pre-
sent in EAE, which allowed for the diffusion of high-molecular dyes. The uptake of 
dyes correlated well with the axonal calcium content (Witte et al., 2019). 
Assessing an additional contribution by intracellular stores, perhaps even prior to 
pore formation, was the primary motivation for this thesis.  
1.3.4 Traumatic axonal injury 
Traumatic axonal injury (TAI) can be regarded as a pathoanatomical subgroup of 
traumatic brain and spinal-cord injury. The amount of axonal damage is a key pre-
dictor of functional outcome and mortality following CNS trauma (Medana & Esiri, 
2003). Previously unrecognised, TAI can entail progressive white-matter loss and 
neurodegeneration for a period of years after the injury in addition to the immediate 
axonal pathology (Johnson, Stewart, Begbie, et al., 2013).  
Primary axotomy – albeit an import experimental paradigm which is also employed 
in this thesis – is, in fact, a rare finding in TAI (except for sharp-force trauma). A 
more common pattern of degeneration is defined by the appearance of varicosities 
and undulations, which can progress to ‘secondary axotomy’ (Christman, Grady, 
Walker, Holloway & Povlishock, 1994). These morphological alterations are gener-
ally attributed to cytoskeletal disruption. In fact, the special viscoelastic properties 
of microtubules can make them brittle after sudden elongations, like in the moment 
of impact. The following twisting and misalignment of microtubular fragments along 
the axon creates the beaded morphology. In an attempt to reorganise the cytoskel-
etal architecture, microtubules are depolymerised, leading to a temporal interruption 
of axonal transport, which again causes progressive swelling (Johnson, Stewart & 
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Smith, 2013). Special attention should be paid to the degradation of the cytoskeleton 
just below the axolemma (membrane skeleton). Ankyrins link the spectrin-actin com-
plex to membrane proteins, which is crucial, e.g. for proper ion channel and -pump 
location at the nodes of Ranvier. Consistently, nodal and paranodal pathology with 
fragmentation of nodal axoplasm are prominent histological features in TAI and con-
cur with ion channel and conductance dysfunction as well as a destabilisation of the 
cell membrane (Reeves, Greer, Vanderveer & Phillips, 2010). Cytoskeletal protec-
tion is a vivid field of research. Microtubule stabilisers, such as paclitaxel, have been 
shown to alter the rate of axonal degeneration (Kleele et al., 2014), and epothilone 
B has been deemed a promising neuroprotectant in spinal-cord injury (Ruschel et 
al., 2015).  
As previously discussed, calcium dyshomeostasis also has long been implicated to 
be a pivotal effector of secondary axonal damage in TAI (Povlishock, 1992). Nota-
bly, several studies indicate that initial calcium dysregulation in TAI is caused by 
release from intra-axonal calcium stores, such as the ER (Staal et al., 2010; David 
P. Stirling et al., 2014). Later, a more gradual and lasting calcium dysregulation en-
sues. This implies that ER calcium release is upstream of the influx of extracellular 
calcium. However, the significance of calcium entry from the extracellular space also 
has a solid experimental foundation. Williams et al. (2014) demonstrated that axons 
can exist in a metastable state for hours after spinal-cord contusion. Meanwhile, the 
accumulation or buffering of elevated intracellular calcium determines these axons’ 
fate. They can either progress to secondary axotomy if their calcium remains high, 
or they can recover. The source of this calcium was proven to be membrane mech-
anopores by dye-loading experiments, like my host laboratory found in EAE. Hence, 
the study of membrane-sealing agents is of high therapeutic interest. Candidates 
include polyethylene glycol (PEG), Mitsugumin 53 (a tripartite motif protein) and Kol-
lidon VA64, which has proven promising in rodent TBI (Hill, Coleman & Menon, 
2016; Miller et al., 2014). Nevertheless, a preceding contribution of intraorganellar 
calcium is still plausible (vide infra). 
1.3.5 ER calcium in axonal degeneration 
In this chapter, I will list a number of studies that implicate the role of ER-derived 
calcium in axonal degeneration. 
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The most solid foundation of experimental evidence for ER calcium release can be 
found in the models of anoxia and ischemia. Notably, there is a significant overlap 
between ischemia and other axodegenerative-injury paradigms (Stys, 1998). In is-
chemic axons, a rise of intracellular calcium can be detected, even when extracel-
lular calcium is absent or chelated, and the intracellular calcium sources have been 
shown to sufficiently trigger the degenerative cascade without extracellular calcium 
influx (Ouardouz et al., 2003). Particularly ischemia, which is more severe than an-
oxia since it also involves a reduction of nutrient supply, has been demonstrated to 
recruit ER calcium stores in addition to extracellular calcium influx. The latter has 
been validated in the optic nerve of rats and spinal-cord explants in vitro (Stirling & 
Stys, 2010). 
Stys et al. (2010) developed a fascinating mechanistic model of ER calcium 
involvement in axonal degeneration. They postulate the existence of so-called inter-
modal nanocomplexes, which are clusters of molecules involving GluR5- and GluR6 
containing kainate receptors. These could potentially be activated by glutamate re-
lease from inflammatory cells or the reversal of axonal glutamate transporters under 
injury. GluR5-dependent ER calcium release is triggered by a G-protein-coupled 
activation of phospholipase C, which catalyses the generation of IP3. IP3 acts on 
IP3Rs to release intraorganellar calcium. GluR6 kainate receptors, however, lead to 
a depolarisation-induced excitation-contraction coupling-like release of calcium 
through RYRs. NO generated the neuronal nitric-oxide synthase (nNOS), which has 
been posited as an important modulator of this coupling mechanism. The molecules 
mentioned occur in close proximity to each other by means of immunoprecipitation 
assays and immunoelectron microscopy and have therefore been termed ‘nano-
complexes’ (Ouardouz et al., 2009; Stirling & Stys, 2010). Indeed, glutamate exci-
totoxicity has been determined not only to be important in grey-matter pathology, 
but also in white-matter degeneration. Accordingly, kainate receptor agonists and 
glutamate can cause axonal injury experimentally and elicit a lasting cytoplasmic-
calcium rise (Li & Stys, 2000; Matute, 1998). If, in turn, kainate receptor antagonists 
are administered (in this example, NBQX), the rise in cytoplasmic calcium can be 
blocked efficiently. Another way to diminish glutamate-mediated calcium flux is 
blocking RyR with ryanodine, while a calcium-free perfusate was also an efficient 
way to reduce cytoplasmic-calcium rise. This points at an interdependence of extra-
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cellular calcium influx and RyR activation, just as it is known for excitation-contrac-
tion coupling (Ouardouz et al., 2009). Internodal nanocomplexes could thus promote 
focal cytoplasmic calcium accumulation in an ER-enhanced manner and contribute 
to secondary axotomies. Primary axotomies (silk suture of spinal nerves in rats) 
were also reported to result in ER-calcium depletion, which was assessed by the 
surrogate marker of the reduction of caffeine-evoked ER calcium release. Further-
more, ER calcium was measured directly, employing the low-affinity calcium indica-
tor mag-Fura-2-AM (Rigaud et al., 2009). In a model of stretch injury, a biphasic 
increase of cytoplasmic calcium could be detected. The rapid, primary increase was 
dependent on intracellular calcium sources, while the smaller and delayed second-
ary increase was attributed to extracellular sources, since it was diminished in a 
calcium-free medium (Staal et al., 2010). 
Villegas et al. (2014) found that calcium release through RYRs and IP3Rs entails 
the activation of MPTP, which can be triggered by mechanical and toxic insults. ER 
calcium channel blockers had an inhibitory effect on injury-induced axonal degen-
eration. Accordingly, the genetic knockdown of ER calcium release channels had 
the same effect. In response to the attenuation of ER calcium release, mitochondrial 
swelling and dysfunction could also be significantly delayed.  
Finally, a recent study by Stirling et al. (2014) established a deleterious role of ER 
calcium depletion in secondary-bystander axon degeneration in a whole spinal-cord 
explant laser-lesioning model. ‘Bystander degeneration’ indicates that some axons 
which are not transected by the initial laser lesioning still succumb to secondary 
degeneration. The study found that removal of extracellular calcium was completely 
ineffective in attenuating bystander degeneration in laser-induced spinal-cord pa-
thology, which led to the investigation of intracellular calcium pools. A RyR gain of 
function mutant mouse line exhibited more severe bystander degeneration, while 
bystander degeneration (in wildtype and mutant lines) was attenuated by the phar-
macological blockade of RyRs and IP3Rs with the respective antagonists ryanodine 
and 2-APB. 
Combined, all of these studies clearly raise interest in the contribution of ER-calcium 
release to the axodegenerative cascade – especially with regard to other patholo-
gies such as neuroinflammation, which is one of the main objectives of this thesis.  
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1.4 Intravital calcium imaging 
Osamu Shimomura, Martin Chalfie and Roger Y. Tsien were awarded the Nobel 
Prize in Chemistry in 2008 ‘for the discovery and development of the green fluores-
cent protein, GFP’. GFP was later tweaked and modified to generate a mesmerising 
portfolio of variants, which today spans the entire spectrum of visible light and be-
yond (Ehrenberg, 2008).  
In addition to the diversified spectral properties, improved brightness and photosta-
bility, fluorescent proteins (FP) soon entered the realm of biosensing. Today, more 
than a hundred biosensors have been developed, which allow for the detection of 
ions, redox conditions, enzymatic reactions and specific molecules (Palmer, Qin, 
Park & McCombs, 2011). ‘Such sensors, can be targeted to specific locations within 
a cell, expressed within specific cell types in a transgenic organism, and incorpo-
rated into organisms for long-term imaging’ (Palmer et al., 2011). These benefits of 
biosensors have all been explored in this thesis, in which I measured calcium in a 
subcellular compartment (the ER), in cell types of interest (neurons) and I created a 
transgenic organism (a mouse line) for 2-photon imaging. 
1.4.1 Principles of calcium indicators 
The design of genetically encoded calcium indicators (GECIs) based on FP-variants 
has followed two distinct pathways: GECIs containing a single FP, and GECIs which 
consist of two different FPs that interact via a process called fluorescence reso-
nance energy transfer (FRET, vide infra). 
The single-FP-type sensors are based on circularly permutated FPs in combination 
with a calcium-responsive element. The underlying mechanism depends on the al-
teration of the fluorophores by the degree of protonation. The protonation state 
changes with the conformation of the calcium-responsive element (often calmodu-
lin-derived). This type of calcium sensor is generally characterised by a high dy-
namic range and a narrow range of excitation and emission wavelengths. Conse-
quently, two or more of these indicators with different wavelengths can be monitored 
independently in the same experiment. This single FP-type of GECI is typically in-
tensiometric, which means that the intensity of the signal is proportional to the 
amount of bound calcium. The readout is a single-channel measurement. However, 
there are confounding factors which influence intensity, such as expression levels 
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and movements of the specimen. Therefore, it is difficult to determine the resting-
state calcium level using intensiometric sensors. Intensiometric calcium sensors 
are, however, superior in measuring temporal dynamics in stable specimens and 
feature a large dynamic range (Palmer et al., 2011; Thestrup et al., 2014). The most 
popular single-FP sensors include the green G-CaMPs (Nakai, Ohkura & Imoto, 
2001), their red counterpart R-CaMP (Akerboom et al., 2013) and GECOs (Zhao et 
al., 2011).  
The opposite of intensiometric sensors are ratiometric sensors – in particular, emis-
sion ratiometric sensors, which allow one to determine the calcium level by the ratio 
of two FPs’ intensities, thereby providing a relative measure. These sensors are 
advantageous in imaging moving specimens and resting-state calcium levels, since 
they are not influenced by changes in optical-path length, excitation-light intensity 
and GECI-expression level. These factors combined with the superior baseline 
brightness make FRET-based GECIs the sensors of choice for transgenic organ-
isms and intravital imaging. The archetypal ratiometric calcium sensors are the 
cameleons, which are the oldest and most optimised GECIs. Cameleons consist of 
two spectrally overlapping fluorescent proteins (mostly YFP and CFP variants), 
which are tethered together by a calcium-sensitive domain – in this case, calmodulin 
– and the M13 peptide from myosin light-chain kinase (Miyawaki, Griesbeck, Heim 
& Tsien, 1999). Upon calcium binding, a conformational change in the calcium bind-
ing domain occurs, and the two FPs approximate. Within a distance of 5–100 Å, the 
spectrally overlapping FPs transfer energy via FRET. In the case of a CFP-YFP 
couple, CFP acts as donor and YFP as acceptor of this radiation-less energy trans-
fer. With decreasing distance of the FPs, CFP emission is increasingly quenched, 
and YFP emission is sensitised. Apart from the donor-acceptor distance, the effi-
ciency of the energy transfer also depends on the dipole orientations of donor and 
acceptor, and the environmental factors which influence dipole interactions, such as 
types of solvents, degree of hydration, pH and temperature. The practical conse-
quence of FRET is that it can serve as a nanoscale ruler, which translates submi-
croscopic distances into varying fluorescence intensities (Murphy & Davidson, 2012; 
Palmer et al., 2011; Schumacher, 2015). 
Cameleon calcium indicators underwent a notable history of improvements and 
modifications. The earliest cameleon included the FP’s blue-fluorescent protein 
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(BFP) and S85T GFP. However, a spectral red shift was favourable for cellular im-
aging, due to reduced phototoxicity of the excitation light, as well as diminished light 
scattering and auto-fluorescence. Thus, the spectrally red-shifted pair of ECFP and 
EYFP replaced BFP and S85T GFP and became known as the YC family of camele-
ons (creating truly red FRET-based GECIs for deeper-tissue penetration is an on-
going endeavour to date; however, they still suffer from poor dynamic ranges) 
(Miyawaki et al., 1997; Palmer et al., 2011). The FPs were further improved to in-
crease photostability as well as folding at 37°C and reduce pH and chloride-sensi-
tivity (Griesbeck, Baird, Campbell, Zacharias & Tsien, 2001). However, each sensor 
features its individual advantages, and there is an abundance of choice. For exam-
ple, EYFP V68L/Q69K containing GECIs have reduced chloride and pH-sensitivity, 
but have less-efficient maturation at 37 °C and are dimmer than their counterparts, 
venus and citrine. Venus and citrine, in turn, are more susceptible to chloride and 
pH-influences (Griesbeck et al., 2001). These characteristics are important to con-
sider when designing an experiment involving GECIs. Subsequently, circularly per-
muted FPs have been integrated into FRET GECIs. Here, the original N- and C-
termini of the original FPs are fused together, and new termini are defined. This 
leads to an altered dipole orientation, and it can increase the dynamic range drasti-
cally (Nagai, Yamada, Tominaga, Ichikawa & Miyawaki, 2004). The calcium-sensi-
tive linker has become another target for modifications. Instead of calmodulin and 
the M13 peptide, troponin C has been incorporated into GECIs. This was a neces-
sary step, since calmodulin has abundant interactions with cellular proteins which 
can hamper an experiment. In both troponin C- and calmodulin-based linkers, the 
calcium-binding linker consists of two globular domains with two calcium-binding 
sites on each. This can lead to abundant calcium buffering and nonlinear kinetics 
(Palmer et al., 2011; Thestrup et al., 2014). In an effort to reduce the complexity of 
the calcium-binding site, Thestrup et al. (2014) created GECIs with a minimal cal-
cium binding domain of toadfish (Opsanus tau) troponic C with fewer calcium-bind-
ing sites and improved dynamic ranges. These sensors were called Twitch-sensors; 
they possess a superior Hill coefficient and are less likely to interfere with calcium 
buffering. A low-sensitivity Twitch variant (Twitch2B 54S+) was used to measure ER 
calcium in this thesis.  
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1.4.2 ER calcium indicators 
Since the majority of GECIs was destined for cytoplasmic measurements, enhanc-
ing their sensitivity has been a primary focus in the evolution of calcium indicators. 
This allowed, for example, the measurements of fast synaptic transients in neurons. 
However, the amount of calcium differs over several orders of magnitude in different 
subcellular environments. This renders high-sensitivity calcium indicators with a low-
dissociation constant (Kd) useless in the ER, where the free calcium concentration 
can be up to 10.000 times the cytoplasmic concentration. Moreover, the ER has a 
more oxidising environment, which allows disulphide bond formation and proteins in 
the ER, including GECIs, are subject to covalent modifications, such as glycosyla-
tion (Gerasimenko, Petersen & Gerasimenko, 2014). 
Consequently, ER calcium indicators had to be specialised in order to function in 
this unique milieu. Initially, intra-ER free calcium could only be measured by dye-
loading techniques. Mostly acetoxymethyl (AM) esters of low-affinity calcium dyes 
(Mag-Fura-2 and others) were used, which accumulated in the ER and other orga-
nelles. After dye loading, cytosolic dialysis using patch-clamp techniques is re-
quired, so that imaging under physiological conditions is precluded (Gerasimenko 
et al., 2014; Suzuki, Kanemaru & Iino, 2016). An elegant way to circumvent the 
necessity of cellular dialysis is targeted esterase-induced dye loading (TED). Here, 
the esterification of the AM-ester is carried out directly in the ER lumen by a genet-
ically encoded, ER-targeted carboxylesterase. This obviates the need of cytoplas-
mic dialysis, since the remaining dye can be easily washed out (Samtleben et al., 
2013). 
However, GECIs are still the indicators of choice for intravital imaging. Recent ad-
vances in ER environment-optimised GECI design have proven the feasibility of this 
concept. The first ER-targeted GECIs were YC3er and YC4er. Their Kd-value was 
raised to the low micromolar range by inserting point mutations into the calmodulin 
domain. Still, a Kd-value of 4.4 µM in case of YC3er is too low to faithfully report ER 
calcium alterations. YC4er was better suited and offered a Kd-value of 700 µM (albeit 
biphasic) but had the drawback of a limited dynamic range (Miyawaki et al., 1997). 
Further improvements yielded the sensor D1ER, which was engineered to be insen-
sitive to interactions with endogenous calmodulin and offered an increased dynamic 
range (Palmer, Jin, Reed & Tsien, 2004). 
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Moreover, single-FP calcium indicators have been engineered to enable ER calcium 
measurements. One such sensor is CatchER, containing charged residues close to 
the fluorophore in EGFP, which act as calcium-binding moiety. CatchER offers the 
benefits of being excitation-ratiometric and having a high dynamic range of 230 %. 
This sensor was demonstrated to be capable of measuring calcium fluxes in mouse 
myofibre SR (Tang et al., 2011). Another attractive alternative is the CEPIA family 
of GECIs. CEPIA indicators are based on GECOs with inserted point mutations in 
the calmodulin domain. Spectral properties of CEPIAs match those of GECOs. Con-
sequently, red and green CEPIA variants are available – even an emission-rati-
ometric CEPIA variant, GEM-CEPIAer. These sensors offer superb dynamic ranges 
(470 %–2100 %) and have been successfully employed to visualise the process of 
ER calcium replenishment following synaptic input in Purkinje cells in mice (Okubo 
et al., 2015; Suzuki et al., 2014). Further alternatives in this group of single-FP ER-
GECIs have been designed and include ER-LAR-GECO1 (Jiahui Wu et al., 2014) 
and GCaMPer (Henderson et al., 2015). Finally, erGAP1 is based on a fusion of 
aequorin and GFP. Despite including aequorin, it is independent of the cofactor coe-
lenterazine. It is believed that aequorin serves as a calcium-sensing element and 
influences the fluorophore in GFP by conformational changes. This indicator is also 
excitation-ratiometric and has been successfully used in transgenic mice, where ER 
calcium release could be measured in acute hippocampal slices (Navas-Navarro et 
al., 2016; Rodriguez-Garcia et al., 2014).  
An overview of the physical properties of this enumeration of ER-targeted GECIs 
can be found in Table 1. Also included in this table is the eventual choice that we 
made for measuring ER-calcium dynamics in a transgenic mouse line. For intravital 
imaging, we needed an emission-ratiometric sensor which would compensate for 
differences in expression levels, optical-path-length differences and movements. 
Transgenic mice expressing FRET indicators TN-XXL and CerTN-L15 were suc-
cessfully used in my host laboratory previously to measure cytoplasmic axonal cal-
cium dynamics in transgenic mice (Schumacher, 2015). Thus, we sought indicators 
with similar spectral properties. Due to the reported low dynamic range and bright-
ness of D1ER and D4ER FRET GECIs, we chose to target a high-Kd variant of the 
improved Twitch sensors to the ER, Twitch2B 54S+ (Thestrup et al., 2014). The 
emission-ratiometric, high dynamic range indicator GEM-CepiaER could have been 
a suitable alternative as well. However, we could only generate very low intensities 
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in peripheral nerves in a virus-based expression system, which were also subject to 
rapid photobleaching. The physical properties of Twitch2B54S+ (originally deter-
mined without the ER retention tag KDEL) are included in Table 1. 
1.4.3 Intravital microscopy of the nervous system 
Two important concurrent developments made in-vivo microscopy of the nervous 
system possible: the advent of new imaging techniques – namely, two-photon laser-
scanning microscopy (TPLSM) – and the development of transgenic technologies, 
allowing the labelling of single neurons (Misgeld & Kerschensteiner, 2006). 
The labelling of individual neurons was achieved with the so-called Thy1-XFP mice, 
where XFP indicates any fluorescent protein or fluorescent functional indicator un-
der the control of the modified Thy1-promoter. The Thy1-promoter is a pan-neuronal 
regulatory element, which gives rise to a strong neuronal expression with a variable 
extent. Dependent on the chromosomal integration site, the reporter expression can 
be restricted to a small percentage of neurons and can thereby create a Golgi-like 
staining pattern (subset-labelling), or the expression can include all neurons (full-
labelling). Subset-labelling is particularly desired for intravital imaging, since it re-
duces the density of the structures of interest (e.g. axons, dendrites) and allows 
easier tracking over time (Misgeld & Kerschensteiner, 2006). The first Thy1-XFP 
transgenic mice were created by Feng et al. (2000) and contained a number of 
spectral variants with individual expression patterns (among others GFP, YFP, CFP, 
DsRed). Subsequently many more reporters have been established in Thy1-
trangenic lines, which enabled the assessment of organelle transport and distribu-
tion, synaptic release and spiking activity as well as mitochondrial redox state 
(Marinkovic, Godinho & Misgeld, 2015). Neuronal calcium concentrations could also 
be measured by placing GECIs under the control of the Thy1-promoter, which re-
sulted in the transgenic line CerTN-L15 (Heim et al., 2007). This line was used to 
determine calcium as a key contributor to axonal degeneration in FAD (Witte et al., 
2019). 
The potential of these transgenic lines could only be fully exploited when TPLSM 
became widely accessible. This imaging technique uses very high intensities of 
longer-wavelength light to excite FPs, instead of their characteristic lower peak-ex-
citation wavelengths. Key to this excitation process is that two photons of longer 
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wavelength arrive at the fluorophore nearly simultaneously, thereby adding their en-
ergies together. This requires intense light pulses from an ultra-fast laser. Thereby, 
excitation is limited to the focal point, which obviates the need for a pinhole to ex-
clude out-of-focus light, as it is used in confocal microscopy (intrinsic optical sec-
tioning of TPLSM). Consequently, even scattered-emission light can be used for 
detection, since it must have originated in the focal point. This accounts for the prac-
ticality of TPLSM for intravital imaging, together with the facts that the infrared exci-
tation light can penetrate tissue easily and that out-of-focus bleaching and photo-
toxicity are kept at low levels (Lichtman & Fraser, 2001; Misgeld & Kerschensteiner, 
2006). From the beginning, TPLSM has been used to shed light on calcium dynam-
ics in neurons. Initially, vital dyes (calcium green) were loaded to dendrites in neo-
cortical neurons and faithfully reported calcium rises in coincidence with sodium ac-
tion potentials, which proved the practicality of this novel imaging technique 
(Svoboda, Denk, Kleinfeld & Tank, 1997). Today, by making use of the abundant 
arsenal of GECIs in conjunction with modern TPLSM, even in-vivo measurements 
of calcium in organelles as small as the axonal ER are feasible, as will be demon-
strated in this thesis. 
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Table 1: Overview: physical properties of ER-GECIs 
GECIs with a single FP can be divided into: intensiometric and ratiometric indicators. Single-FP-type GECIs and FRET-type GECIs are illustrated 
schematically. Twitch2B 54S+ ER which is used in this thesis and its physical properties are highlighted in yellow. Illustrations adapted from 
Palmer et al. (2011). Table adapted and modified from Suzuki et al. (2016). 
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2 Objectives 
The preceding work has demonstrated calcium to be the fate-determining mediator 
of focal axonal degeneration in neuroinflammatory lesions and in the model of spi-
nal-cord contusion (Schumacher, 2015; Williams et al., 2014). Moreover, mechano- 
or nanopores in the membrane were established as important paths of entry for 
calcium from the extracellular space in both models (Bewersdorf, 2017; Williams et 
al., 2014). Recent studies also implicate that calcium from a major organellar store, 
the ER, can be sufficient to trigger the axonal degeneration cascade (Ouardouz et 
al., 2003; Stirling et al., 2014). Such a contribution of ER calcium deregulation is a 
compelling finding, since numerous methods of pharmacological manipulation of the 
ER calcium homeostasis exist. Consequently, this thesis aims to shed light on ER 
calcium dynamics (perhaps even as an upstream regulator) in neuroinflammatory 
lesions and in the traumatic spinal-cord injury models. The following questions were 
specifically addressed: 
1. Is there a modality for in-vivo imaging of intra-ER free calcium in single 
axons? 
1.1. Can the axonal ER be targeted, visualised and morphologically character-
ised using fluorescent reporters? 
1.2. Is there a calcium indicator that can generate a conclusive readout of intra-
ER free calcium, and can we ascertain that it actually measures calcium? 
1.3. Can this indicator of intra-ER free calcium be stably expressed in a trans-
genic mouse line with expression patterns, levels and locations applicable 
to in-vivo imaging of the spinal cord? 
1.4. If such a transgenic line can be generated, does the indicator report intra-
ER free calcium adequately upon pharmacologic manipulation in an in-vivo 
setting of the spinal cord? 
2. How is intra-ER free calcium affected in paradigms of axonal degenera-
tion? 
2.1. Can changes of intra-ER free calcium or ER morphology be detected in le-
sions of acute EAE, and, if so, do these influence the axonal fate in the de-
generation process? 
2.2. Can changes of intra-ER free calcium or ER morphology be detected in 
traumatic spinal-cord injury paradigms? 
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3 Materials and Methods 
3.1 Materials 
3.1.1 Reagents  
3.1.1.1 Reagents for surgery and in vivo imaging 
Agarose Sigma-Aldrich® Chemie GmbH, 82024 
Taufkirchen, Germany 
Bepanthen Augen- und Nasensalbe 5 g 
(eye ointment) 
Bayer Vital GmbH, Leverkusen, Deutsch-
land 
Cutasept F Lösung 250 ml 
(disinfectant spray) 
Bayer Vital GmbH, Leverkusen, Germany 
 
Ethanol 70%  CLN GmbH, 
85416 Niederhummel, Germany 
Forene (Isoflurane)  Abbott AG, Baar, Switzerland 
Ketamine hydrochloride 10% 
(Ketamine) 
Bremer Pharma GmbH, Warburg, 
Deutschland 
Ringerlösung Fresenius KabiPac 
(Ringer’s solution) 
Fresenius KaBI Dtl., Bad Homburg, 
Deutschland 
Sterile artificial mouse cerebrospinal 
fluid (aCSF) 
 
Solution A: 
8,66 g NaCl (Merck) 
0,224 g KCl (Merck) 
0,206 g CaCl2 · 2H2O (Sigma-Aldrich) 
0,163 g MgCl2 · 6H2O (Sigma-Aldrich) 
Solution B: 
0,214 g Na2HPO4 · 7H2O (Merck) 
0,027 g NaH2PO4 · H2O (Merck) 
dH20 ad 500 ml 
Mixture of solutions A and B in a 1:1 ratio 
Xylariem 20 mg (Xylazine) Riemser Arzneimittel AG, Greifswald-Insel 
Riems, Germany 
Midazolam B. Braun 5mg/ml  
 
B. Braun Melsungen AG, Melsungen, Ger-
many  
Domitor® (Medetomidin) 1mg/ml  
 
Orion Pharma Corporation, Espoo, Fin-
land  
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Fentanyl B. Braun 0.1mg  B. Braun Melsungen AG, Melsungen, Ger-
many  
Dimethylsulfoxid (DMSO)  Sigma-Aldrich Chemie GmbH, 82024 
Taufkirchen, Germany  
Thapsigargin 
 
Merck KGaA, 64293 Darmstadt, Germany 
 
 
3.1.1.2 Reagents for cell and explant imaging  
Ionomycin, Calcium Salt (1:1) 
 
Life Technologies GmbH, 64293 Darm-
stadt, Germany 
10x Normal Ringer’s solution Made in Konnerth labortatory, Munich, 
Germany 
NaHCO3 21.84g 
NaH2PO4* H2O 1.72g 
KCl 1.86g 
NaCl 73.05g 
Dissolved in dH2O. 1 l total volume. 
1x Normal Ringer’s solution 2ml CaCl2, 1M 
1ml MgCl2, 1M 
100ml Ringer solution (10x) 
3.6g Glucose  
dH2O ad 1l 
prepared in house 
HBSS (10X), calcium, magnesium, no 
phenol red 
Thermo Fisher Scientific Inc. Waltham, 
Massachusetts, USA 
HHBSS (1x) 50ml 10x HBSS 
1 g Glucose 
2.38 g HEPES 
dH20 ad 500 ml 
adjust pH to 7.4 
HHBSS (1x) with 10mM calcium 50ml 10x HBSS 
1 g Glucose 
2.38 g HEPES 
0.485 g CaCl2 
dH20 ad 500 ml 
adjust pH to 7.4 
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3.1.1.3 Reagents for tissue processing/ immunohistochemistry 
Phosphate Buffer (PB) 0,2 M  27,598 g NaH2PO4· H2O, 35,598 g Na2 
HPO4· 2H2O  
dH2O ad 1l  
Phosphate Buffered Saline (PBS), 10x 
103,23 mg Na2HPO4 · H2O  
103,23 mg Na2HPO4 · H2O 26,52g 
Na2HPO4 · 2H2O  
40g NaCl H2O bidest. added to 1l Pre-
pared in house.  
PFA (paraformaldehyde) 4%  
 
8% PFA (Sigma-Aldrich) in dH2O, heated 
up to 55 °C and stirred additional 10 min,  
filtrated and mixed in a 1:1 ratio with 0,2 M 
PB (Phosphate buffer), pH adjusted to 7,2- 
7,8  
Gibco Goat Serum  Invitrogen GmbH, Darmstadt, Germany  
Sucrose  
 
Sigma-Aldrich® Chemie GmbH, 82024 
Taufkirchen, Germany  
TBS 10x (Tris buffered saline), pH=7,6  61 g Tris base (121,14 g/mol), (Sigma- Al-
drich)  
90 g NaCl dH2O ad 1l  
Tissue Tek optimal cutting temperature 
(O.C.T.) 
akura Finetek Europe B.V., Alphen aan 
den Rijn, The Netherlands 
Triton X-100  Sigma-Aldrich® Chemie GmbH, 82024 
Taufkirchen, Germany  
Vectashield Mounting Medium, Fluores-
cence H-1000  
Vector Labs, Burlingame, CA 94010, USA  
Rabbit polyclonal to GRP78 BiP antibody  
(ab21685) 
Abcam, Cambridge, MA 02139-1517, USA 
Alexa Fluor® 647 Goat Anti-Rabbit IgG 
(H+L) Antibody 
Life Technologies GmbH, 64293 Darm-
stadt, Germany 
 
3.1.1.4 Reagents for molecular cloning and cell culture 
T4 DNA Ligase Buffer (10X) New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
Nuclease-free water New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
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T4 DNA Ligase New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
10x CutSmart® Buffer New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
10x NEBuffer 4 New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
DNA Polymerase I, Large (Klenow) Frag-
ment 
New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
Phusion® High-Fidelity DNA Polymerase New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
5X Phusion HF and GC Buffer New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
10 mM dNTPs New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
BamHI-HF New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
NotI-HF New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
ClaI New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
HindIII-HF New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
PvuI-HF New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
EcoRI-HF New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
XhoI-HF New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
Qiagen Plasmid Maxi Kit Qiagen, Venlo, Netherlands 
Qiagen Plasmid Mini Kit Qiagen, Venlo, Netherlands 
Pronucleus Injection Buffer Tris 5mM 
EDTA 0.1 mM 
Adjust pH to 7.6, filter sterilize and store at 
4°C, prepared in house 
MfeI-HF New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
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NheI-HF New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
BlpI New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
SacI-HF New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
Lipofectamine™ 2000 Transfection Rea-
gent 
Life Technologies GmbH, 64293 Darm-
stadt, Germany 
NEB® 5-alpha Electrocompetent E. coli New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
Sodium hydroxide solution Life Technologies GmbH, 64293 Darm-
stadt, Germany 
SOC Outgrowth Medium New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
AccuTaq™ LA DNA Polymerase with 10x 
buffer (used for genotyping) 
 
Merck KGaA, 64293 Darmstadt, Germany 
 
Ethidium bromide Sigma-Aldrich Chemie GmbH, 82024 
Taufkirchen, Germany 
Alkaline Phosphatase, Calf Intestinal (CIP) New England Biolabs, Ipswich, Massachu-
setts 01938, USA 
Dulbecco’s modified Eagle medium 
(DMEM) 
Invitrogen, Carlsbad, California, USA 
Fetal Bovine Serum, certified, heat inacti-
vated, US origin 
Thermo Fisher Scientific Inc. Waltham, 
Massachusetts, USA 
Penicillin/Streptomycin solution Sigma-Aldrich® Chemie GmbH, 82024 
Taufkirchen, Germany 
Poly-L-lysine hydrobromide Sigma-Aldrich® Chemie GmbH, 82024 
Taufkirchen, Germany 
Lipofectamine 2000 Transfection Reagent Invitrogen, Carlsbad, California, USA 
QIAquick Gel Extraction Kit Qiagen, Venlo, Netherlands 
 
3.1.1.5 Reagents for immunization 
Myelin Oligodendrocyte Glycoprotein 
(MOG) 
 
Stock solution, produced by laboratory of 
Martin Kerschensteiner, 82152 Planegg, 
Germany 
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M. tuberculosis H37 RA Sigma-Aldrich® Chemie GmbH, 82024 
Taufkirchen, Germany 
Incomplete Freund Adjuvans (IFA)  Sigma-Aldrich® Chemie GmbH, 82024 
Taufkirchen, Germany 
 
Pertussistoxin (Ptx) from Bordetella 
pertussis, inactivated 
 
Sigma-Aldrich® Chemie GmbH, 82024 
Taufkirchen, Germany 
 
Sodium acetate (3mM, pH 3) Merck KGaA, 64293 Darmstadt, Germany 
 
3.1.2 Tools and materials 
3.1.2.1 Tools and materials for surgery and in vivo imaging 
Wella contura W7807 (Hair clipper)  Wella, Darmstadt, Germany 
BD Plastipak Hypodermic luer slip 
syringe 1 ml (syringe for 
Ketamine/Xylazine and Ptx injection ) 
Becton, Dickinson and Company, Franklin 
Lakes 
(New Jersey), USA 
 
Feather stainless steel blade (surgical 
blade) 
 
pfm medical ag, Cologne, Germany 
 
Noyes Spring Scissors (Large spring 
scissors) 
 
Fine Science Tools GmbH, Heidelberg, 
Germany 
 
Vannas-Tübingen Spring Scissors 
(Small angled spring scissors) 
Fine Science Tools GmbH, Heidelberg, 
Germany 
Dumont Mini Forceps – Inox Style 5 
 
Fine Science Tools GmbH, Heidelberg, 
Germany 
Hypodermic Needles BD Microlance 3 
30 Gauge (0,3 mm, yellow) for 
subcutaneous injection of Ptx and anes-
thesia 
Becton, Dickinson and Company, Franklin 
Lakes 
(New Jersey), USA 
 
Hypodermic Needles BD Microlance 
3 23 Gauge (0,6 mm, blue) for 
subcutaneous emulsion immunization 
Becton, Dickinson and Company, Franklin 
Lakes 
(New Jersey), USA 
BD Plastipak hypodermic luer slip syringe 
1 ml (syringe for injection of Ptx, anesthet-
ics) 
Becton, Dickinson and Company, Franklin 
Lakes 
(New Jersey), USA 
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Ethicon Ethilon monofil 6-0 size, 
667H (skin suture) 
 
Johnson & Johnson Medical GmbH, 
Norderstedt, 
Germany 
Ethicon Vicryl 4-0 size, MIC101H 
(intracorporal suture) 
Johnson & Johnson Medical GmbH, 
Norderstedt, 
Germany 
Sugi (absorbent triangles)  Kettenbach GmbH & Co. KG, Eschenburg, 
Germany 
Spongostan special (hemostatic gelatin 
sponge) 
Ethicon Inc. Somerville, New Jersey, USA 
Metal plate Custom-made 
Cast Alnico Button Magnets Eclipse Magnetics Ltd, Sheffield, UK 
Rubber bands  
Infinite Horizons Impactor  Precision Systems and Instrumentation, 
Fairfax Station, VA 22039, USA 
P-30 Vertical Micropipette Puller Sutter Instruments, Novato, California, 
USA 
Safety-Multifly-Set 21Gx3/4” TW (0,8 x 19 
mm)  
Sarstedt AG & Co., Nümbrecht, Germany  
51500D Digital New Standard Stereotaxic, 
Rat and Mouse 
Stoelting Europe, Terenure, Dublin 
D6WY006, Ireland 
Thin wall Borosilicate Glass Micropipettes Sutter Instrument, Novato, CA 94949, USA  
Support cushion  
 
3.1.2.2 Tools and materials for cell and explant imaging 
minuten pins (0.2-mm diameter, shortened 
to 4 mm), FST: 26002-20 
Fine Science Tools GmbH, Heidelberg, 
Germany 
10 cm plastic petri dishes Sigma-Aldrich Chemie GmbH, 82024 
Taufkirchen, Germany 
15 cm glass petri dish Sigma-Aldrich Chemie GmbH, 82024 
Taufkirchen, Germany 
Metal plate  
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3.5-cm tissue culture dish filled with Syl-
gard polymer  
Dow Corning Inc., Midland/Michigan, USA 
.Tubing to oxygenate explants during the 
dissection procedure  
 
Warner Instruments, Holliston, MA 01745, 
USA 
Vacuum system with suction tube  Warner Instruments, Holliston, MA 01745, 
USA 
Warner W4 64-0704 22 mm Coverslips 
square 
Warner Instruments, Holliston, MA 01745, 
USA 
Warner Large closed Diamond Bath RC-
21B 
Warner Instruments, Holliston, MA 01745, 
USA 
Flow Valve Warner Instruments, Holliston, MA 01745, 
USA 
Syringe Holder, eight 60 cc syringes  Warner Instruments, Holliston, MA 01745, 
USA 
Heating ring for 3.5-cm dishes  Warner Instruments, Holliston, MA 01745, 
USA 
Vaccum grease Warner Instruments, Holliston, MA 01745, 
USA 
 
3.1.2.3 Tools and materials for for tissue processing/ immunohistochemis-
try 
12-Well Microtiter plates  Becton, Dickinson and Company, Franklin 
Lakes, New Jersey, USA 
15 ml and 50 ml Falcon tubes Greiner Bio-One GmbH, Frickenhausen, 
Germany 
Transparent nail varnish  
Microscope slides 76x26 mm  Gerhard Menzel Glasbearbeitungswerk, 
GmbH & Co. KG, Braunschweig, Germany  
Microscope cover slips 24x60 mm  Gerhard Menzel Glasbearbeitungswerk, 
GmbH & Co. KG, Braunschweig, Germany 
Parafilm  
 
Brand GmbH & Co. KG, Wertheim Ger-
many  
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Pipettes, pipette tips and tubes (2ml and 
1,5 ml)  
Eppendorf AG, Hamburg, Germany 
Tissue Tek Cryomold Standard, 25x20x5 
mm  
Sakura Finetek Europe B.V. , Alphen aan 
den Rijn, The Netherlands  
Tissue Tek Cryomold Biopsy, 10x10x5 mm Sakura Finetek Europe B.V. , Alphen aan 
den Rijn, The Netherlands  
 
3.1.2.4 Tools and materials for molecular cloning 
Gene Pulser®/MicroPulser™ Electropora-
tion Cuvettes 
 
Bio-Rad, California 94547, USA 
 
MicroPulser™ Electroporator Bio-Rad, California 94547, USA 
Kanamycin or Ampicillin containing selec-
tive plates  
Produced and sterilized in house 
Falcon 25cm, Rectangular Canted Neck 
Cell Culture Flask with Vented Cap 
Corning GmbH, 65189 Wiesbaden 
Real-Time PCR Detection System Bio-Rad, California 94547, USA 
Paper filters (185 mm Ø circles)  
 
Whatman Schleicher & Schuell GmbH, 
Dassel, Germany  
 
3.1.3 Technical devices 
3.1.3.1 Technical devices for surgery and in vivo imaging 
 
Olympus KL 1500 LCD (cold light source 
for stereomicroscopy) 
 
Olympus Deutschland GmbH, Hamburg, 
Germany 
 
Olympus Stereo Microscope SZ51  Olympus Deutschland GmbH, Hamburg, 
Germany 
 
FST 250 Hot Bead Sterilizer (sterilizer 
for surgical instruments) 
 
Fine Science Tools GmbH, Heidelberg, 
Germany 
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T/Pump (Heating pad)  Gaymar Industries, Orchard Park (New 
York), USA 
100W infrared lamp Beurer GmbH, Ulm, Germany 
Spinal Cord Clamps NARISHIGE INTERNATIONAL LIMITED, 
London, U.K. 
 
3.1.3.2 Technical devices for microscopy 
Olympus FV1200 MPE multiphoton 
microscope 
x25/1.05 water immersion objective 
Olympus GmbH, Hamburg, Germany 
 
Olympus FVMPE-RS multiphoton micro-
scope 
x25/1.05 water immersion objective 
Olympus GmbH, Hamburg, Germany 
 
MaiTai Deep See® Titanium:sapphire 
Laser 
Newport/ Spectraphysics, Irvine, Califor-
nia, USA 
Olympus FV1000 confocal system 
mounted on BX61 vertical microscope, 
equipped with x10/0.3 dry, x20/0.85 oil and 
x60/1.42 oil immersion objectives 
Olympus GmbH, Hamburg, Germany 
 
Manual XY translation stage Luigs & Neumann Feinmechanik und 
Elektrotechnik GmbH, Ratingen, Deutsch-
land  parts by Thorlabs Inc 
Newton (New Jersey), USA 
 
Upright fluorescence microscope Olympus 
BX51WI, equipped with long-working dis-
tance objectives: 20x/0.5 water-immersion 
dipping-cone objective; 100x/1.0 water-im-
mersion dipping-cone objective for explant 
imaging. 
And Olympus UAPO 40x/ 1,15 water im-
mersion objective with correction collar for 
cell imaging 
Olympus GmbH, Hamburg, Germany 
 
3.1.3.3 Technical devices for cell and explant imaging  
(Kerschensteiner, Reuter, Lichtman & Misgeld, 2008) 
Olympus SZ51 dissection microscope 
equipped with Schott KL 1500 LCD  
Olympus GmbH, Hamburg, Germany 
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Two-channel temperature control system 
(one output for the in-line heater  
and one output for the heating ring; input 
for a temperature probe)  
Warner Instruments, Holliston, MA 01745, 
USA 
Fast shutter and filter wheel   Sutter Instrument Company, Novato, CA 
94949, USA 
Warner TC-324B Temperature controller Warner Instruments, Holliston, MA 01745, 
USA 
Warner W4 64-1561 Platform, heated, 
magnetic 
Warner Instruments, Holliston, MA 01745, 
USA 
Tube Pump Watson-Marlow Fluid Technology Group 
Wilmington, MA 01887, USA 
 
3.1.3.4 Technical devices for for tissue processing/ immunohistochemistry 
HISTO LEICA Vibratome VT1200S Leica Microsystems GmbH, Wetzlar, Ger-
many 
Leica CM1850 Cryostat Leica Microsystems GmbH, Wetzlar, Ger-
many 
KERN EW 150-3M (Scale) Kern & Sohn GmBH, Balingen-Frommern, 
Germany 
Laboratory pH-meter inoLAB WTW Wissenschaftliche-Technische 
Werkstätten, Weilheim, Germany 
Magnetic stirring hotplateMR 3001K and 
stirring bars 
Heidolph Instruments GmbH & Co. KG, 
Schwabach, Germany 
Vortex-Genie 2 Scientific Industries, Inc., Bohemia, New 
York, USA 
Olympus IX71 inverse fluorescence micro-
scope (initial assessment of stainings and 
expression) 
Olympus GmbH, Hamburg, Germany 
 
3.1.4 Data analysis/Software 
Adobe Creative Suite 6 (Photoshop, 
Illustrator) 
Adobe Systems, Inc., San Jose, California, 
USA 
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ImageJ/ FIJI  
 
General Public License 
http://rsbweb.nih.gov/ij/download.html 
Graphpad Prism GraphPad Software, La Jolla, California, 
USA 
 
Microsoft Office (Powerpoint, Excel, 
Word) 
 
Microsoft Corporation, Redmond, 
Washington, 
USA 
 
µManager Open source microscopy software 
(Edelstein et al., 2014) 
SnapGene software GSL Biotech; available at snapgene.com 
 
3.2 Methods 
3.2.1 Molecular cloning 
The GECI source plasmid pRSETB-Twitch2B-54S+ was kindly provided by Dr. Oli-
ver Griesbeck (Max Planck Institute of Neurobiology, Martinsried, Germany). It en-
codes Twitch2B-54S+, consisting of mCerulean3, a low-calcium-affinity toadfish 
Troponin C-minimal domain linker (1 functional EF-hand) and cpVenusCD (Thestrup 
et al., 2014). Suitable endonuclease-cleavage sites were generated by overhang 
PCR using the custom-made upstream primer L-BamHI-pRSETB and downstream 
primer R-pRSETB-NotI (synthesised by metabion international AG, 82152 Planegg, 
Germany). The pCMV G-CEPIA1er was a gift from Masamitsu Iino (Addgene plas-
mid # 58215) (Suzuki et al., 2014) and is itself based on pShooterTM Vector 
pCMV/myc/ER (Invitrogen, Carlsbad, California, USA). The pCMV G-CEPIA1er was 
used as a backbone for the assembly of the eukaryotic ER-targeting vector pCMV-
Twitch2B 54S+ ER by restriction with BamHI and NotI-enzymes and subsequent 
ligation. Special attention in vector design was paid to an expression-enhancing in-
tron sequence in the backbone’s 5’-region and to in-frame cloning with mouse im-
munoglobulin Vh-signalling sequence, as well as the ER retention peptide KDEL and 
myc-tag. Transformation was performed, either by heat shock or electroporation, 
using standard molecular-cloning protocols. Minipreps of positively ampicillin se-
lected E. coli cultures and – following restriction digest verification – maxipreps were 
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carried out using Qiagen kits. pCMV-Twitch2B 54S+ ER coding sequence was con-
firmed in maxipreps by sequencing (Eurofins Genomics, 85560 Ebersberg, Ger-
many). A negative control of pCMV Twitch2B 54S+ER was created by synthesis of 
a linker domain, which replaced all amino acids implicated in calcium binding in the 
functional EF-hand 1 and the EF-hand 2 (which is notably already crippled by the 
54S insertion) (Dotson & Putkey, 1993) by randomly chosen aliphatic amino acids. 
The synthesis of the mutated-linker DNA fragment was carried out by Eurofins Ge-
nomics (85560 Ebersberg, Germany). The mutational-linker DNA was used to re-
place the functional linker domain using the restriction enzymes BlpI and SacI. A 
schematic representation of pCMV-Twitch2B 54S+ ER can be found in Figure 5.  
The pCMV-Twitch2B 54S+ ER plasmid was used for transfection of HEK cells (see 
chapter 3.2.3) and for the generation of the Thy-1 Twitch2B 54S+ ER plasmid, from 
which transgenic mouse lines were generated (see chapter 3.2.7). The Thy-1 ex-
pression vector is derived from a gene that encodes a small immunoglobin super-
family member, Thy-1 (Ingraham, Lawless & Evans, 1986), which is endogenously 
expressed in many cell types, including immune cells and neurons (Marinkovic et 
al., 2015; Morris, 1992). By identifying the cis-acting elements which control neu-
ronal expression and removing the elements which control thymus expression, spe-
cific neuronal expression can be achieved (Vidal, Morris, Grosveld & Spanopoulou, 
1990). The Thy-1 backbone vector used in this thesis was originally described by 
Caroni (1997) (Marinkovic et al., 2015). A schematic representation of the neuron 
specific Thy-1 vector and its regulatory elements can be found in Figure 6A. In order 
 
Figure 5: Plasmid map pCMV-Twitch2B 54S+ ER 
Schematic representation of pCMV-Twitch2B 54S+ER plasmid. Locations of fluo-
rescent proteins, linker site and EF hand domains are annotated. Red asterisks 
indicate the sites of mutation in pCMV-Twitch2B mutated linker plasmid.  
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to allow linearisation after the assembly of the Thy-1 vector with the Twitch2B 54S+ 
ER insert, the Thy-1 vector backbone needed to be modified. The original prokary-
otic-expression cassette (including an ampicillin-resistance gene and origin of repli-
cation) was replaced by the prokaryotic-expression cassette from pmTurquoise2-
mito (including kanamycin resistance and origin of replication). The pmTurquoise2-
Mito was a gift from Dorus Gadella (Addgene plasmid #36208). Suitable endonucle-
ase-cleavage sites were generated by overhang PCR using the custom-made up-
stream primer L-PvuI-MfeI-Backbone and downstream primer R-Backbone-BmtI-
EcoRI (synthesised by metabion international AG, 82152 Planegg, Germany). The 
steps to yield maxipreps are the same as described above. This Thy-1(modified) 
plasmid was subsequently used as backbone for the generation of the Thy1(modi-
fied)-Twitch 2B 54 S+ ER plasmid. Again, endonuclease cleavage sites were gen-
erated by overhang PCR using the custom-made upstream primer L-XhoI-
Twitch2B54S+ER and downstream primer R-Twitch2B54S+ER-XhoI (synthesised 
by metabion international AG, 82152 Planegg, Germany). Thy1(modified) plasmid 
backbone and the insert Twitch2B54S+ER with resulting overhangs were cleaved 
using XhoI. The backbone was dephosphorylated using CIP-enzyme to avoid reli-
gation in blunt-ended cloning. The resulting Thy1(modified)-Twitch 2B 54 S+ ER 
plasmid was confirmed by sequencing (Eurofins Genomics, 85560 Ebersberg, Ger-
many), and a schematic representation can be found in Figure 6B. 
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The plasmid pAAV-mEmeraldER was required for the production of an adeno-asso-
ciated virus (AAV) (see chapter 3.2.4) in order to express a bright, photostable struc-
tural marker in the neuronal ER. The insert was generated from the mEmerald-ER-
3 plasmid, which contains a calreticulin-signalling sequence and a KDEL-retention 
sequence. The mEmerald-ER-3 plasmid was a gift from Michael Davidson 
(Addgene plasmid #54082), and endonuclease cleavage sites were added by over-
hang PCR using the custom-made upstream primer L-ClaI-mEmeraldER and down-
stream primer R-mEmeraldER-HindIII (synthesised by metabion international AG, 
82152 Planegg, Germany). The AAV-MCS backbone plasmid was kindly provided 
by Dr. Florence Bareyre. Both insert and backbone were cut using HindIII and ClaI 
restriction enzymes, ligated and transformed to bacteria. The resulting plasmid was 
 
Figure 6: Thy-1 plasmid maps 
(A) On top: Thy1 regulatory cassette with indication of omitted thymus expression 
elements. Below: Schematic representation of original Thy-1 plasmid with XhoI re-
striction site for insert integration. Modified from (Caroni, 1997; Marinkovic et al., 
2015). (B) Scheme of Thy-1-Twitch2B 54S+ER assembled plasmid. Note that the 
pUC18 prokaryotic expression cassette has been replaced. Twitch2B 54S+ ER 
coding sequence is integrated at XhoI site.  
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confirmed by sequencing (Eurofins Genomics, 85560 Ebersberg, Germany). A 
schematic representation is shown in Figure 7.  
 
The SnapGene software was used to plan cloning strategies. All corresponding se-
quence files are available upon request.  
3.2.2 Experimental animals 
C57BL/6JRj mice obtained from Janvier Labs (53940 Le Genest-Saint-Isle, France) 
were used for virus-injection experiments. Transgenic mouse lines include Thy1-
TwitchER lines generated by the group of Ronald Naumann in the Transgenic Core 
Facility of the Max Planck Institute of Molecular Cell Biology and Genetics (01307 
Dresden, Germany) (see chapter 3.2.7). All experimental mice were kept and bred 
under standard conditions, i.e. they were held in Eurostandard Type II long cages 
365x207x140 mm cages (Tecniplast, Hohenpreißenberg, Germany) and stored in 
an IVC rack system in 12 h light/dark cycles. The maximum number of mice was 
limited to five per cage. The animals were fed autoclaved food (regular food ‘Maus’ 
from Ssniff, Soest, Germany) and water ad libitum (Bewersdorf, 2017; Schumacher, 
2015). All animal work was approved by the Animal Study Committee of the Regier-
ung von Oberbayern.  
3.2.3 Cell culture 
Hek-293 cells were cultured under standard conditions. The cells were grown in 
Dulbecco’s Modified Eagle Medium (DMEM), substituted with 10 % fetal bovine se-
rum and 1 % penicillin/streptomycin. For in-vitro characterisation of Twitch2B 54S+ 
 
Figure 7: Plasmid map pAAV-mEmeraldER 
Schematic representation of pAAV-mEmerald ER plasmid. ITR= Inverted terminal 
repeats. 
……
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ER sensor in the pharmacological ER depletion and replenishment experiment 
~50.000 Hek-293 cells were seeded on poly-l-lysine coated glass coverslips in 6-
well titer plates. The next day, for transfection, 500 ng plasmid DNA of the pCMV-
Twitch2B 54S+ ER construct was diluted in 500 µl sterile PBS, mixed with 0.5 µl 
lipofectamine and incubated at room temperature for 10 minutes. The mixture was 
added on the cells dropwise, and the medium was exchanged with 3 ml fresh me-
dium after two to five hours. Afterwards, the cells were grown for one to two days to 
express the construct sufficiently before imaging. 
For the negative-control cell experiment, 60–100 µl of dense cell suspension was 
seeded on 3–6 cm petri dishes. Hek-293 cells were transfected the next day with 2-
4 µg of pCMV-Twitch2B 54S+ ER or pCMV-Twitch2B mutated linker construct re-
spectively using a standard calcium-phosphate transfection protocol. Cells were 
subsequently imaged using the FVMPE-RS Olympus 2-photon microscope after ex-
pression was confirmed using an epifluorescence microscope. 
3.2.4 AAV production and spinal cord injection 
The production of AAV from the AAV-mEmeraldER-expression constructs was 
kindly assisted and instructed by Charlène Granier (PhD student, Bareyre lab, LMU) 
and Anja Schmalz (technician, Kerschensteiner lab). An AAV 1/2 production was 
performed using standard techniques. Briefly, 6·106 AAV-293 cells were seeded in 
14 cm plates with 10 ml DMEM on each. Cells were transfected with AAV-mEmer-
aldER and Helper plasmid DNA on day 2 using a standard calcium-phosphate trans-
fection protocol. After additional three days of growth, the virus was harvested using 
extremely low protein-binding cellulose acetate membranes. Afterwards, the crude 
lysate was purified with Amicon-ULTRA centrifugation filters. The AAV-mEmer-
aldER virus titer was determined to be 9.79·1010 copies /ml by quantitative PCR, 
using primers specific to the pAAV Cag vector according to an established protocol 
(Veldwijk et al., 2002). 
Spinal-cord injections of the virus were carried out in order to label axons in inter-
costal nerves, which are accessible to imaging by preparation of triangularis sterni 
explants (see chapter 3.2.5). To this end, AAV particles were stereotactically in-
jected into the mouse cervical and/or upper thoracic spinal cord. Shortened glass 
pipettes produced with a vertical pipette puller were filled with 1 µL of AAV mEmer-
aldER solution diluted to 1:2 in 1x sterile PBS. C57BL/6JRj mice older than six 
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weeks were anaesthetised using MMF (15 µL/ mouse g) and a one-level laminec-
tomy was performed of cervical vertebra 7 (identified by prominent spinous pro-
cess). The dura was removed using a hooked needle tip in the space between C7 
and Th1. The coordinates for the bilateral injection were chosen to be 0.5 mm lateral 
of the central vein and 0.9 mm below the dorsal surface in order to reach α-motor 
neurons in the ventral horn. The neck muscles were loosely adapted to cover the 
injection site by suturing, and the skin was closed with metal clips. Animals were 
subsequently allowed to recover in a pre-heated chamber and monitored daily for 
signs of discomfort or neurological deficit. Triangularis sterni explants were prepared 
six to eight weeks after the injection. The protocol was modified from Breckwoldt 
(2014). To verify the injection protocol, transverse spinal cord sections of the injec-
tion site were examined by confocal microscopy using an FV1000 confocal system. 
The staining of α-motor neurons and morphological signs of toxicity were assessed. 
3.2.5 Explant imaging and laser transections 
For the preparation of triangularis sterni muscle explants, mice were euthanised six 
to eight weeks after AAV-mEmeraldER, with spinal-cord injections using isoflurane. 
The rib cage, which contains intercostal nerves and the triangularis sterni muscle, 
was isolated using paravertebral cuts, cleaned of muscles attached to the rib cage 
externally, and then pinned into Sylgard-coated dishes using minuten pins. After-
wards, the rib cage was placed on a heated stage (32-35 °C) in normal Ringer so-
lution and bubbled with carbogen gas (95% O2, 5% CO2) (Breckwoldt et al., 2014; 
Kerschensteiner et al., 2008). Recordings were performed in the middle part of in-
tercostal nerves, which contained mEmeraldER-labelled axons.  
For structural imaging, a BX51 wide-field microscope was used equipped with 
x20/0.5 N.A. and x100/1.0 N.A. dipping-cone water immersion objectives, a filter 
wheel with a shutter, a 525/50 nm emission filter (AHF Analysentechnik AG, 72074 
Tübingen, Germany), a 470/40 nm excitation filter (F47-526 AHF Analysentechnik 
AG, 72074 Tübingen, Germany) and a cooled CCD camera in order to image 
mEmeraldER green fluorescence. 
For laser transections of intercostal nerves in explants, confocal imaging was per-
formed using an FV1200 system with an attached confocal unit. For laser transec-
tions, the Mai Tai 2photon laser was tuned to 760–800 nm, a circular region of in-
terest on a labelled axon was defined. Subsequently, this region was illuminated at 
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60–80% laser transmission in the ‘whirl mode’ for 3 to 10 seconds. The lesion site 
was observable by a rise of autofluorescence in the region of interest. Subsequently, 
the light path was changed to confocal imaging. The 488 nm laser line was used for 
excitation, while light from 500–600 nm was detected. The interval was set at ‘free-
run’. The focus was continuously adjusted during recording.  
3.2.6 In vitro characterisation of calcium sensor 
For the pharmacological ER depletion and replenishment experiment, glass co-
verslips with pCMV-Twitch2B 54S+ ER transfected Hek-293 cells (see chapter 
3.2.3) were transferred to a heated (37 °C) Warner Instruments flow chamber by 
using forceps. The chamber was continuously perfused with carbogen-gassed 
HEPES buffered Hank’s balanced salt solution (HHBSS). Pharmacological solutions 
consisted of carbogen-gassed HHBSS containing either 3 µM thapsigargin for ER 
depletion or 10 mM CaCl2 + 5 µM ionomycin for ER replenishment. These were 
directed to the heated flow chamber through a tubing system with a flow valve upon 
opening of a luer lock. Imaging was performed with a widefield BX-51 Olympus 
epifluorescence microscope equipped with a water-immersion Olympus UApo 
40x/1.15 N.A. objective with correction collar to adjust for the variable thickness of 
the coverslip glass. CFP (exposure 300 ms) and YFP-FRET channels (exposure 
150 ms) were alternately recorded at a frequency of 1 Hz. A FRET CFP/YFP filter 
set (F46-052 AHF Analysentechnik AG, 72074 Tübingen, Germany) was used, 
which contains the excitation bandpass filter 436/20 and the dichroic mirror 455LP 
to remove excitation light from the emission-light path. The emission filters, CFP 
bandpass 480/40 nm (F47-480 AHF Analysentechnik AG, 72074 Tübingen, Ger-
many) and YFP bandpass 535/30 nm (F47-535 AHF Analysentechnik AG, 72074 
Tübingen, Germany), were alternated with a fast-moving filter wheel. The images 
were recorded with a cooled CCD camera.  
The experiment was conducted with 10 frames (=20 s) pre-run with HHBSS perfu-
sion, after which the luer lock to the thapsigargin solution was opened. Thapsigargin 
perfusion was maintained for 300 frames (=10 min), after which the luer lock was 
closed again. In an immediately following second-recording, 10 frames (=20 s) pre-
run were acquired, followed by the opening of the luer lock to the ionomycin + CaCl2 
solution. Next, another 300 frames (=10 min) were recorded. A photograph of the 
experimental setup can be seen in Figure 8. 
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For the negative control experiment, transfected cells (either with pCMV-Twitch2B 
54S+ ER or pCMV-Twitch2B mutated linker DNA) were imaged directly in 6 cm petri 
dishes using an Olympus FVMPE-RS 2photon microscope equipped with a x25/1.05 
N.A. water-immersion objective after replacing the medium with 3 ml prewarmed (37 
°C) HBSS without phenol red. Seventy images were acquired every 10 seconds, 
and the focus was continuously adjusted. A total of 1 ml of 20 µM prewarmed (37 
°C) thapsigargin stock solution in HBSS was gently pipetted into the petri dish after 
10 time points to yield 5 µM thapsigargin concentration. The imaging settings were 
as follows: GaAsP1 detector: 500 V, GaAsP2 detector: 550 V, Insight laser tuned to 
840 nm with variable AOTF between experiments. The emission filter cube FV30-
FCY (CH1: BA410-455 / SDM475 / CH2: BA495-540; Olympus GmbH, Hamburg, 
Germany) was inserted. 
3.2.7 Generation of transgenic mice 
Thy1-Twitch2B 54S+ ER transgenic mice (abbreviated as Thy1-TwitchER) were 
generated by pronuclear injection into a C57Bl6 background in cooperation with 
Ronald Naumann (Transgenic Core Facility of the Max Planck Institute of Molecular 
Cell Biology and Genetics, Dresden, Germany). To prepare the DNA for pronuclear 
injection, 10 µg of the Thy1(modified)-Twitch 2B 54 S+ ER plasmid were linearised 
 
Figure 8: Experimental setup for in vitro sensor characterisation 
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using the restriction endonucleases NheI HF and MfeI HF. The DNA was run on an 
ethidium bromide free 1 % agarose gel and loaded without loading dye. The respec-
tive band with a calculated size of 8794 bp was cut out. In order to achieve this 
without inducing UV damage to the DNA, an outlying control lane with a small 
amount of the cut plasmid was stained individually with ethidium bromide and used 
as reference for the cut-out site (Figure 9A). The cut-out gel fragments were purified 
using the QIAquick Gel Extraction Kit. The DNA was eluted in pronuclear injection 
buffer. The eluted DNA’s concentration was determined to be 57.5 ng/µl using a 
Nanodrop (ThermoFisher Scientific, Waltham, Massachusetts, USA) spectrometer. 
Pronuclear injection was carried out by the Naumann laboratory. Specific PCR pri-
mers and a corresponding thermocycler program were designed to generate a band 
of 235 bp in the presence of the Thy1-Twitch2B 54S+ ER insert: 
Myc2_Fwd: 5' CCGAGGTGAAATTCGAAGGG 3' 20bp, Tm= 58,63 °C  
Myc2_Rev: 5' TCTTCTGAGATGAGTTTTTGTTCTG 3' 25bp, Tm= 57,51 °C  
Thermocycler program: 1: 94 °C 1 min 2: 94 °C 10 s 3: 55,5 °C 5s  
4: 72 °C 15 s 5: GOTO 2 Repeat 29 times 6: 72°C 10 min 7: 4 °C forever  
From 43 tails sent by the Naumann laboratory, 11 were tested positive using this 
genotyping PCR. The corresponding agarose gel can be seen in Figure 9B. The 
offspring of these 11 mice represented the founder lines, which were subsequently 
screened for expression patterns and brightness of the Twitch2B54S+ ER GECI 
insert. 
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3.2.8 Screening and immunohistochemistry of Thy-TwitchER mice 
Offspring of the 11 founder lines were screened as previously described (Marinkovic 
et al., 2015). Explants were prepared and imaged as described in chapter 3.2.5 in 
order to assess expression in intercostal nerves and neuromuscular junctions 
(NMJs). After extraction of the rib cages, animals were transcardially perfused with 
4 % wt/vol paraformaldehyde (PFA) diluted in 1x phosphate buffered saline (PBS) 
and then post-fixed in 4 % PFA in PBS for 24 hours. Afterwards, spinal cord, brain 
and eyes were micro-dissected under an Olympus Stereo Microscope SZ51. Eyes 
and spinal cord were incubated in 30 % sucrose in 1x PBS for a minimum of 24 
hours for cryoprotection. Cryoprotected samples were embedded in O.C.T. and rap-
idly frozen in an ethanol-dry-ice bath. Some 30-50 µm sections were prepared using 
a Leica CM1850 cryostat. A total of 50-100 µm brain sections were cut using a 
HISTO LEICA vibratome VT1200S. The samples were mounted on microscope 
slides; a drop of Vectashield was applied and cover slips were gently placed on top. 
The edges were sealed using nail varnish. Subsequent imaging was performed with 
an Olympus FV1000 confocal microscope. The 515 nm laser line was used for ex-
citation with a 440/515/635 excitation dichroic mirror placed in the light path. The 
emission light was sent through a 535-565 nm bandpass filter and collected with a 
 
Figure 9: Thy1-TwitchER linearisation and genotyping gels 
(A) Linearisation digest gel (NheI HF, MfeI HF) of Thy1-Twitch2B 54S+ ER plasmid 
for pronuclear injection, control lane. Upper band of 8794 bp was cut from aligned 
neighbouring unstained gel section. (B) Agarose gel from genotyping PCR. 11 
Thy1-Twitch2B 54S+ ER positive lanes are labelled with founder line number. The 
plus sign indicates positive control (5 ng of Thy1-Twitch2B 54S+ ER plasmid); the 
minus sign indicates negative control (water). The same 2-log DNA ladder as la-
belled in (A) was used on all gels.  
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photomultiplier tube (PMT). The PMT voltage was adjusted to prevent oversaturated 
pixels. x10/0.3 N.A. dry, x20/0.85 N.A. oil-immersion and x60/1.42 N.A. oil-immer-
sion objectives were used. Mosaic scans of brain slices were produced using the 
x20/0.85 N.A. oil-immersion objective and 20 % overlap between images. Images 
were stitched in Image J. Expression of the GECI construct was assessed in the 
cortex, hippocampus, cerebellum, spinal cord, dorsal root ganglia and retina. 
To validate the sensors’ localisation in the ER, immunostainings of the ER resident 
chaperone GRP78/BiP were performed on cryoprotected lumbar spinal cords. 
Some 50 µm-thick sagittal sections were cut using a cryostat. Sections were stained 
with the free-floating immunohistochemistry protocol shown in Table 2. Stained 
samples were mounted in Vectashield and sealed with nail varnish. The stainings 
were analysed using an Olympus FV1000 confocal microscope exciting with 488 
nm and 635 nm laser lines and a 405/488/559/635 excitation dichroic mirror. A 535-
565 nm bandpass filter was used to collect FP fluorescence in channel 1. An SDM 
640 dichroic mirror was used to collect AF 647 infrared-emission light in channel 2. 
Based on the in-vitro and in-vivo (vide infra) screening results, two transgenic lines 
were selected for further breeding: Thy1-TwitchER 481 because of a particularly 
bright subset labelling in the dorsal spinal column apt for in vivo imaging, and Twer 
489, because of a full labelling, which also includes cerebellar Purkinje cells. 
 
Step Temperature Time Medium 
1 Washing Room tem-
perature (RT) 
3 x 10 
min 
1x PBS 
2 Blocking RT 1 h 10% goat serum (g. s.)/0.5 
%Triton X-100 (T)/PBS 
3 Primary anti-
body 
4°C, shaker overnight 1:200 rabbit polyclonal to 
GRP78 BiP antibody (diluted in 
1 % g.s./ 0.5 % T/ PBS) 
4 Washing RT 4 x 10 
min 
0.5 %T/ PBS 
5 Secondary anti-
body 
RT 3 h AF 647 goat anti rabbit 1:1000 
(diluted in 1 % g.s./ 0.5 % T/ 
PBS) 
6 Washing RT 3 x 30 
min 
PBS 
Table 2: Free-floating GRP78 BiP immunohistochemistry protocol 
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3.2.9 In-vivo 2-photon imaging of Thy1-TwitchER mice  
Thy1-TwitchER mice were used for 2-photon imaging of the spinal cord’s dorsal 
column. Surgery was performed according to an established protocol 
(Kerschensteiner et al., 2005; Nikić et al., 2011; Romanelli et al., 2013). Mice were 
anaesthetised by intraperitoneal injection of MMF (a mixture of 0.5 mg/kg me-
detomidin, 5 mg/kg midazolam and 0.05 mg/kg fentanyl) and kept in a heating pad 
for approximately 15–30 min in order to ensure sufficient depth of anaesthesia. The 
fur above the spinal cord was shaven; animals were fixed on a metal plate with their 
limbs outstretched using elastic rubber bands and magnets. A median incision was 
made above the lower lumbar spinal segments with a surgical blade. Using spring 
scissors, tissue was removed down to the autochthonous back musculature, which 
was carefully dissected to allow access to the lateral processes and laminae of the 
lumbar vertebrae L4 and L5. Bilateral laminectomies were performed, and the lam-
inae were gently removed by applying tension on the spinous process and attached 
muscles. Bleeding was controlled by using triangular cotton swabs (sugis) and a 
hemostatic sponge material (spongostan) drenched in artificial cerebrospinal fluid 
(ACSF). The exposed spinal cord was repeatedly rinsed with ACSF. The dura mater 
was punctually incised with a hooked 30-gauge hypodermic needle tip, pinched with 
a Dumont mini forceps (size 5) and carefully stripped off. For immobilisation of the 
spinal cord, the vertebrae adjacent to laminectomy were clamped using a Narishige 
clamping device, and the animal’s tail was fixed. Subsequently, a 2 % agarose well 
was constructed surrounding the laminectomy site in order to keep the immersion 
liquid, ACSF, at a sufficient level for imaging. 
In-vivo microscopy of exposed dorsal column axons was performed using an Olym-
pus FV1200-MPE 2-photon microscope equipped with a femto-second pulsed tita-
nium-sapphire laser (Mai Tai HP-DS). The laser was tuned to 840 nm, a wavelength 
which has been validated for CerTN-L15 mice, which also express a CFP/YFP con-
taining fluorescent GECI (Schumacher, 2015). The laser was modulated in intensity 
with an acousto optic tunable filter (AOTF). Emission was detected using gallium 
arsenide phosphide (GaAsP) detectors, which were generally set at a voltage of 640 
V for the CFP channel and 500 V for the YFP channel, unless otherwise indicated. 
We used 455-490 and 526-557 nm emission bandpass filters to detect CFP and 
YFP channels. Images were acquired at 12 bits with a 25x/1.05 N.A. dipping cone 
water-immersion objective. Volume stacks were acquired penetrating up to 60 µm 
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into the tissue from the dorsal surface. During imaging, animals were kept under 
constant anaesthesia with regular assessment of breathing and reflexes. Animals 
were euthanised with isoflurane after imaging. 
3.2.9.1 In-vivo 2-photon imaging of pharmacological ER depletion 
For pharmacological characterisation of the Thy1-TwitchER 481 line, the ER-deple-
tion agent thapsigargin was applied on the exposed spinal column. One pre-appli-
cation stack was acquired with GaAsP1 detector voltage at 600 V and GaAsP2 de-
tector voltage at 500 V. All other parameters matched the description above. The 
ACSF in the agarose well was then replaced by 10 µM thapsigargin in ACSF. For 
this purpose, a 1 mM thapsigargin dimethyl sulfoxide (DMSO) stock solution was 
diluted in ACSF 1:100, thereby keeping the DMSO concentration at 1 %. The spec-
imen position was adjusted to match the pre-stack location. Subsequently, the spinal 
cord was imaged in 10 min intervals under continuous thapsigargin bath application. 
At least 5 stacks were recorded. 
3.2.9.2 In-vivo 2-photon imaging of EAE lesions 
EAE was induced in mice older than six weeks using a standard protocol (Abdul-
Majid et al., 2000). Mice were immunised with 250 µl of an emulsion containing 400 
µg of purified recombinant myelin oligodendrocyte glycoprotein (MOG, N1-125, pro-
duced in E. coli) and incomplete Freund’s adjuvant with 5 mg/ml mycobacterium 
tuberculosis H37 Ra. Animals were anaesthetised with KX (mixture of 87 µg/g body 
weight Ketamine and 13 µg/g body weight Xylazin) and received three subcutane-
ous injections of the described emulsion, 50 µl at the base of the tail and 100 µl in 
both flanks. On the day of immunisation and 48 hours later, 350 ng of pertussis toxin 
(Ptx) were administered intraperitoneally. Following the immunisation, the animals’ 
weight and neurological status was assessed on a daily basis. A standardised EAE 
scoring scale for evaluation of neurological deficits was employed: 0, no detectable 
clinical signs; 0.5, partial tail weakness; 1, tail paralysis; 1.5, gait instability or im-
paired righting ability; 2, hind-limb paresis; 2.5, hind-limb paresis with partial drag-
ging; 3, hind-limb paralysis; 3.5, hind-limb paralysis and fore-limb paresis; 4, hind-
limb and fore-limb paralysis; 5, death. Only animals with a score ≥ 2 were used for 
experiments, since at these stages, confluent lesions can be found in the superficial 
dorsal spinal cord ( Sorbara et al., 2014). Animals were imaged at two days (+/- 1 
day) after the onset of neurological symptoms, i.e. a score > 0. 
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Regions were selected for imaging based on the density of cellular infiltrates, which 
were detectable by autofluorescence and based on the presence of axonal degen-
eration stages (Nikić et al., 2011). Four or more stacks were acquired of each 
mouse. Imaging one region twice was avoided by meandering through the sample 
in a stereotypical way. The stacks were acquired with a z-step size of 1 µm, zoom 
2, 1024x1024 pixels and a pixel dwell time of 2 µs. 
3.2.9.3 In-vivo 2-photon imaging of laser-induced spinal-cord injuries 
The Thy1-TwitchER line 509 was used for a laser-induced spinal-cord-injury exper-
iment (LiSCI) (breeding of this line was later discontinued). In order to transect bun-
dles of axons, the 2-photon laser was tuned to 760 nm wavelength, and an elliptic 
area traversed by >10 axons was illuminated for 10s at 70–100 % laser transmission 
in the whirl mode. This reliably led to a local transection of the superficially passing 
axons, while sparing adjacent regions, which remained structurally unaltered. Tran-
sected axons could be identified by fragmentation of the ER, which progressed from 
the lesion site. The lesion was visible by autofluorescence.  
One pre-lesion stack was recorded. After laser lesioning, the field of view was 
moved cranially, so that the lesion site was directly adjacent to the imaging region, 
in order to avoid damaging the GaAsP detectors by the bright autofluorescence. 
Stacks were acquired at 2 min intervals for at least 14 min. Standard imaging pa-
rameters described above were used. 
3.2.9.4 In-vivo 2-photon imaging following spinal-cord contusion 
The Thy1-TwitchER line 509 was used for contusion experiments. An established 
protocol was adapted (Williams et al., 2014). In contrast to the other imaging exper-
iments, the dura mater was not removed in order to prevent obscuration by capillary 
bleeding. Contusions were administered using the Infinite Horizons impactor with 
the impact force set to 40 kDynes. Animals with significant subdural bleeding were 
excluded.  
For two time-point experiments, mice were imaged before and after the contusion. 
The stage coordinates were noted, and drawings were made of the vascular pat-
terns, as seen under epifluorescence illumination. After impacting, the well was re-
filled with a sufficient amount of ACSF for objective immersion, and the clamping 
device was reaffixed to the stage. The pre-position or, if obscured, the positions 
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directly adjacent to it were set. This process of administering the contusion and re-
positioning the mouse correctly took approximately five minutes. The post-contusion 
stack was acquired using the same imaging parameters as in the pre-contusion 
stack. Occasionally, the laser intensity had to be slightly reduced, in order to avoid 
saturation of pixels in brightly labelled ER fragments. For the contusion time-series 
experiment, z-stacks of the same region were acquired at 15 min intervals for 1 
hour. 
3.2.10 Image processing and analysis 
Images were post-processed using the open-source image-analysis software, Im-
ageJ/Fiji as well as Adobe Photoshop. In Fiji, the YFP(FRET) channel – with a gen-
erally better signal-to-noise ratio than the CFP channel – was visualised in a grey-
scale look-up table. In the case of spinal-cord in-vivo imaging data, regions of inter-
est (ROIs) of individual axons (only 1 ROI per axon was selected), as well as directly 
adjacent non-axonal background regions with similar size, were encircled as exem-
plified in Figure 10. Regions with saturated pixels were avoided. Mean grey values 
of axonal and non-axonal background ROIs were measured in the CFP and 
YFP(FRET) channels and subtracted in Microsoft Excel. The YFP(FRET)/CFP ratio 
of background corrected regions of interest was calculated. Background-corrected 
YFP(FRET)/CFP ratios were interpreted as proxy of ER-calcium concentration, as 
has been established previously for FRET-based GECIs (Mank & Griesbeck, 2008). 
For baseline characterisations, all axons crossing a virtual medio-lateral line were 
measured. The YFP/CFP ratios were normalised either to the mean of control mice 
or to the mean of the first time point of an experiment, as indicated. Only axons that 
could be tracked over all frames were included to time-series analyses. The same 
principles apply to cell experiments (1 ROI per cell plus adjacent cell-free back-
ground region were selected). For EAE experiment evaluation, each axon was as-
signed an FAD stage from zero to two based on visual-morphology assessment. In 
order to assign stage 1, a clear continuity of the beaded axon had to be detectable, 
as opposed to stage 2 axons, where the axonal continuity had to be visually dis-
rupted (Nikić et al., 2011). 
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Ratiometric images presented in this thesis were generated as follows: maximum- 
intensity projections of single channels were created, and a binary-threshold mask 
of axonal/cellular structures was generated from the YFP(FRET) channel. Projec-
tion images were multiplied by the binary mask, and the resulting images were di-
vided by each other (YFP(FRET)/CFP). This image was displayed with a custom 
look-up table, which represents the highest ratios as yellow and the lower ratios as 
violet or black. The boundary values for this look-up table were determined individ-
ually for each experimental setup. A despeckle filter was applied in Photoshop to a 
projection of the YFP(FRET) channel. The generated ratiometric RGB images were 
blended with this greyscale YFP(FRET) channel projection image using the ‘Over-
lay’ layer function. These images were only used for presentation purposes and not 
for analyses. 
3.2.11 Statistical analysis 
GraphPad Prism version 7.01 was used to calculate statistical significance. Un-
paired t-tests were employed where normal distribution could be confirmed using 
the Shapiro-Wilk normality test. The Mann-Whitney U test was used when normal 
distribution could not be confirmed. The data was considered significant when p 
values were <0.05. Significance levels are indicated in the figure legends and dis-
cussed in the corresponding passage. 
 
Figure 10: ROI selection for data analysis 
(A) Exemplary selection of axonal ROI (yellow) and non-axonal ‘background’ ROI 
(green) in Thy1-TwitchER transgenic mouse YFP channel in greyscale (saturated 
pixels red). Scale bar 10 μm (B) Exemplary selection of cellular ROI (yellow) and 
non-cellular ‘background’ ROI (green) in pCMV-Twitch2B 54 S+ ER transfected 
Hek-293 cell YFP channel in greyscale.  
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4 Results 
The structure of this chapter is based on the previously set objectives (chapter 2). I 
will demonstrate that intra-ER free calcium can be reliably measured in single axons 
and that intra-ER free calcium is dynamically altered in paradigms of axonal degen-
eration. 
4.1 Imaging intra-ER free calcium in single axons 
4.1.1 Targeting and visualising the axonal ER 
The axonal ER is very narrow – with a diameter that can vary between 15 and 30 
nm – and can be relatively sparse dependent on the neuronal subtype (Mark 
Terasaki, 2018). Therefore, it was necessary to validate that a concentration of FPs 
sufficient for imaging could be achieved in the peripheral axonal ER. Previously, 
neurite ER targeting and imaging of FPs in transgenic or virus-injected mice had 
only been accomplished with dendrites (Kucharz et al., 2011b; Okubo et al., 2015). 
A neurotropic AAV1/2 was produced which encodes for mEmeraldER, an ER-tar-
geted version of the bright, photostable GFP-variant mEmerald with an N-terminal 
calreticulin ER-signalling peptide and a C-terminal KDEL ER-retention sequence 
(see chapter 3.2.1). The calreticulin ER-signalling peptide and KDEL ER-retention 
sequence was used before to achieve dendritic ER expression in Thy1-EGFP-ER 
transgenic mice (Kucharz et al., 2011b).  
For preliminary validation of AAV-mEmeraldER, Hek-293 cells were infected with 
the virus, and an ER fluorescence pattern was visible. Next, spinal-cord injections 
of AAV-mEmeraldER were performed at levels C7/Th1 in C57BL/6JRj mice to yield 
fluorophore expression in intercostal nerve axons. Regional ER pattern expression 
at the injection site could be verified in 4 % PFA-fixed spinal-cord slices (prepared 
four weeks post-injection) by confocal microscopy (Figure 11A, B). The fluorescence 
pattern in neuronal somata was reminiscent of rough ER sheets; a nuclear envelope 
was also visible. Tubular ER fluorescence could also be detected in dendrites and 
axons, with bundles of labelled axons emerging from the ventral horns. Neurons 
appeared vital, and the regional damage caused by the injection was minimal. To 
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assess intercostal nerve mEmeraldER labelling, explants were prepared and im-
aged by widefield epifluorescence microscopy. Labelling of intercostal nerve axons 
was achieved with varying labelling densities. At 100x magnification, dense tubular 
ER could be visualised with prominent, bright subsurface cisternae-like structures. 
At the nodes of Ranvier, ER tubules become more sparse, and subsurface ER fea-
tures are more subtle (Figure 11C). Time-series imaging revealed occasional, 
brightly labelled, distally bound ‘comets’ reminiscent of vesicular structures, which 
moved rapidly and straight along the axon. One could hypothesise that these rep-
resent either a vesicular ER subcompartment for rapid supply of distal ER regions 
or mEmeraldER mistargeted to other vesicular organelles, or mere proteinaceous 
aggregates of mEmeraldER. The tubular axonal ER also displayed some motility in 
the sense of small, translational movements of tubules and the wobbling of loosely 
attached end-standing tubules/vesicles. 
To study potential ER response patterns following laser induced axonal injury, mor-
phological response patterns have been demonstrated for mitochondria, which swell 
and round up (Breckwoldt, 2014). Laser transections of single axons in intercostal 
nerves were carried out using punctual high-energy 2-photon laser illumination. 
Confocal imaging was employed. Indeed, a disintegration of the tubular ER into 
small, optically resolvable vesicular fragments was detected immediately proximally 
and distally to the injury site. Subsequently, the fragments seemed to fuse and cre-
ate larger vesicular bodies with bright mEmeraldER fluorescence. Notably, mEmer-
aldER fluorescence concentrated in the fragments, which indicates that the integrity 
of the ER membrane during the fragmentation remains intact and does not allow 
dissipation of molecules as large as FPs (~27 kDa). A representative time series 
can be seen in Figure 11D. The fragments were highly mobile, potentially indicating 
a detachment from the cytoskeleton, and concentrated in spatial intervals, where 
they often formed large clusters. The extent of vesicularisation spread over a maxi-
mum of several hundred micrometres from the injury site. Vesicularisation of the ER 
in response to injury of the plasma membrane has been described before in cell 
culture (Raeymaekers & Larivière, 2011). ER fragmentation in dendrites has also 
been described in paradigms of glutamate excitotoxicity and ischemia (see chapter 
1.2.5). In this thesis, axonal ER fragmentation could be established as a consistent 
and stereotypical morphological response to laser-induced injury and was consid-
ered as an indicator of ER-effective trauma in the following experiments. 
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Figure 11: AAV-mEmeraldER spinal cord injections and explant 
laser transections 
(A) Confocal image of spinal cord transversal section close to AAV-mEmerald ER 
injection site at 20x magnification; (B) at 60x magnification (α-motor neurons). (C) 
Widefield epifluorescence image of intercostal nerve axon at 100x magnification, 
rib cage explant of mouse injected with AAV-mEmeraldER. (D) Intercostal nerve 
axon laser-induced injury. Red asterisks indicate site of laser lesion. Confocal time 
series, rib-cage explant of mouse injected with AAV-mEmeraldER. Scale bars 25 
µm.   
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4.1.2 Twitch2B 54S+ ER can measure intra-ER free calcium 
Finding a suitable ratiometric calcium indicator was a prerequisite for reliability in 
vivo intra-ER free calcium measurements. Reasons for this are manifold: expression 
of individual axons can vary over time; movement artefacts can cause apparent 
changes in fluorescence intensity; and one time-point measurements, i.e. baseline 
characterisation, were required for the assessment of FAD stages in EAE. These 
requirements precluded the use of intensiometric ER-calcium indicators, despite 
their higher dynamic ranges. Obvious candidates which remained were GEM-Ce-
pia1er and ER-targeted FRET-based cameleons (see chapter 1.4.2). GEM-Ce-
pia1er was also analysed in cell culture and in intercostal nerves after GEM-Ce-
pia1er AAV injections. Owing to similar emission maxima as in FRET-based camele-
ons (for which corresponding filter cubes were available), the usage of GEM-Ce-
pia1er was, in theory, feasible. However, cellular imaging of GEM-Cepia1er required 
much higher excitation intensity than its cameleon counterparts, and the fluores-
cence yielded in both cells and explants was meagre (data not shown). Moreover, 
the excitation maximum is located at 391 nm wavelength, i.e. in the UV spectrum, 
which could account for considerable phototoxicity (Suzuki et al., 2014). Conse-
quently, it was opted against GEM-Cepia1er, despite its beneficial ratiometry, high 
dynamic range and high Kd-value (558 µM). Alternatively, Twitch2B 54S+ was 
cloned in frame with an N-terminal mouse immunoglobulin Vh-signalling peptide and 
a C-terminal KDEL ER-retention sequence (see chapter 3.2.1). Notably, this ER-
targeting approach had been successful before for labelling dendrites in cerebellar 
Purkinje cells in mice (Okubo et al., 2015). Twitch2B 54S+ ER had originally been 
generated in a screening for high dynamic range, minimal domain CFP/YFP-deriv-
ative-based FRET indicators (Twitch indicators) by Thestrup and colleagues 
(Thestrup et al., 2014). While the primary incentive of this screening was the search 
for highly sensitive calcium sensors with linear response kinetics, a number of low-
affinity calcium sensors were also yielded. Among these was Twitch2B-54S+ ER, 
with a high Kd-value of 174 µM and a dynamic range of 320%. This indicator was 
selected for further in-vitro characterisation for several reasons: First, resting axonal 
[Ca2+]ER had been determined to be on average ~150 µM (de Juan-Sanz et al., 
2017), which ideally matched the Kd of Twitch2B-54S+ER and would, in principle, 
enable ideal-response kinetics. Secondly, the sensor belongs to the family of FRET-
based (CFP/YFP derivative containing) ratiometric indicators, for which all filters 
 
  71 
were readily available and 2-photon excitation spectra and corresponding phototox-
icity had been determined beforehand (Schumacher, 2015). Thirdly, the FPs com-
prising the indicator (cpVenusCD and mCerulean3) offer high quantum yields and 
photostability, which is especially beneficial concerning the limited volume of axonal 
ER, which can only accommodate small amounts of sensor and restricts diffusion 
of new sensor molecules. Fourthly, FRET-based ER-calcium indicators that had 
previously been described suffered from low dynamic ranges. Lastly, Dr. von Blume 
(Max Planck Institute of Biochemistry, Martinsried, Germany) had made successful  
use of low-affinity calcium indicators of the Twitch family in the Golgi apparatus, 
which also constitutes a high calcium-content organelle (personal communication). 
For in-vitro characterisation of the sensor in Hek-293 cells, pharmacological manip-
ulations were used which can either cause ER calcium depletion by blocking the 
SERCA (thapsigargin) or can equilibrate calcium concentrations through mem-
 
Figure 12: HEK cell ER calcium depletion and replenishment 
(A) Representative pseudo-coloured ratiometric images of the fast phases of ER 
calcium depletion and replenishment in a Hek-293 cell with 3 µM thapsigargin (TG) 
and 10 mM ionomycin + 10 mM CaCl2 (Ionomycin); widefield-epifluorescence mi-
croscopy. (B) Graphs depict sequential depletion and replenishment of ER cal-
cium; 1st, 3rd quartiles and mean values are shown; recorded and measured with 
two-second intervals; a total of 14 individual cells in two independent imaging/treat-
ment rounds were analysed.  
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branes in the presence of high extracellular calcium and thereby replenish ER cal-
cium (ionomycin + CaCl2). Time-series analyses in Hek-293 cells demonstrated that 
Twitch2B-54S+ ER can indicate sequential ER-calcium depletion with 3 µM 
thapsigargin perfusion and ER-calcium replenishment with 10 µM ionomycin + 10 
mM CaCl2 perfusion. Graphs obtained from the time-series analysis of 14 individual 
cells in two independent imaging rounds are demonstrated in Figure 12B. Values 
are normalised to the mean of the first time-point. A dynamic range of ~ 300% 
(Rmax/Rmin) could be achieved, a value slightly below the dynamic range determined 
for purified Twitch2B 54S+ sensor (Thestrup et al., 2014), which could be, in part, 
accounted for by incomplete ER calcium depletion (the concentration, even after 
blocking the SERCA, is known to remain well over the cytoplasmic concentration in 
the range of tens of micromolar). 
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In order to verify that the sensor actually measures calcium levels, the following 
control experiment was performed: the calcium-responsive EF hand domains were 
 
Figure 13: Mutated EF hands Twitch2B control 
(A) Representative pseudo-coloured ratiometric images of Hek-293 cells trans-
fected with mutated EF hands Twitch 2B ER control plasmid (top) and functional 
Twitch2B 54S+ ER plasmid (bottom) treated with 5 µM thapsigargin; imaged with 
2-photon microscope. YFP channel in upper row, pseudocoloured YFP/CFP ratio 
in lower row. (B) Graphs depict responses of mutated and functional Twitch ER; 
thapsigargin is added at t=0 s; a total of 37 cells transfected with mutated Twitch2B 
ER and 39 cells transfected with functional Twitch 2B ER from four independent 
experiments were analysed. Error bars indicate standard deviation. Scale bars 5 
µm.  
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replaced by non-functional aliphatic linker domains in pCMV-Twitch2B 54S+ ER, 
thereby creating pCMV-Twitch2B mutated linker ER (see chapter 3.2.1). In Hek-293 
cells, ER calcium depletion with 5 µM thapsigargin does not cause changes in the 
ratio of the Twitch2B-mutated linker ER protein, while ratios in the functional 
Twitch2B 54S+ ER decline in the shape of a sigmoidal curve. This is demonstrated 
in Figure 13. The graph in Figure 13B displays the measurements from 37 pCMV-
Twitch2B mutated linker-transfected cells (negative control) and from 39 cells 
pCMV-Twitch2B 54S+ ER transfected cells (positive control), each in four independ-
ent experiments. Thus, changes in the ratio of functional Twitch2B 54S+ ER can 
reliably be attributed to functional EF-hand domains (i.e. a calcium-dependent pro-
cess) and not changes of the FPs themselves (e.g. by changes in pH and protona-
tion status). 
4.1.3 Generation and screening of Thy1-TwitchER transgenic mice 
 
Figure 14: Twitch2B 54 S+ ER expression in Thy1-TwitchER trans-
genic mouse lines 
(A-C) Confocal overviews of Thy1-TwitchER 481 fixed-tissue screening showing 
(A) a mosaic scan of a sagittal brain section, (B) a retinal section and (C) a hori-
zontal hemi-section of the spinal cord and an adjacent DRG with sparse subset 
labelling. (D) Twitch2B 54S+ ER positive Purkinje-cells of cerebellar section in 
Thy1-TwitchER 489 transgenic mouseline. Scale bars are 1 mm in (A), 5 µm in (B), 
100 µm in (C) and 10 µm in (D).   
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After verifying the functionality of the Twitch2B 54 S+ ER sensor in Hek-293 cells, 
Thy1-TwitchER mice were generated by pronuclear injection of linearised Thy1-
Twitch2B 54S+ ER DNA (see chapter 3.2.7). Eleven PCR positive transgenic mouse 
lines were yielded, which were then subjected to a previously described screening 
protocol, which involved rib-cage explant ex-vivo imaging (fluorescence in inter-
costal nerves and NMJs was evaluated), in-vivo imaging of the spinal cord and prep-
aration of brain, spinal cord and DRG slices from PFA-fixed mice (Marinkovic et al., 
2015) (see chapter 3.2.8). Two of the lines obtained turned out to be particularly 
interesting and were selected for continued breeding. Thy1-TwitchER 481 displayed 
strong expression in both the CNS and PNS in a sparse subset of neurons (Figure 
14A-C). Notably, neuronal somata showed significantly brighter fluorescence than 
their processes, which hints at different luminal ER volumes and complicates axonal 
ER imaging. The sparse subset labelling of DRG neurons (Figure 14C) is correlated 
with the subset labelling of axons in the superficial dorsal column, as seen by in-
vivo imaging. The subset labelling of axons in the dorsal column facilitates spinal 
cord in-vivo imaging by making the axons and stages of FAD more easily distin-
guishable. The second transgenic mouse line, which was kept for continued breed-
ing, was Thy1-TwitchER 489, which featured relatively bright and ‘full’ (~90 % of 
neurons) expression of the transgene, including expression in cerebellar Purkinje 
cells (Figure 14D), useful for electrophysiological experiments with cerebellar brain 
slices. All other lines lacked Purkinje cell expression. Another transgenic mouse line, 
Thy1-TwitchER 509, was used in several experiments of this thesis (when indi-
cated). However, breeding of this line was later discontinued due to limited breeding 
space. Thy1-TwitchER 509 is characterised by a subset expression in ~60 % of 
DRG neurons, which yields a higher labelling density in spinal cord in-vivo imaging. 
Fluorescence intensity was weak in comparison to Thy1-TwitchER 481, which de-
teriorated the signal-to-noise ratio. 
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To test whether Twitch 2B 54S+ was correctly localised in the ER, immunostainings 
of GRP78/BiP were carried out (see chapter 3.2.8). GRP78/BiP has previously been 
expressed in mouse dorsal-root axons (Stirling et al., 2014). Confocal imaging of 
stained spinal cord sections revealed that GRP78/BiP colocalises with the calcium 
indicator Twitch2B 54S+ in the Thy1-TwitchER481 transgenic line in spinal inter-
neurons (Figure 15). Spectral bleed-through between the channels was avoided by 
choosing a secondary antibody with an infrared emission spectrum and by sequen-
tial scanning of single channels (Alexa Fluor 647). GRP78/BiP clearly also stained 
ER of cells which did not display sensor expression, including glia, while DRG neu-
rons and axons were only weakly stained. Axonal ER tended to be fragmented after 
4 % PFA perfusion. Therefore, colocalisation could only be reliably demonstrated in 
spinal interneurons, where bright GRP78/BiP staining could be observed. 
 
Figure 15: Twitch2B 54 S+ ER colocalisation with GRP78/BiP 
Representative confocal image of an immunostained spinal cord sagittal slice, 
which demonstrates the colocalisation of the ER marker GRP78/BiP (red channel) 
and Twitch2B 54S+ ER (green channel). Note the GRP78/BiP positive cells in the 
overlay image, which do not express Twitch2B 54S+ ER. Scale bar 5 µm.  
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4.1.4 Thy1-TwitchER transgenic mice report intra-ER free calcium levels 
 
Figure 16: Functional characterisation of the Thy1-TwitchER 481 
transgenic mouse line with thapsigargin 
(A) Representative time series of Thy1-TwitchER 481 spinal cord in-vivo imaging 
experiment. Continuous 10 µM thapsigargin bath application (SERCA inhibitor) 
from t=0 onwards. On the left, greyscale YFP channel intensity projections; on the 
right, corresponding ratiometric (YFP(FRET)/CFP) images. (B) Graph obtained 
from two independent experiments, where a total of 25 axons were tracked over 
time. Error bars indicate standard deviation. 
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A pharmacological characterisation ensued the morphological screening of the 
Thy1-TwitchER 481 transgenic line. Depletion of intra-ER free calcium was 
achieved by a bath application of 10 µM thapsigargin dissolved in ACSF. DMSO of 
the stock solution was diluted to 1 % in ACSF. In-vivo imaging of the spinal cord 
(see chapter 3.2.9) revealed a gradual decline of the YFP(FRET)/CFP-ratio, which 
is consistent with a higher proportion of calcium-free sensor molecules. Analysis of 
a total of 25 axons tracked over time in two independent ER depletion experiments 
demonstrated that after 50 minutes of thapsigargin bath application, all axons were 
uniformly depleted in their ratios (Figure 16). Superficial axons depleted faster than 
deeper axons, probably owing to restricted thapsigargin diffusion into the tissue. 
Compared to Hek293-cell ER calcium depletion, which only requires 1–10 minutes, 
calcium depletion of the axoplasmic reticulum took significantly longer (~50 min). 
There could be several explanations for this phenomenon. Firstly, the effective con-
centration of thapsigargin reaching the axons by diffusion could be lower due to 
diffusion limitation by the tissue and dilution by interstitial fluids. Secondly, neurons 
could have a larger total supply of ER calcium, which might diffuse from somatic 
stores to axons, as long as these are not sufficiently blocked by the SERCA-inhibitor 
thapsigargin (assuming that axonal ER is continuous with somatic ER). Thirdly, the 
axonal ER might have less intrinsic calcium leak than somatic ER, which is feasible 
since axonal ER is SER without translocon pores (as opposed to the abundant RER 
in somata). Notably, the decrease of ratios also led to a reduced spread, potentially 
by an equilibration of ER calcium levels at the lowest possible level after pharmaco-
logical depletion and by reduced sensor response characteristics at concentrations 
far below the its Kd-value. Thus, Thy1-TwitchER mice reliably detected and reported 
relative changes in intra-ER free calcium of the axoplasmic reticulum. This finding 
confirmed that a sensor with a Kd suitable for measurement, axoplasmic reticulum 
calcium levels were selected. 
4.2 Intra-ER free calcium in paradigms of axonal degeneration 
With the generation of the transgenic Thy1-TwitchER mouse lines, a novel tool was 
at hand to directly visualise changes of calcium in the axoplasmic reticulum. More-
over, we observed an intriguing morphological response pattern: ER vesicularisa-
tion following laser-induced axonal injury in AAV mEmeraldER-injected mice. Ef-
fects of this vesicularisation process on ER calcium homeostasis could only be 
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speculated on using structural ER markers, but combined with ER calcium indicators 
these were open to direct investigation. Since ER calcium dyshomeostasis is dis-
cussed and plays an important role in axonal degeneration (see chapter 1.3.5), we 
further investigated changes of ER calcium as well as the phenomenon of ER ve-
sicularisation in various axonal degeneration paradigms. 
4.2.1 ER calcium release occurs late and is not causative for FAD  
An important mode of axonal degeneration that has been discovered in EAE is FAD, 
which is characterised by the succession of morphological degeneration stages. 
Stage 0 axons are morphologically unaltered, while stage 1 axons are defined by 
focal axonal swellings (while the axon’s continuity is maintained), and stage 2 axons 
are disrupted in their continuity and fragmented. Stage 1 axons are capable of re-
covery, while stage 2 axons are irrevocably damaged. The probability of the pro-
gression to the next stage is determined by the amount of cytoplasmic calcium. Ax-
ons with high cytoplasmic calcium  are more prone to undergo FAD and less likely 
to recover than axons with low/recovered cytoplasmic calcium (see chapter 1.3.1) 
(Nikić et al., 2011; Witte et al., 2019). In this thesis, the contribution of ER-derived 
calcium to the detrimental cytoplasmic-calcium rise observed in FAD was evaluated. 
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Figure 17: ER calcium in EAE 
(A) Representative in vivo 2-photon microscopy intensity projections (top, YFP 
channel) and the corresponding colour-coded ER calcium levels (bottom, 
YFP/CFP ratio) under control conditions (left) and subsequent to EAE induction, 
two days after onset (right). The images show the superficial dorsal funiculi of the 
spinal cord in Thy1-TwitchER 481 mice. (B) Exemplary images colour-coded for 
ER calcium (YFP/CFP ratio) of axons under control conditions (upper left) and ax-
ons representative of the morphological FAD stages 0 (upper right), 1 (lower left) 
and 2 (lower right) 2 days after onset of EAE (C) ER calcium of single axons 
(YFP/CFP ratio normalised to the mean of control axons) in healthy spinal cord 
and FAD stages in EAE. Grey bars indicate mean values. The percentages indi-
cated below show the proportion of axons with formally depleted [Ca2+]ER < control 
mean – 3 SD. Mann-Whitney U test control vs. EAE stages 0-2 in n = 6 control 
mice and n = 4 EAE mice. Scale bars are 25 µm in (A) and 10 µm in (B). n.s P > 
0.5, ***P < 0.001. Caption modified from and figure layout adapted from Witte et 
al. (2019). Experimenter: Alexander Scheiter 
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Figure 18: Thapsigargin depletes ER calcium in EAE 
(A) In vivo 2-photon maximum intensity projection of spinal cord axons of Thy1-
TwitchER 481 mice in EAE lesions. Left: pre-10 µM thapsigargin (TG) bath appli-
cation. Right: 50 min post 10 µM thapsigargin bath application. Top: Greyscale 
images of YFP channel. Bottom: Ratiometric (YFP(FRET)/CFP) images colour-
coded for ER calcium levels ([Ca2+]ER). Scale bar 25 µm. (C) [Ca2+]ER of single 
axons. Note that Mouse 1 and 2 belong to different Thy1-TwitchER lines (478 and 
481) and were imaged with different detector voltages. Thus, the YFP(FRET)/CFP 
channel ratio was normalised to the mean of the pre-TG time point for each mouse. 
Grey bars indicate combined mean values. Percentages (below) show the propor-
tion of axons with formally depleted [Ca2+]ER < control mean – 3 SD.  
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To this end, ER calcium was measured in spinal axons of healthy Thy1-TwitchER 
481 control mice and in axons of acute spinal lesions of Thy1-TwitchER 481 mice 
induced with EAE (see chapter 3.2.9.2). Four mice with an EAE score ≥ 2 and 6 
healthy control mice were imaged. Significant depletion of ER calcium was only de-
tectable in a small fraction of fragmented, i.e. stage 2, axons. This depletion did not 
reach values below the mean minus three standard deviations but was statistically 
significant compared to control. The cut-off value of the mean plus three standard 
deviations had previously been employed for a binary scoring approach in the as-
sessment of cytoplasmic calcium elevations (Witte et al., 2019). Stage 0 control ax-
ons did not display a significant decrease of ER calcium, as compared to healthy 
control axons. Neither did ER calcium in stage 0 axons differ significantly from stage 
1 axons (Figure 17). A Mann-Whitney test was employed, testing control axons 
against stage 0, stage 1 and stage 2 axons in a population based analysis respec-
tively since normal distribution could not be confirmed with the Shapiro-Wilk normal-
ity test. These data indicate that ER calcium only depletes in the late, irreversible 
stage of FAD. Consequently, ER calcium depletion does not predict the fate of ax-
ons undergoing FAD, unlike cytoplasmic calcium elevation. Thus, the observed cy-
toplasmic calcium elevations are not caused by calcium efflux from the ER, the most 
important organellar calcium store. However, this dataset can only securely assess 
relative ER calcium depletions in the range of the strong pharmacological depletions 
caused by thapsigargin, for which a substantial sensor response has been demon-
strated in Thy1-Twitch ER 481 mice (chapter 4.1.4). Notably, thapsigargin depletion 
could also be reliably measured in EAE lesions of two Thy1-TwitchER mice (lines 
481 and 478), which affirms the functionality of the Twitch2B 54S+ ER sensor under 
inflammatory conditions. Fifty minutes post thapsigargin application 33.3% of axons 
could formally be categorised as depleted, i.e. measured YFP(FRET)/CFP ratios 
were below the mean minus three standard deviations (Figure 18). Nonetheless, 
minute changes of ER calcium would likely be obscured due to the large interaxonal 
spread and due to the employed method of single time-point population analysis. 
Regarding axonal ER morphology, resolvable ER vesicularisation/fragmentation 
was not detectable in in FAD. 
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4.2.2 ER calcium release occurs early in models of LiSCI and spinal cord 
contusion 
Given that neither ER fragmentation nor ER calcium dysregulation (at least prior to 
the disruption of axonal continuity) was observable in EAE, other paradigms of ax-
onal degeneration were investigated. Since laser lesioning of intercostal nerve ax-
ons was shown to induce ER fragmentation in AAV-mEmeraldER-injected mice (see 
chapter 4.1.1), laser-induced spinal-cord injury (LiSCI) was chosen to search for 
detectable ER calcium alterations. Breckwoldt et al. (2014) were previously able to 
image temporal calcium in Thy1-TN-XXL mice following LiSCI. A localised calcium 
influx spread at a speed of ~3.8 µm/s from the transection site. With regard to this 
cytoplasmic calcium dysregulation, a concomitant dysregulation of ER calcium 
seemed likely. 
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Following LiSCI in Thy1-TwitchER 509 mice (see chapter 3.2.9.3), ER fragmenta-
tion occurred in severed axons and spread to a maximum distance of ~300 µm from 
 
Figure 19: Thy1-TwitchER laser transections 
(A) In-vivo 2-photon maximum intensity projection of spinal-cord axons of Thy1-
TwitchER 509 mice at time points pre-laser lesion, 0 min post-laser lesion, and 12 
min post-laser lesion. Left: Greyscale images of YFP channel. Right: Ratiometric 
(YFP(FRET)/CFP) images colour-coded for ER calcium levels ([Ca2+]ER). Laser 
lesion site partly included on right edge. Scale bar 25 µm. (B) Graph contrasts 
[Ca2+]ER time courses of a total of 37 transected axons2 [Ca2+]ER to a total of 18 
untransected axons obtained from five Thy1-TwitchER 509 mice beginning at time 
point of 0 min post-contusion. Error bars indicate standard deviation. Unpaired t-
test control transected vs. untransected except for 4 minutes time point transected 
vs. untransected Mann-Whitney U test. n.s P > 0.5, **P < 0.01, ***P < 0.001  
  
 
n.s. ** *** *** *** *** ***
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the transection site at the end of the observation period (12 minutes post-transec-
tion). The [Ca2+]ER time course of a total of 37 transected axons was compared to a 
total of 18 untransected axons obtained from 5 Thy1-TwitchER 509 mice (Figure 
19). Transected axons were differentiated from non-transected axons by the occur-
rence of resolvable ER fragmentation. Untransected axons were chosen not to trav-
erse the lesion site (which was detectable by strong autofluorescence). The ROI for 
[Ca2+]ER measurements was selected to be within a range of a 100 µm from the 
transection site. In the case of transected axons, the ROI was traversed by an ER 
fragmentation front. Z-stacks were acquired at two-minute intervals for a total of 12 
minutes following LiSCI. [Ca2+]ER was measurably reduced in transected axons com-
pared to non-transected axons and the decrease persisted for the total time of ob-
servation (12 minutes). The ratios of transected axons were significantly different 
from non-transected axons at all time points except for the first time point immedi-
ately after transection using unpaired t-tests or a Mann-Whitney test (for the 4 
minutes time point, where normal distribution could not be confirmed with the 
Shapiro-Wilk normality test). 
Regions of morphologically intact ER calcium had already displayed ER calcium 
depletion, so it remained unclear whether the fragmentation process per se was 
causative for the observed ER calcium depletion. However, it cannot be ruled out 
that visually intact axonal ER was, in fact, disrupted in its continuity at a submicro-
scopic level. The observed depletion of [Ca2+]ER was small in comparison to the ef-
fect of the thapsigargin-mediated depletion. A possible explanation could be that the 
electrochemical gradient for ER-calcium release is reduced by excessive calcium 
influx to the cytoplasm from the extracellular space. 
With respect to this potential limitation of ER calcium release in laser transections, 
the paradigm of spinal-cord contusion was chosen to study [Ca2+]ER dynamics. Wil-
liams et al. (2014) previously demonstrated that cytoplasmic calcium dysregulation 
occurs in a spinal-cord contusion model. Axolemmal mechanopores were discov-
ered to be an important port of calcium entry. Raised cytoplasmic calcium levels 
increased the degeneration probability. Intriguingly, many axons with increased cal-
cium recovered homeostasis without intervention (see chapter 1.3.4). Thus, the spi-
nal-cord contusion model offers a ‘window of opportunity’ for therapeutic interven-
tions, where axons still remain a recoverable state (in contrast to axonal transec-
tions, where the axonal fate is set). It can be speculated that the cytoplasmic calcium 
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elevations in the contusion model are less pronounced than in direct axonal tran-
section and maintain the steep physiological gradient for ER calcium release – 
which might, in turn, contribute to a further detrimental cytoplasmic calcium rise. 
 
  87 
Contusions were carried out as outlined in chapter 3.2.9.4 in a total of four Thy1-
TwitchER 509 mice. A comparison of pre- and ~5-min post-contusion 2-photon 
 
Figure 20: ER calcium in contusion model 
(A) In-vivo 2-photon maximum intensity projection of spinal-cord axons of Thy1-
TwitchER 509 mice at time points pre-contusion (left) and five min post-contusion 
(right). Top: Greyscale images of YFP channel. Bottom: Ratiometric 
(YFP(FRET)/CFP) images colour-coded for ER calcium levels ([Ca2+]ER). Scale 
bar 25 µm. (B) Graph depicts axonal [Ca2+]ER measurements of a control Thy1-
TwitchER 509 mouse before and after a five-min waiting interval, as opposed to 
[Ca2+]ER from 4 contused Thy1-TwitchER 509 mice pre-contusion and five min 
post-contusion. Bars indicate mean value. Unpaired t-test control pre vs. control 5 
min. Mann-Whitney U test pre-contusion vs. 5 min post-contusion. n.s P > 0.5, ***P 
< 0.001  
 
n.s. ***
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stacks revealed that resolvable ER fragmentation occurred in a large proportion of 
contused axons, while [Ca2+]ER was homogeneously depleted in all contused axons. 
The decrease of [Ca2+]ER was found to be statistically significant in a population-
based analysis including all contused mice pre- compared to post-contusion using 
a Mann-Whitney test, while the ratios of the control mouse axons were not signifi-
cantly altered using an unpaired t-test according to the results of the Shapiro-Wilk 
normality test (Figure 20). The pre-contusion data displayed a large spread, which 
was attributable to one mouse (Mouse #4), which might have accidentally been pre-
contused during the laminectomy. As a control, a Thy1-TwitchER 509 mouse was 
repeatedly recorded in five-minute intervals in order to exclude phototoxicity or pho-
tobleaching mediated changes of the YFP(FRET)/CFP ratio. The control did not 
show a significant change of reported [Ca2+]ER. When testing per animal with Mann-
Whitney tests all contused mice except for Mouse #4 had significantly decreased 
sensor ratios 5 minutes after contusion compared to the pre-contusion time point. 
The homogeneity of [Ca2+]ER depletion was in stark contrast to the changes which 
had previously been observed in cytoplasmic calcium levels. Cytoplasmic calcium 
levels differed between axons and predicted their fate (Williams et al., 2014). Since 
all axons display a similar extent of [Ca2+]ER depletion, it is unlikely that these are 
causative for cytoplasmic calcium elevations observed in Thy1-TN-XXL in only a 
fraction of axons. Notably, the experimental procedures had been carefully adapted 
to the protocol of Williams et al. (2014) (identical contusion device, contusion forces, 
imaging procedures and surgery technique). Thus, only a fraction of axons should 
undergo axonal degeneration due to the contusion damage. It appears that the 
events of [Ca2+]ER depletion and ER fragmentation are not fatal to spinal axons and 
can recover completely. In fact, the homogeneity of these events’ appearance indi-
cates they happen in a regulated fashion, which could even be speculated to play a 
protective role. 
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In another contusion experiment, which was, however, carried out in only one Thy1-
TwitchER 509 mouse, [Ca2+]ER was tracked over time (Figure 21). Following the ex-
pected initial [Ca2+]ER depletion, the time-series analysis revealed a recovery 
 
Figure 21: Temporal dynamics of ER calcium in contusion model 
(A) In-vivo 2-photon maximum intensity projection of spinal-cord axons of Thy1-
TwitchER 509 mice at time points pre-contusion, 15, 60 and 120 min post-contu-
sion. Left: Greyscale images of YFP channel. Right: Ratiometric (YFP(FRET)/CFP) 
images colour-coded for ER calcium levels ([Ca2+]ER). Arrows indicate an example 
axon with initially depleted [Ca2+]ER (15 min), which later replenishes (60 min), 
before depleting again (120 min). Scale bar 25 µm. (B) Graph depicts axonal 
[Ca2+]ER measurements of a single contused Thy1-TwitchER 509 mouse pre-con-
tusion ,15, 60 and 120 min post-contusion.  
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[Ca2+]ER to pre-contusion values after ~1 hour, while at ~2 hours post-contusion, 
several axons dropped to low [Ca2+]ER. Moreover, many axons managed to recon-
stitute ER continuity. The finding that YFP(FRET)/CFP ratios can recover (and de-
plete again) strengthens the finding of initial [Ca2+]ER depletion. Since ratios can be-
have dynamically, it is unlikely that the initial depletion is imitated by confounding 
factors, e.g. blood, which might selectively obscure YFP channel intensity. Never-
theless, these findings should be interpreted with caution, as the experiment was 
only conducted once. Subsequent repetition of contusion time-series analyses by 
Jonas Lehmitz, the successor for the axonal ER calcium project, substantiated the 
findings of initial ER-calcium depletion with subsequent recovery in spinal-cord con-
tusions (see chapter 5.2.2). 
In conclusion, [Ca2+]ER alterations and ER fragmentation have been discovered in 
two axonal degeneration paradigms: LiSCI and spinal-cord contusion. Importantly, 
ER-fragmentation and [Ca2+]ER alterations concur and represent a stereotypical re-
sponse pattern to mechanical axonal injury with little variation between axons. The 
discovery of axonal [Ca2+]ER changes and structural ER responses in traumatic injury 
emphasises the lack of these response patterns in EAE, where ER calcium levels 
remain stable until the axon has completely disintegrated and ER fragmentation 
cannot be resolved. 
To conclude, [Ca2+]ER alterations and ER fragmentation have been discovered in 
two axonal degeneration paradigms: LiSCI and spinal cord contusion. Importantly, 
ER-fragmentation and [Ca2+]ER alterations concur and represent a stereotypical re-
sponse pattern to mechanical axonal injury with little variation between axons. The 
discovery of axonal [Ca2+]ER changes and structural ER responses in traumatic injury 
emphasizes the lack of these response patterns in EAE, where ER calcium levels 
remain stable until the axon has completely disintegrated and ER fragmentation 
cannot be resolved. 
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5 Discussion 
5.1 Imaging intra-ER free calcium in single axons: Accomplishments 
and limitations 
In this thesis, a novel tool was generated, which allowed measurement of axonal 
intra-ER free calcium for the first time: the Thy1-TwitchER transgenic mouse line. 
By means of in-vivo 2-photon microscopy, direct axonal imaging of the spinal cord’s 
superficial dorsal column was achieved. Moreover, axonal ER morphology could be 
assessed for the first time in vivo (both by injecting the structural marker AAV-
mEmeraldER and by imaging the Thy1-TwitchER transgenic mouse line), which re-
vealed a unique response pattern to traumatic axonal injury: ER fragmentation. In 
this chapter, the pitfalls and potentials of axonal ER imaging and intra-ER free cal-
cium measurements will be discussed in depth. 
5.1.1 Insights from structural imaging of axonal ER 
The structural marker AAV-mEmeraldER was used as proof of principle to demon-
strate that axonal ER can be successfully labelled and imaged with FPs. This was 
an important prerequisite to evaluate the feasibility of generating a transgenic 
mouse line expressing a calcium indicator in the ER. The calreticulin signalling se-
quence, in combination with the KDEL retention sequence, were used in the AAV-
mEmeraldER construct, since these had previously been employed successfully to 
target and image dendritic ER in a Thy-1 EGFP ER transgenic line by Kucharz et al. 
(2011b). In chapter 4.1.1, we demonstrate that the AAV-mEmeraldER labelling pat-
tern matched the expectations for ER labelling: in confocal imaging of fixed spinal-
cord sections, nuclear envelope- and RER sheet-like structures were noted. Fur-
thermore, the confocal and widefield imaging of explants prepared from AAV-
mEmeraldER-injected mice revealed a dynamic network of tubules, with prominent 
subsurface structures and periodical thinning of the network corresponding to the 
nodes of Ranvier. Although localisation to the ER has not been verified by im-
munostainings for AAV-mEmeraldER injections (as it has been done in the case of 
Thy1-TwitchER mice), the morphological features observed correspond to electron-
microscopic depictions of axonal and somatic ER reported in literature (Terasaki, 
2018; Wu et al., 2017; Yin et al., 2016). Moreover, the morphological pattern yielded 
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was identical to the morphology of Thy1-TwitchER transgenic mice, where ER lo-
calisation was validated by the co-localisation of the ER marker GRP78/BiP and the 
calcium indicator Twitch2B 54S+ ER. 
What remains questionable is the identity of the fast-moving ‘comets’, which were 
incidentally observed in AAV mEmerald ER mice. Notably, similar distally bound and 
fast-moving vesicular structures were occasionally visible in Thy1-TwitchER trans-
genic mice, where they were often associated with depleted ER calcium levels. 
These could represent mere proteinaceous aggregates (FPs have a tendency for 
aggregation when they are expressed at high levels) or vesicles transported by fast-
axonal transport. In the latter case, the observed ‘comets’ could very well represent 
an axonal ER sub-compartment, which is not continuous with the tubular axonal ER, 
and might serve distinct functions, such as the rapid supply of ER resident proteins 
to distal axonal regions. 
The ER fragmentation, or vesicularisation process, observed in laser transections 
of AAV-mEmeraldER-injected mouse explants was a particularly intriguing finding. 
ER fragmentation had previously been reported as an ER response pattern, in re-
sponse to excitotoxicity and ischemia in dendrites (see chapter 1.2.5). In this thesis, 
ER fragmentation was established as a consistent response to traumatic ER injury, 
including laser transections and contusions. As in dendritic non-traumatic para-
digms, ER fragmentation in axons was demonstrated to be reversible in the case of 
spinal-cord contusions. Thus, ER fragmentation is not fatal to axons, and a coping 
program must exist. Given the regularity at which ER fragmentation occurs, one 
might speculate that it could even serve as a protective response to traumatic and 
non-traumatic injury mechanisms – for example, by limiting the ER stress response 
by restricting the diffusion of local luminal proteins. 
5.1.2 Assessing the chosen ER calcium indicator 
A primary focus of GECI engineering throughout the last years has been to enhance 
GECI sensitivity in order to resolve calcium fluctuations in the nanomolar range. This 
enabled researchers to measure cytoplasmic-calcium transients elicited by single-
action potentials (Tang et al., 2011). Contrarily, the generation of probes with lower 
calcium affinities which are necessary for measurements of calcium in high-calcium 
organelles, such as the ER, has long been an orphaned field of research. However, 
with recent implications of organellar calcium in physiology and pathophysiology, 
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interest in low-affinity GECIs has revived and has yielded a number of valuable new 
tools, including CEPIA and GAP1 calcium indicators, which have both been vali-
dated for intra-ER free calcium measurements. (Rodriguez-Garcia et al., 2014; 
Suzuki et al., 2014). Using G-CEPIAer, it has been possible to visualise dendritic 
synaptic activity-evoked ER calcium dynamics in cerebellar slices (Okubo et al., 
2015). erGAP1 also allowed ex-vivo measurements of ER Ca2+ release in acute 
hippocampal slices triggered by cholinergic receptors. Moreover, sarcoplasmic re-
ticulum calcium oscillations could be recorded in transgenic flies (Navas-Navarro et 
al., 2016), which only represented the second report of imaging ER calcium dynam-
ics in an in-vivo setting. Previously, the first report of in-vivo endoplasmic reticulum 
calcium imaging had visualised SR calcium decrease following muscle twitches in 
mice expressing the ER-targeted cameleon-family indicator D1ER (Rudolf, 
Magalhães & Pozzan, 2006).  
Thus, there was only a limited literature foundation on in-vivo ER calcium imaging, 
which, moreover, had only been achieved previously in somatic ER. This compli-
cated the choice of a suitable sensor for in-vivo intra-ER free calcium measurements 
in neuronal processes. At the beginning of this thesis, the concentration of ER cal-
cium in the axonal endoplasmic reticulum could only be speculated on. Favourably, 
de Juan-Sanz et al. (2017) carried out the first solid calculations of intra-ER free 
calcium in primary dissociated hippocampal neurons, where a mean concentration 
of ~150 µM was determined for somata. Furthermore, they demonstrated that ax-
onal ER calcium was not significantly different from somatic ER calcium, as ex-
pected from the assumption of ER continuity. The calculations were based on the 
measured fluorescence-intensity changes of several ER-GCaMP variants with dif-
ferent calcium affinities upon ionomycin-mediated saturation, assuming the pre-de-
termined in-vitro characteristics of the sensors. Notably, neuronal ER calcium varied 
significantly between cells, reflecting different states of activity. Nevertheless, it re-
mained unclear whether ER calcium in the neuronal population of interest (DRG 
neurons) in vivo is located in a similar range. According to Palmer et al. (2011), an 
ideal sensor’s Kd-value should be located in the range of ± 5 times the resting con-
centration, which represents the steep part of the binding curve, in order to be ca-
pable of measuring small concentration changes. Given that Twitch2B 54S+ dis-
plays a Kd-value of 174.0 µM, it would meet this criterion, even in cases of ER cal-
cium concentrations significantly higher than the ~150 µM assumed by Juan-Sanz 
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et al. (2017). However, this Kd-value was determined by calcium titrations of purified 
sensor protein in a cuvette using fluorescence spectrophotometry (Thestrup et al., 
2014), which does not take into account influences of the in-vivo setting and the 
modifications added to the sensor for ER targeting. While the N-terminal signalling 
peptide is cleaved upon translocation to the ER, the C-terminal KDEL-peptide re-
mains and can, in theory, alter the sensor’s structure and calcium affinity. Also de-
termined in the cuvette, Twitch2B 54S+ displays a dynamic range (∆R/R) of 320% 
(Thestrup et al., 2014), which is larger than the dynamic range of the cytoplasmic 
calcium sensor CerTN-L15 (95%); previously, this was successfully employed for 
in-vivo calcium imaging of cytoplasmic calcium in EAE (Heim et al., 2007; 
Schumacher, 2015). The amount of putative ER calcium change was unknown, so 
that a high dynamic range would, in theory, allow researchers to resolve compara-
tively small relative differences. Further advantages, which led to the choice of 
Twitch 2B 54S+, include its characteristic of being a FRET-based ratiometric sensor, 
which can help cancel out movement artefacts in an in-vivo setting and enable one 
time-point imaging. In fact, it comprises two fluorescent proteins with a high quantum 
yield and high photostability, mCerulean3 and cpVenusCD. Furthermore, the single 
functional EF-hand toadfish Troponin C-minimal domain linker leads to quasi-linear 
response kinetics over a large range in vitro (Thestrup et al., 2014) (see chapter 
1.4.2). 
Expressed in Hek-293 cells, Twitch 2B 54S+ ER responded to pharmacological de-
pletion (administration of the SERCA-blocker thapsigargin) and replenishment (ad-
ministration of ionomycin in a high calcium milieu) of the endoplasmic reticulum as 
expected. It displayed a dynamic range of ~300 %, similar to the dynamic range of 
320%, determined in cuvette measurements for Twitch 2B 54S+ (Thestrup et al., 
2014). This similarity of dynamic ranges indicates that the addition of the KDEL re-
tention sequence did not lead to a marked alteration of the sensor’s properties. 
Given that the N-terminal signalling peptide should be cleaved upon import to the 
endoplasmic reticulum, it can be assumed that this modification does not alter the 
sensor’s properties. 
Notably, signals obtained with FRET-based GECIs can be perturbed by a variety of 
environmental factors, which include temperature, pH, chloride and magnesium; 
these can affect either the fluorophores or the troponin-derived calcium-responsive 
element (Grienberger & Konnerth, 2012). Apart from temperature, which was tightly 
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regulated by a temperature-control system in case of the cell experiments, the other 
parameters were not directly accounted for. Regarding pH, mCerlulean3 has an 
acid-dissociation constant (pKa) of 4.7 and mVenus has a pKa-value of 6 (Bajar, 
Wang, Zhang, Lin & Chu, 2016), which is important to consider when imaging in 
acidic environments, such as the Golgi apparatus (Wu et al., 2000). De Juan-Sanz 
et al. (2017) measured ER pH changes in neuronal somata using ER-pHluorin in 
response to 500 µM ionomycin application and reported a pH increase from 7.25 to 
7.68. Such an alkalinisation is unlikely to impact the fluorophores. Advances in FP 
development have reduced chloride and magnesium sensitivity (Griesbeck, Baird, 
Campbell, Zacharias & Tsien, 2001). However, the influence of chloride and mag-
nesium concentration shifts on the Twitch2B 54S+ ER ratio cannot be ruled out 
completely. At least in the case of thapsigargin ER depletion, it is unlikely that the 
sensor’s fluorophores were perturbed by other environmental influences, since the 
ratio of the mutated EF hand control sensor remained stable, which indicates that 
the observed drop in ratios is caused primarily by the calcium-sensitive domain (see 
chapter 4.1.2). 
5.1.3 Remarks on the yielded transgenic lines 
Several Thy1-TwitchER transgenic lines were yielded, of which Thy1-TwitchER 509, 
Thy1-TwitchER 489 and Thy1-TwitchER 481 were used in this thesis (see chapter 
4.1.3). Thy1-TwitchER 481 mice were characterised by relatively bright sensor ex-
pressions in the superficial dorsal column. A rather small proportion of predomi-
nantly thick axons was labelled. In contrast, Thy1-TwitchER 509 displayed a larger 
proportion of labelled superficial dorsal column axons, which, however, required 
higher-laser intensities to generate sufficient emission light. Thy1-TwitchER 489 
mice were selected primarily because of the full labelling pattern, which is useful for 
imaging NMJs in triangularis sterni explants and because of the sensor expression 
detected in Purkinje cells, which can be used for electrophysiological studies in cer-
ebellar slices. 
The sensor’s brightness in axons was sufficient for in-vivo imaging of the spinal cord. 
As determined for the Thy1-TwitchER 509 line, signal-to-noise ratios of ~3 could be 
achieved for CFP, while signal-to-noise ratios of ~8 were obtained for YFP using 
optimised detection settings (GaAsP1 detector voltage of 640 V for CFP; GaAsP2 
detector voltage of 500 V for YFP). For the cytoplasmic calcium GECI transgenic 
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line CerTN an optimum signal-to-noise ratio of ~4 for both CFP and YFP channel 
was previously reported and CerTN was successfully used for in-vivo imaging of the 
spinal cord (Schumacher, 2015). The relatively low baseline signal-to-noise ratios 
of the CFP channel can be explained by the quenching of the donor’s fluorescence 
by FRET under high ER-calcium conditions. The low CFP signal-to noise ratio com-
bined with intraER free calcium variations between different axons putatively ac-
count for the large spread of baseline ratios observed in the Thy1-TwitchER trans-
genic lines. Inter-neuronal ER calcium variations have previously been reported (de 
Juan-Sanz et al., 2017). Thus, ER calcium is not as tightly maintained at a fixed 
baseline level as cytoplasmic calcium, which displays minimal interaxonal spread 
(Schumacher, 2015). The larger interaxonal ER calcium spread precludes the de-
tection of smaller ratio changes in population-based analyses. However, the track-
ing of relative intra-ER free calcium changes of single axons in response to the ap-
plication of the SERCA inhibitor thapsigargin were solidly achieved. In addition to a 
decrease in ratios, a reduction of the interaxonal spread was observed, which points 
to an equilibration of ER calcium levels between individual axons (see chapter 
4.1.3). This finding indicates that the sensor’s properties are unlikely to be perturbed 
in single axons. Possible perturbations leading to an interaxonal ratio spread despite 
a maximum ER calcium depletion could have been sensor concentration-dependent 
FRET or depth-dependent attenuation of individual channels’ signals. 
An effective co-localisation of the Twitch 2B 54S+ sensor with the ER-resident chap-
erone GRP78/BiP was demonstrated using immunostainings of spinal neurons. 
However, immunostainings of dorsal column axons were not obtained, since 4% 
PFA perfusion fixation led to a fragmentation of axonal ER, potentially because of 
the short period of ischemia and ionic dyshomeostasis during the period of  PBS 
flushing preceding PFA injection (see chapter 1.2.5). Moreover, the GRP78/BiP an-
tibody used did not yield a sufficiently strong staining of dorsal column axons. The 
co-localisation of GRP78/BiP and the Twitch 2B 54S+ sensor in somata of DRG 
neurons could be successfully demonstrated using an adapted staining protocol with 
optimised antibody incubation times by subsequent work by my colleague Jonas 
Lehmitz (Witte et al., 2019). Considering that the Twitch 2B 54S+ ER sensor reports 
high calcium levels, which are unlikely to be reached in other cellular compartments 
than the ER, and that no significant cytoplasmic sensor fluorescence can be de-
tected following ER fragmentation (a state in which the cytoplasm can be clearly 
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differentiated from vesicularised ER compartments), a high targeting efficiency of 
the sensor can be assumed. 
To assess the novelty of the generated Thy1-TwitchER transgenic lines, it can be 
said that at that time, the only other reported transgenic mice expressing an ER 
calcium indicator were mice expressing the excitation ratiometric erGAP1 under the 
control of the ubiquitous promoter CAG-GS, which also showed neuronal expres-
sion (Rodriguez-Garcia et al., 2014). Obvious advantages of the Thy1-TwitchER 
lines are the emission ratiometric property of the Twitch 2B 54S+ sensor, which can 
be imaged with commonly available CFP/YFP FRET filter sets, the neuron-specific 
expression achieved by the Thy1-promoter and the superior brightness of the incor-
porated fluorophores, which enabled in-vivo imaging of ER calcium in axons for the 
first time. 
5.2 Discussing the role of intra-ER free calcium in paradigms of ax-
onal degeneration 
In this thesis, several important new insights were gleaned on the behaviour of intra-
ER free calcium levels in three different paradigms of axonal degeneration: ER cal-
cium in neuroinflammatory EAE lesions only declined in late stages of FAD (making 
it an unlikely early effector), while ER calcium following LiSCI and spinal-cord con-
tusions responded with an early and generalised decrease in conjunction with ER 
fragmentation. Remarkably, these phenomena were completely reversible in the 
spinal-cord contusion model. Different modes of axonal degeneration, e.g. toxic, is-
chemic, neuroinflammatory or mechanical insults, can bear striking resemblances 
in terms of executed molecular pathways. Dysfunctional axonal transport, mitochon-
drial disturbance and increased intra-axonal calcium are considered to be the key 
convergence points of all axonal degeneration programs (Coleman, 2005). The 
strikingly diverse behaviour of ER contrasts to the stereotypically observed increase 
of cytoplasmic calcium and adds a new component of diversity to the concepts of 
‘commonality amid diversity’ (Coleman, 2005) for axon-degeneration mechanisms. 
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5.2.1 Identifying the source of detrimental calcium influx in EAE 
Axon loss is a pathognomonic feature of MS and its animal model, EAE, and deter-
mines the extent of disability in patients. Hence, it is imperative to analyse the pro-
cess of axonal degeneration and identify the molecular pathways involved. A multi-
tude of pathological features are observable in EAE, which include mitochondrial 
dysfunction (decrease of the mitochondrial membrane potential and morphological 
alteration), axonal beading and impaired cytoskeletal and axonal transport function 
(Nikić et al., 2011; Sorbara, Misgeld & Kerschensteiner, 2012). However, in order to 
assess the therapeutic value of any of these changes, it is of paramount importance 
to determine the sequence of events – to reveal which event is simply an epiphe-
nomenon of the initiated degeneration cascade and which event is truly causative. 
A newly discovered pathological feature that can already be detected in stage 0 
axons, is a long-lasting cytoplasmic calcium increase. Retained high cytoplasmic 
calcium is predictive of FAD progression (Schumacher, 2015). In contrast, the re-
constitution of normal cytoplasmic calcium levels favours a morphological recovery 
of axons. This was a particularly interesting finding, since it indicated that FAD was 
not a cul-de-sac but rather offers a time window for therapeutic intervention. Despite 
the lack of direct scientific evidence, it is tempting to consider this cytoplasmic cal-
cium rise as a primary, upstream event in the degeneration cascade of EAE. In fact, 
axonal swellings could be explained by the calcium-dependent activation of cal-
pains, which can degrade the cytoskeleton (George et al., 1995; Yang et al., 2013). 
Moreover, calcium accumulates in the mitochondrial matrix at high cytoplasmic cal-
cium levels. Excessive mitochondrial calcium uptake can lead to mitochondrial dys-
function and the initiation of cell-death programs (e.g. via MPTP formation) 
(Pivovarova & Andrews, 2010). Consequently, the assumption of calcium as an 
early effector in the FAD cascade is plausible. Notably, cytoplasmic calcium eleva-
tions have also been found to be fate-determining following transection and contu-
sion injuries (Adalbert et al., 2012; Vargas, Yamagishi, Tessier-Lavigne & Sagasti, 
2015; Williams et al., 2014). Assessing whether ER calcium release contributes sig-
nificantly to the cytoplasmic calcium elevations in EAE was one of the main objec-
tives of this thesis. Next I will therefore discuss the contribution of different calcium 
sources to axon degeneration in neuroinflammatory lesions. 
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5.2.1.1 ER calcium release  
By means of the newly developed ratiometric calcium reporter mouse line Thy1-
TwitchER 481, ER calcium was accessible to direct measurement for the first time. 
The sensor expression was sufficient to image the limited ER volume in single axons 
in active EAE lesions. Measurements of [Ca2+]ER in the different stages of FAD 
showed neither a significant difference between [Ca2+]ER of healthy control axons 
and stage 0 axons, nor a significant difference between [Ca2+]ER in stage 0 and stage 
1 axons in EAE lesions. Only [Ca2+]ER of irreversibly damaged stage 2 axons differed 
significantly from [Ca2+]ER in stage 1 axons (see chapter 4.2.1). The latter finding 
served as an important internal control, since it could be expected that energetic 
failure upon complete axonal fragmentation would lead to a depletion of ER calcium 
due to a reduction of SERCA activity. Notably, not all stage 2 axons showed a clear 
decrease in [Ca2+]ER, which again could be explained by an equilibration of cytoplas-
mic calcium and, subsequently, ER calcium to extracellular calcium concentrations. 
Stage 2 axons have lost their structural continuity and are thus considered inacces-
sible to therapeutic interventions. The dataset depicted contains data from four 
Thy1-TwitchER 481 with induced EAE and six healthy Thy1-TwitchER 481 control 
mice. The EAE experiments were later repeated by Jonas Lehmitz and yielded a 
total of seven control and seven EAE mice; they reached the same conclusions as 
the dataset acquired for this thesis. An important addition acquired by the dataset 
of Jonas Lehmitz was the caffeine-induced depletion of [Ca2+]ER at the end of each 
experiment. Caffeine depletion led to a robust decrease of ER calcium even below 
the arbitrary value of mean – 3 standard deviations in both EAE and control mice 
(the mean + 3 standard deviations was used for binary scoring for cytoplasmic cal-
cium levels) (Witte et al., 2019). Likewise, in this thesis, thapsigargin application on 
EAE lesions decreased [Ca2+]ER of one-third of axons below the value of the mean 
– 3 standard deviations after 50 minutes. The measurement of ER depletion indi-
cates that the responsiveness of the sensor is maintained in EAE lesions. A draw-
back of the Thy1-TwitchER 481 transgenic line is that it preferentially labels larger-
calibre axons compared to the Thy1-CerTN line used for cytoplasmic-calcium imag-
ing. Since smaller axons are more prone to undergo FAD, it is harder to find degen-
erating axons than in the Thy1-CerTN line. Additionally, labelling is overall sparser 
than in Thy1-CerTN line.  
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It could be argued that the depletion of ER calcium could occur only temporarily and 
might not be as prolonged as the observed cytoplasmic-calcium elevations. Thus, a 
single time-point analysis might be insufficient to detect such temporarily restricted 
events. However, when Jonas Lehmitz analysed single axons over 15 min in 30 
second intervals, no significant ER calcium fluctuations were observable in axons 
traversing EAE lesions. Another point to consider is that small [Ca2+]ER changes 
would likely be overlooked in the population-based analysis approach used in this 
thesis, due to the relatively high interaxonal variation in [Ca2+]ER. Nevertheless, large 
[Ca2+]ER variations in the dimension of caffeine or thapsigargin-mediated depletion 
were robustly detected in the population-based analysis approach and can be ex-
cluded for stage 0 and stage 1 axons in EAE lesions. 
In addition to the absence of large [Ca2+]ER transients, another line of argumentation 
can be pursued. Jonas Lehmitz determined whether [Ca2+]ER release, when it oc-
curs, measurably changes cytoplasmic-calcium levels. To this end, a substance was 
required that can rapidly deplete ER calcium in a spinal cord in in-vivo imaging set-
ting (contrary to thapsigargin which needs ~1 hour for complete ER store depletion). 
Caffeine, a reported voltage-independent activator of all three RyR subtypes 
(Thomas & Williams, 2012), depleted [Ca2+]ER to the lower measurement limit of 
 
Figure 22: Caffeine effect on [Ca2+]ER and [Ca2+]cyt 
(A, C) Intensity projections of healthy spinal cord dorsal funiculi (YFP channel, top) 
and colour-coded calcium levels (YFP/CFP ratio, bottom) of [Ca2+]ER in (A), i.e. in 
Thy1-TwitchER mice and [Ca2+]cyt in (C), i.e. in Thy1-CerTN-L15 mice. Time-lapse 
images before and after application of 50 mM caffeine. (B, D) Graphs of respective 
experiments illustrated as mean ± SD (n=26 axons in B, 46 axons in D). Data nor-
malised to mean values of initial measurements.  Scale bars = 25 µm. Figure 
adapted from and caption modified from Witte et al. (2019). Experimenter: Jonas 
Lehmitz. 
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Twitch2B 54S+ ER within three minutes. In contrast, caffeine application on spinal 
cords of Thy1-CerTN cytoplasmic calcium reporter mice did not lead to a marked 
increase of cytoplasmic calcium (Witte et al., 2019) (Figure 22). Thus, even the rapid 
ER calcium depletion caused by caffeine is insufficient to increase cytoplasmic ax-
onal calcium to an extent measurable with the CerTN calcium sensor. Albeit surpris-
ing, a recent report by de Juan-Sanz et al. (2017) has yielded very similar results in 
vitro. By using the cytoplasmic intensiometric indicator GCaMP6f with a Kd-value of 
375 nM, these researchers were able to measure the calcium transients elicited by 
the application of the SERCA-inhibitor cyclopiazonic acid (CPA) in the dendrites of 
dissociated hippocampal neurons. The CPA-induced cytoplasmic calcium increase 
in dendrites corresponded to an elevation of 11.8 nM, which is similar to the cyto-
plasmic-calcium elevation measured for a single action potential (9.6 nM). In axons, 
no significant cytoplasmic-calcium increase following CPA treatment could be de-
tected. Juan-Sanz et al. (2017) concluded that both dendritic and axonal ER occupy 
only a small volume percentage and thus – despite the high [Ca2+]ER concentration 
of ~150 µm – store only small absolute amounts of calcium, while axonal ER had to 
be even sparser than dendritic ER. Although the in-vivo imaging approach in this 
thesis lacks the resolution to visualise the axonal ER network and determine its per-
centage of axonal volume, confocal imaging revealed a steep intensity gradient in 
the labelling of neuronal somatic ER and axonal ER. The lower-labelling intensity of 
axonal ER compared to the somato-dendritic department suggests a smaller volume 
fraction. Based on these results, a significant contribution of ER-derived calcium to 
the constant cytoplasmic calcium elevations in FAD can be ruled out.  
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In addition, an essential experiment performed by my colleague Christoph Mahler 
clearly implicated extracellular calcium – which is around ten-thousand-fold higher 
than in the cytoplasm – as the predominant source for the cytoplasmic-calcium ele-
vation in FAD. Superfusion of neuroinflammatory lesions with the calcium chelator 
EGTA was capable of reconstituting intraaxonal calcium level and prevented axonal 
degeneration (Figure 23). However, this experiment alone is insufficient to rule out 
an additional influence of [Ca2+]ER. For example, SOCE could result from a depletion 
of ER stores (Jun Wu et al., 2016), which would mitigate a calcium influx from the 
extracellular space. In this scenario [Ca2+]ER depletion would be accentuated by a 
triggered extracellular calcium influx via ORAI channels. However, cytoplasmic-cal-
cium measurements in Thy1-CerTN mice treated with the RyR agonist caffeine 
 
Figure 23: Removal of extracellular Ca2+ reverses cytoplasmic 
Ca2+ accumulation and prevents axon degeneration  
(A) 2-photon in-vivo intensity projections of the spinal cord dorsal funiculus in an 
EAE mouse. The upper image displays colour-coded cytoplasmic calcium levels 
before, the lower image after 4 hours of EGTA calcium chelation. (B) Cytoplasmic 
calcium levels separately displayed for morphological stage 0 axons (left) and 
stage 1 axons (right) before and after chelation of extracellular calcium after 4 
hours of EGTA incubation. The percentages of axons with cytoplasmic calcium 
ratios > 3 times the standard deviation of control mean (± SEM) is noted on top 
and the corresponding range is depicted in yellow. Statistical testing per animal in 
n=5 control and n=5 EAE mice, paired t-test. (C) Tracing the axonal fate of stage 
0 axons (left) and stage 1 axons (right) with and without EGTA calcium chelation 
after 4 hours (chi-square test). Scale bar in A = 25 µm. *P < 0.05; **P < 0.01; ***P 
< 0.001. Figure adapted from and caption modified from Witte et al. (2019). Exper-
imenter: Christoph Mahler 
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showed no detectable late-phase cytoplasmic calcium increase, which could be at-
tributed to SOCE. 
5.2.1.2 Influx of extracellular calcium 
While the results of this thesis rendered the ER an unlikely contributor to the ob-
served elevations of cytoplasmic calcium, a pathway for the entry of calcium from 
the extracellular space could be established by parallel work in the Kerschensteiner 
laboratory. Various groups had proposed the reversal of Na+/Ca2+ exchanger and 
calcium influx through plasma-membrane calcium channels and glutamate exci-
totoxicity as putative mechanisms for the increase of cytoplasmic calcium in axonal 
degeneration (Friese, Schattling & Fugger, 2014; Mahad, Trapp & Lassmann, 
2015). However, parallel experiments performed by Christoph Mahler clearly indi-
cated that the opening of glutamate receptors mediated by the agonist glutamic acid 
was insufficient to cause a distinct cytoplasmic-calcium increase in axons. Notably, 
however, a cytoplasmic-calcium increase could very well be elicited in neuronal so-
mata, which served as an important internal positive control confirming a sufficient 
diffusion and concentration of glutamic acid. In addition, a protective effect of 
bepridil, an inhibitor of the Na+/Ca2+ exchanger, on FAD progression was not ob-
servable (Witte et al., 2019). 
After ruling out calcium release from internal stores and calcium influx via glutamate 
receptors or the Na+/Ca2+ exchanger, the importance of nanoscale ruptures in the 
plasma membrane was evaluated. These ruptures had previously been described 
as source of increased detrimental cytoplasmic calcium in traumatic neuronal inju-
ries, namely in a model of spinal-cord contusion (Williams et al., 2014). Experiments 
employing different macromolecules of different sizes with a fluorescent tag, which 
included 0.8 kD cadaverine or 3, 10 and 70 kD dextran, clearly demonstrated a 
permeability of a subset of axons (especially stage 1 and 2 axons, but also a signif-
icant proportion of normal-appearing axons) to these dyes in the EAE. Contrarily, 
healthy animals displayed persistent exclusion of the dye from the axoplasm. Im-
portantly, dextrans of the size of 70 kD remained excluded from the axoplasm in 
EAE, suggesting a size of less than 10 nm of the assumed membrane pores. The 
dye-uptake correlated positively with calcium-uptake in an in-vivo experiment with 
subdurally fluorescently tagged cadaverine-injected EAE mice on a single axon level 
(Witte et al., 2019). 
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These results clearly suggest that membrane disruption constitutes a primary path-
way of calcium entry into the axoplasm from the extracellular space. Evidently the 
question arises how these nanoruptures are formed and consequently resealed. 
One possibility is that they are mere ‘mechanopores’ as a result of axonal swelling 
and a disruption of the cytoskeleton. While a disruption of the membrane by sheer 
mechanical force seemed plausible in the spinal-cord contusion experiments per-
formed by Williams et al. (2014), in the context of EAE, the fact that the axonal 
swellings often occur after an initial increase of cytoplasmic calcium content pre-
cludes this interpretation. Thus, another scenario of a possible disruption of the 
plasma membrane by toxic mediators should be discussed. Candidates for toxic 
mediators are reactive oxygen species, which can result in lipid peroxidation (Di 
Domenico, Tramutola & Butterfield, 2017). Further possibilities are secreted phos-
pholipases and damage that could be directly inflicted by immune cells. Finally, the 
immune system could directly harm the membrane by means of the membrane at-
tack complex or perforin (Witte et al., 2019). Apparently when the plasma membrane 
is disrupted, internal lipid bilayers, such as the ER membrane, are also at risk. How-
ever, ER fragmentation was observable neither in stage 0 nor 1 axons. Only Stage 
2 axons regularly showed signs of a disrupted ER network. This finding should be 
interpreted with caution, since there could still be architectural ER alterations at the 
sub-microscopic level. Still, even if internal lipid bilayers were also affected, the 
amount of calcium sequestered in the ER would still not be capable of inducing the 
rise of cytoplasmic calcium observed in EAE as it was delineated above. 
5.2.2 Analysing the depletion ER calcium in traumatic axonal injury 
This thesis first described the occurrence of ER fragmentation in axons following 
traumatic mechanical injury. Previously, ER fragmentation in an in-vivo setting had 
only been observed in dendrites in response to cardiac arrest and ischemia 
(Kucharz et al., 2011b). Kurcharz et al. (2011b) have already described the reversi-
ble nature of the process of ER fragmentation, a finding which could also be repro-
duced for acute traumatic injury to ER of the spinal cord, albeit in only one exemplary 
experiment, which had, for reasons of temporal constraints, not been further pur-
sued by me. However, repetition of the proposed longitudinal experiment by Jonas 
Lehmitz in a total of five mice over a time course of 125 min post-contusion clearly 
demonstrated the reversibility of ER fragmentation following contusion injury (Figure 
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24). Here, the initial evaluation of microscopically visible fragmentation revealed ER 
fragmentation rates of ~80–90% immediately post-contusion, which gradually 
dropped to an ER fragmentation rate of ~60–70% after two hours of recovery. Trac-
ing single axons visually, over time, confirmed the occurrence of ER fragmentation 
recovery. The drop of ER calcium – ensuing spinal-cord contusion that could be 
established in this thesis – was again observed by Jonas Lehmitz. Importantly, like 
ER fragmentation, ER calcium recovered over the course of time. The drop of ER 
calcium was ubiquitous and independent of the ER fragmentation state. The homo-
geneity of the ER calcium depletion and fragmentation following a defined contusion 
injury indicates that these processes do not constitute a fate-determining axonal 
alteration, unlike the individual axonal cytoplasmic calcium increase observed by 
Williams et al. (2014). However, neither by laser transection nor by contusion ex-
periments could a threshold be reached, which would only lead to a decrease of ER 
calcium in only a subset of axons (while ER fragmentation was observed in the vast 
majority of axons and also only spared a few axons). Thus, a fate-tracing approach, 
as it had been applied by Williams et al. (2014), was neither feasible nor reasonable, 
since in order to elicit a sufficient ratio of degenerating axons, a sufficient force 
needs to be applied. One candidate for a fate-tracing experiment would, however, 
be a secondary depletion of ER calcium after initial recovery, which had only been 
observed in a small subset of axons (see chapter 4.2.2). Even if these events could 
be reproduced in a greater number, the question would still remain as to whether 
the second drop of ER calcium observed constitutes an important step of the de-
generation cascade or a mere epiphenomenon of axonal demise and energy failure. 
The latter can be deemed more likely, since the secondary drop of ER calcium has 
only been observed very late (after 120 minutes), while the cytoplasmic-calcium in-
crease happens almost instantaneously following axonal injury. Even if ER calcium 
release and ER fragmentation cannot be attributed to have a prominent role in the 
axonal degeneration cascade, the temporal variability observed can act as an im-
portant positive control to the TwitchER mouse line generated, since it can rule out 
that the observed changes of sensor ratios are merely artefactual – for example, 
due to the photo bleaching of one preferential FP or occlusion of only a portion of 
the signal by bleeding at the contusion site. Thus, the changes observed in ratio are 
most likely genuine, with the restrictions of genetically encoded calcium sensors 
discussed in chapter 4.1.2 applying. 
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5.3 Concluding remarks and outlook 
This thesis has yielded a novel transgenic mouse line, which allowed for the meas-
urement of intra-ER free calcium in vivo for the first time. This was achieved by 
targeting the expression of the genetically encoded ratiometric low-affinity calcium 
indicator Twitch2B 54 S+ to the neuronal endoplasmic reticulum. While G-CE-
PIA1ER has been successfully employed to measure ER calcium in murine slice 
cultures (Okubo et al., 2015), the intesiometric property of this sensor precluded its 
application for the 2-photon spinal cord in-vivo imaging technique ( Misgeld, Nikic & 
Kerschensteiner, 2007). By means of this novel transgenic mouseline, large calcium 
transients elicited by the SERCA inhibitor thapsigargin could be potently and reliably 
visualised in an in-vivo imaging setting. Changes of a similar extent were undetect-
able in a population-based analysis in EAE, which demonstrated that ER calcium 
 
Figure 24: ER calcium and fragmentation rate following spinal 
cord contusion 
(A) 2-photon in-vivo intensity projections (top: YFP channel, bottom: colour-coded 
YFP/CFP ratio) of the dorsal spinal funiculus of Thy1-TwitchER 481 mice before 
(left) and sequentially after (middle and right) contusion injury. (B) Graph displays 
the ER calcium levels before (Pre) and sequentially after contusion in black (mean 
minus standard deviation) and the corresponding ER fragmentation rate in red 
(mean plus standard deviation). Images acquired in 15 minutes intervals in n=5 
mice. (C) Respective YFP/CFP ratios separately displayed for axons with and with-
out overt ER fragmentation. Dark grey as mean plus and light grey as mean minus 
standard deviation. Scale bar in A = 25 μm. Figure adapted from and caption mod-
ified from Witte et al. (2019). Experimenter: Jonas Lehmitz. 
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dysregulation does not contribute to the process of focal axonal degeneration. How-
ever, in the paradigms of laser transection and spinal-cord contusion injury, a global 
axonal response of ER calcium release, in conjunction with the process of ER frag-
mentation in a large subset of axons, was observed. In the context of spinal-cord 
contusion, both ER fragmentation and ER calcium release were partially reversible 
over a time course of two hours (as it was later confirmed by my colleague Jonas 
Lehmitz). ER fragmentation following mechanical injury was a completely novel find-
ing. Furthermore, calcium imaging of the process of ER fragmentation had not been 
achieved before. It appears that ER calcium depletion often concurs with ER frag-
mentation; however, fragmented ER can also retain high calcium levels. Initial ER 
fragmentation and ER calcium depletion are not fate-determining factors in axonal 
degeneration, since they occur in the majority of axons in the paradigm of spinal-
cord contusion, of which only a small proportion are subject to later demise. Thus, 
changes of ER continuity and ER calcium content can be ruled out as main effectors 
of axonal degeneration in EAE, as well as traumatic axonal injury. Nonetheless, 
these dynamic changes of an organelle pose a to date largely unknown cellular re-
sponse mechanism that warrants further examination. Given the importance of the 
endoplasmic reticulum concerning ion homeostasis, cellular-stress responses and 
protein trafficking (Verkhratsky, 2005), a continuous or long-lasting disintegration of 
its structure might severely impair cellular function. Thus, an approach to monitor 
the differential capacity of single neurites to re-establish ER continuity over a time 
course of two hours or longer paired with a survival analysis appears promising. If 
ER fragmentation and subsequent ER fusion could be established as a fate-deter-
mining factor in long-term axonal survival, the recent work of Kucharz et al. (2018) 
could be of great interest. Kucharz et al. (2018) managed to shed light on the mo-
lecular mechanisms of ER fragmentation and fusion. Not only did they demonstrate 
that ER fission can be caused in vivo in the paradigm of cortical spreading depolar-
isation, but they also found that physiological stimuli, such as whisker stimulation, 
can evoke ER fission detectable by fluorescence recovery after photobleaching. ER 
fission coincided with a loss of synaptic activity and could be inhibited by pharma-
cological inhibition of N-methyl-D-aspartate receptors and by inhibition of the down-
stream effector of Ca2 + /calmodulin-dependent protein kinase II. ER fusion was, in 
turn, impaired by dynamin GTPases inhibition. 
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With emergent molecular insights into the process of ER fragmentation and fusion 
and the tools developed in this thesis for imaging ER structural and functional dy-
namics, exciting new avenues are opened for future research regarding the axo-
plasmic reticulum and its role in neurodegeneration. 
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